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$EVWUDFW 
The prevalence of cardiovascular disease is lower in premenopausal women 
compared to age-matched males and postmenopausal females. Differences in 
risk may be due to sex differences in endothelial function. Therefore, this 
thesis examined the effects of gender on endothelium-dependent 
vasorelaxation in porcine isolated coronary arteries (PCAs). Distal PCAs were 
studied under myographic conditions and pre-contracted with U46619. 
Concentration-response curves to bradykinin, an endothelium-dependent 
vasorelaxant, were constructed in the presence of various inhibitors. Inhibition 
of NO and prostanoid synthesis (EDH-type response) produced greater 
inhibition in males compared to females. Eliminating H2O2 using PEG-catalase 
significantly reduced the bradykinin-induced vasorelaxation in the absence, but 
not in the presence of L-NAME and indomethacin in females, and had no 
effect in males. Inhibition of JDS MXQFWLRQV ZLWK FDUEHQR[RORQH DQG Į-GA 
inhibited the EDH-type response in females but not in males. Inhibition of 
SKCa channels reduced the EDH-type response in PCAs from both sexes but 
inhibition of IKCa had an effect only in females but not males. Western blot did 
not detect any differences in the expression of Cx40, 43 or IKCa between sexes.  
H2O2 caused concentration-dependent vasorelaxations which were 
significantly inhibited by PEG-catalase, TEA, 60 mM K+ and 500 nM ouabain. 
Inhibition of NOS, cyclo-oxygenase, gap junctions, SKCa, IKCa, BKCa, Kir, KV, 
KATP, cGMP, Na+-Ca2+ exchanger or removal of endothelium had no effect on 
the H2O2-induced vasorelaxation. 1 mM H2O2 inhibited both KCl-induced 
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vasorelaxation and rubidium-uptake consistent with inhibition of the Na+/K+-
pump activity.  
The effects of the antioxidant Tiron® under different gassing conditions 
(95% O2/5% CO2 or 95% air/5% CO2) were investigated. The bradykinin-
induced vasorelaxations in PCAs were unaffected by different levels of 
oxygenation. Tiron® increased the potency of bradykinin only when gassed 
with 95% O2/5% CO2 and the enhancement in vasorelaxation was prevented 
by catalase. Similarly, Tiron® enhanced the EDH-type response when gassed 
with 95% O2/5% CO2 in PCAs from both sexes. Biochemical analysis using 
Amplex Red demonstrated that H2O2 ZDV JHQHUDWHG LQ .UHEV¶-Henseleit 
solution when gassed with 95% O2/5% CO2, but not with 95% air/5% CO2. 
Inhibition of Nox had no effect in PCAs from females but DPI, a non-
selective Nox inhibitor reduced the potency of the bradykinin-induced 
vasorelaxation in males. In the EDH-type responses, inhibition of Nox had no 
effect in females, but in males, ML-171 (a selective Nox inhibitor) and DPI 
enhances while VAS2870 (a selective Nox inhibitor) reduces the bradykinin-
induced vasorelaxation. ML-171 had no effect on the forskolin-induced 
vasorelaxation but decreased the potency of U46619-induced tone in both 
sexes in the absence or presence of endothelium. Nox activity was reduced by 
DPI and ML-171, but not VAS2870 in PCAs from both sexes. Sex differences 
in the functional study of Nox could be attributed to the differential expression 
of Nox proteins where expression of Nox1 and Nox2 were greater in males but 
Nox4 was greater in females. This may underlie the greater oxidative stress 
observed in males.  
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Bradykinin-induced EDH-type responses in PCAs from both sexes 
were essentially abolished by 2-APB (TRPC&TRPM antagonist). SKF96365 
(TRPC antagonist) inhibited the bradykinin-induced vasorelaxation in males, 
and EDH-type response in both sexes. Pyr3 (TRPC3 antagonist) inhibited both 
the NO and EDH components of the bradykinin-induced vasorelaxation in 
males, but not females. RN1734 (TRPV4 antagonist) reduced the potency of 
the NO component of the bradykinin-induced vasorelaxation in females only, 
but inhibited the EDH-type response in both sexes. 2-APB, SKF96365 and 
RN1734 all reduced the H2O2-induced vasorelaxation, whereas Pyr3 had no 
effect. No differences in expression level of TRPC3 and TRPV4 between sexes 
were detected using Western blot.  
 In conclusion, present study demonstrated clear sex differences in 
endothelial function in PCAs where H2O2, MEGJs, IKCa and TRPV4 channels 
play a role in the bradykinin-induced vasorelaxation only in female pigs while 
Nox-generated reactive oxygen species and TRPC3 channels play a role in the 
bradykinin-induced vasorelaxation only in male pigs. Therefore, gender-
specific drug treatment for cardiovascular disease may be a novel therapeutic 
strategy. 
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1.1 Introduction 
Regulation of the vascular tone plays an important role in maintaining blood 
pressure and flow. Increases in blood pressure can lead to cardiovascular 
diseases (CVDs) such as atherosclerosis, ischaemic heart disease, heart failure, 
renal damage and stroke. According to the British Heart Foundation, CVD is 
WKH 8.¶V ELJJHVW NLOOHU DQG DFFRXQWV IRU PRUH WKDQ 000 premature deaths 
annually (Scarborough et al., 2010). According to the European cardiovascular 
disease statistics, CVD causes more than 4 million deaths in Europe and more 
than 1.9 million deaths in the European Union each year (Nichols et al., 2012). 
It is estimated that the overall CVD cost the European Union economy nearly 
¼ELOOLRQ D\HDU(Nichols et al., 2012).  
In the coronary circulation, regulation of  vascular tone is controlled by 
endothelium-derived mediators such as endothelium-derived relaxing factors 
(EDRF), nitric oxide (NO) (Furchgott & Zawadzki, 1980; Palmer et al., 1987), 
prostacyclin (PGI2) (Dusting et al., 1977; Moncada et al., 1976) and 
endothelium-derived hyperpolarization-type (EDH) response (Feletou & 
Vanhoutte, 2013; Taylor & Weston, 1988). These endothelium-derived 
mediators are produced following increase in intracellular calcium upon 
stimulation by agonists such as bradykinin, acetylcholine (ACh) or shear stress 
(Griffith, 2004; Inagami et al., 1995). The release of NO and PGI2 will then 
activate guanylyl cyclase and adenylyl cyclase respectively causing an increase 
in the cGMP and cAMP levels in the vascular smooth muscle
 
followed by cell 
hyperpolarization and relaxation (Inagami et al., 1995) (Figure 1.2). 
Conversely, in pathological conditions such as diabetes, hypertension and 
aging, similar endothelium-dependent agonist including ACh, bradykinin or 
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shear stress stimulate the release of endothelium-derived contracting factors 
(EDCFs) causing vasoconstriction (Versari et al., 2009). Examples of EDCFs 
include endothelin, angiotensin II and cyclooxygenase-derived products 
thromboxane A2 and prostaglandin H2 (Versari et al., 2009).   
In the normal healthy vasculature, endothelial cells play an important 
role in maintaining vascular homeostasis (Figure 1.1). The significant role of 
endothelial function in regulation of vascular tone was first reported in 1980 by 
Furchgott and Zawadzki. Using rabbit isolated thoracic aorta , Furchgott and 
Zawadzki demonstrated that acetylcholine-induced vasorelaxation was 
endothelium-dependent and removal of the endothelial cells either 
mechanically or by collagenase essentially abolished the vasorelaxation 
(Furchgott & Zawadzki, 1980). A small contraction was uncovered at higher 
concentration of acetylcholine in the endothelium-denuded aorta (Furchgott & 
Zawadzki, 1980).  
 
Figure 1.1 Structure and composition of blood vessel. The innermost layer is 
made up of endothelial cells, followed by the internal elastic lamina and 
vascular smooth muscle cells. Figure adapted from Silverthorn & Johnson 
(2010).  
Endothelial cells 
Vascular smooth 
muscles cells 
Internal elastic lamina 
Fibrous tissue 
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At the time of discovery, it was hypothesized that the endothelium-
derived substance(s) induced by ACh acted directly on the vascular smooth 
muscle to produce vasorelaxation (Furchgott & Zawadzki, 1980). This 
endothelium-derived relaxing factor (EDRF) was later identified as nitric oxide 
(NO) (Palmer et al., 1987). Prostacyclin, a derivative of  arachidonic acid was 
first reported to inhibit platelet aggregation (Moncada et al., 1976). It was later 
confirmed by the same research group that the endogenous prostacyclin causes 
vasorelaxation in bovine coronary artery (Dusting et al., 1977).  
A third endothelium-derived mediator termed endothelium-derived 
hyperpolarizing factor (EDHF) was reported in the 1980s (Bolton et al., 1984; 
Taylor & Weston, 1988). In mesenteric arteries from guinea-pig, Bolton et al. 
(1984) demonstrated that carbachol produced a concentration-dependent 
hyperpolarization and proposed that the hyperpolarization is caused by a factor 
released from the endothelium. A later study defined EDHF responses as the 
remaining proportion of endothelium-dependent vasorelaxation which is 
independent of NO or prostacyclin (Taylor & Weston, 1988). Taylor & 
Weston (1988) described a clear difference between EDHF and EDRF where 
EDHF causes vascular smooth muscle relaxation through hyperpolarization of 
the cells with no changes in the cGMP or cAMP levels. Since the introduction 
of the term EDHF nearly three decades ago, many entities have then been 
proposed to be an EDHF (Campbell et al., 1996; Edwards et al., 1998; 
Edwards et al., 2010; Griffith, 2004; Shimokawa, 2010). However, it has now 
EHHQ DJUHHG WKDW WKH WHUP µ('+)¶ VKRXOG QR ORQJHU EH XVHG DQG WKH
endothelium-derived mediators which cause endothelium-dependent 
5 
 
hyperpolarization (EDH) should be indicated by their proper names such CNP, 
EETs, H2O2, H2S and CO (Feletou & Vanhoutte, 2013). 
 
1.2 The release and mechanism of action of Endothelium-Derived 
Hyperpolarization (EDH)-type responses 
A present view on the release of endothelium-derived hyperpolarization 
mediators within the endothelial cells and the responses of the vascular smooth 
muscle cells is summarised in Figure 1.2. Many endothelium-derived 
mediators have been proposed to be responsible for EDH-type responses over 
WKH SDVW GHFDGH \HW QRQH KDV DSSHDUHG WR EH D µXQLYHUVDO ('+¶ (Griffith, 
2004). In 2010, the EDH-mediated responses were classified into two 
categories (Edwards et al., 2010) 7KH ILUVW FDWHJRU\ LV WKH µFODVVLFDO¶ ('+
pathway in which an increase in intracellular Ca2+ concentration 
hyperpolarizes the endothelial cells leading to activation of the small (SKCa) 
and intermediate (IKCa) conductance Ca2+-activated potassium channels on 
endothelial cells (Busse et al., 2002; Edwards et al., 2010; Gluais et al., 
2005a). Activation of these potassium channels in turn hyperpolarizes the 
vascular smooth muscle either through the transfer of electrical signalling via 
myoendothelial gap junctions (MEGJs) (Chadha et al., 2011; Chaytor et al., 
2003; Chaytor et al., 1998; de Wit & Griffith, 2010; Edwards et al., 2000; 
Harris et al., 2000; Kenny et al., 2002b; Kerr et al., 2012; Sandow et al., 2002) 
or through efflux of K+ ions from endothelial SKCa and IKCa channels acting on 
barium-sensitive inwardly rectifying potassium channels (K ir) and the ouabain-
sensitive Na+/K+ ATPase pump respectively (Edwards et al., 1998; Edwards et 
al., 2010).  
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The second EDH-type pathway involves direct hyperpolarization of the 
vascular smooth muscle by endothelium-derived mediators including 
arachidonic acid derivatives (epoxyeicosatrienoic acids, EETs) (Campbell et 
al., 1996), C-type natriuretic peptide (CNP) (Chauhan et al., 2003; Wei et al., 
1994), hydrogen peroxide (H2O2) (Matoba et al., 2000; Shimokawa, 2010) and 
K+ ions (Edwards et al., 1998; Feletou & Vanhoutte, 2013). In most studies, 
the EDH-type response is defined as the remaining proportion of endothelium-
dependent vasorelaxation which are resistance to NO synthase and COX 
inhibition using pharmacological inhibitors L-NAME and indomethacin 
respectively (Beny & Schaad, 2000; Edwards et al., 2010; McCulloch et al., 
1997; Quignard et al., 1999; Senadheera et al., 2012).  
Emerging evidence has now shown that transient receptor potential 
(TRP) channels, expressed on both the endothelial cells and vascular smooth 
muscle cells play a role in regulation of vascular tone (Earley & Brayden, 
2010; Sukumaran et al., 2013). More specifically, TRPV4 channels from the 
vanilloid TRP subfamily and TRPC3 from the canonical TRP subfamily have 
been reported to play a role in NO- and EDH-mediated vasorelaxation (Bagher 
et al., 2012; Bubolz et al., 2012; Earley et al., 2009; Huang et al., 2011; 
Luksha et al., 2009; Senadheera et al., 2012; Zheng et al., 2013b). TRP 
channels are Ca2+-permeable cation channels which can be activated by shear 
stress, oxidative stress, light, temperature or chemical stimuli (Balzer et al., 
1999; Bari et al., 2009; Earley & Brayden, 2010; Yao & Garland, 2005). To 
date, 28 mammalian TRP isoforms have been identified and they have been 
divided into six subfamilies based on their protein sequence homology and 
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DNA: ankyrin TRPA, canonical TRPC, melastatin TRPM, mucoliptin 
TRPML, polycystin TRPP, vanilloid TRPV (Earley & Brayden, 2010). 
 
Figure 1.2 The release and mechanisms of action of endothelium-derived 
vasorelaxant in regulation of vascular tone.  Schematic diagram demonstrates 
potential pathways in nitric oxide (NO), prostacyclin (PGI2) and endothelium-
derived hyperpolarization (EDH)-mediated vasorelaxation involving transient 
receptor potential (TRP) channels, myoendothelial gap junction (MEGJ), 
calcium-activated potassium (KCa) channels, inwardly rectifying potassium 
(Kir) channels and sodium-potassium adenosine triphosphatase (3Na+/2K+ 
ATPase). Endothelium-derived K+ ions, epoxyeicosatrienoic acids (EET), C-
type natriuretic peptide (CNP) and hydrogen peroxide (H2O2) are some of the 
candidates that have been proposed to be factors for EDH-type mediated 
relaxation. Figure adapted from Shimokawa (2010) and Earley & Brayden 
(2010). 
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1.3 Factors for the EDH-type mediated responses 
1.3.1 C-type natriuretic peptide (CNP) 
C-type natriuretic peptide (CNP), a 22-amino-acid peptide is a vasodilator 
which has been reported to be expressed in human cultured aortic endothelial 
cells and is present in human plasma (Stingo et al., 1992). In patients with 
congestive heart failure, the urinary excretion of CNP has been reported to be 
three times higher than in healthy subjects with no differences detected in the 
plasma CNP levels between the two groups (Mattingly et al., 1994). 
 In porcine coronary arteries (PCAs), rat mesenteric arteries, human 
penile resistance arteries and human omental fat resistance arteries, CNP 
caused a concentration-dependent vasorelaxation which was attenuated by high 
potassium (Barton et al., 1998; Chauhan et al., 2003; Kun et al., 2008; Moyes 
et al., 2014; Wei et al., 1994). In previous studies using PCAs conducted by 
two different research groups, similar maximum relaxation to exogenously 
applied CNP have been reported (Barton et al., 1998; Wei et al., 1994). 
However, further studies using electrophysiological techniques led them to 
generate contradicting conclusions (Barton et al., 1998; Wei et al., 1994). Wei 
et al., (1994) was the first group to propose that CNP could be a factor for 
EDH-type responses on the basis that CNP hyperpolarizes porcine coronary 
smooth muscle cells, which was inhibited by the K+ channel inhibitor TEA, 
and that the CNP-induced vasorelaxation was charybdotoxin (calcium-
activated K+ channel inhibitor)-sensitive. However, in a later study in intact 
PCAs, due to the relatively smaller hyperpolarization and relaxation induced 
by CNP compared to bradykinin, Barton et al. (1998) concluded that CNP is 
unlikely to be a factor for EDH-type responses.   
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 In the Langendorff-perfused rat heart, CNP produced a concentration-
dependent decrease in perfusion pressure (Hobbs et al., 2004) which was 
sensitive to inhibition of NO synthase and blockade of KATP and BKCa channels 
(Brunner & Wolkart, 2001). Measurement of cGMP levels in the coronary 
effluent demonstrated that CNP produces a concentration-dependent increase 
in cGMP levels (Brunner & Wolkart, 2001). However, in the same study using 
rat isolated aorta, inhibition of NO synthase had no effect on the CNP-induced 
vasorelaxation, demonstrating that the mechanism of CNP-induced 
vasorelaxation differs between vascular bed (Brunner & Wolkart, 2001).  
In rat isolated mesenteric arteries, inhibition of the Kir and Na+/K+-
pump essentially abolished the ACh-, CNP- and cANF4-23 (a selective NPR-C 
agonist)-induced EDH-type vasorelaxation (Chauhan et al., 2003). This lead to 
their conclusion that CNP-induced vasorelaxation involved activation of the 
NPR-C receptor (Chauhan et al., 2003).  Later studies using the selective NPR-
C receptor antagonist, M372049 further confirmed that this receptor is 
involved in the CNP-induced vasorelaxation pathway (Hobbs et al., 2004; 
Villar et al., 2007). In the absence of NO and PGI2, HS-142-1, a selective 
NPR-A/B antagonist had no effect on the ACh- or CNP-induced 
vasorelaxation suggesting that NPR-A/B receptors are not involved in the 
CNP-induced vasorelaxation (Chauhan et al., 2003). CNP bioassay using 
effluent collected from rat isolated superior mesenteric arterial bed after 
perfusion with ACh (in the presence of L-NAME and indomethacin) 
demonstrated that, the EDH-type response involved the release of CNP 
(Chauhan et al., 2003). This was dependent on the endothelium and 
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myoendothelial gap junction communication (Chauhan et al., 2003; Hobbs et 
al., 2004).  
In endothelial cell CNP knock-out (ecCNP KO) mice or NPR-C 
receptor knock-out (NPR-C KO) mice, sex differences in the ACh-induced 
vasorelaxation in the absence or presence of L-NAME and indomethacin have 
been reported (Moyes et al., 2014). Moyes et al. (2014) reported a decrease in 
potency for ACh in the EDH-type response only in mesenteric arteries from 
female ecCNP KO and NPR-C KO mice but not males. Similarly, in the 
absence of L-NAME and indomethacin, there is a decrease in potency for 
ACh-induced vasorelaxation only in mesenteric arteries from female but not 
male ecCNP KO mice (Moyes et al., 2014). Their pharmacological response 
study corresponds with their in vivo study, where they have reported that in 
ecCNP KO mice with impaired endothelial function, there is a significant 
increase in mean arterial pressure in female but not male mice compared with 
their respective WT littermates (Moyes et al., 2014).    
In contrast to the studies described above, researchers from other 
laboratories using rat mesenteric arteries and guinea pig carotid arteries 
reported that CNP in unlikely to be a factor for EDH-type response on the 
basis that exogenously applied CNP only produce modest relaxation without 
hyperpolarization and the ACh-induced EDH-type response was insensitive to 
M372049, a selective NPR-C receptor antagonist (Dora et al., 2008; for a 
review see Garland & Dora, 2008; Leuranguer et al., 2008b).  
In human forearm resistance arteries, CNP has been reported to be a 
factor for EDH-type response as the CNP-induced concentration-dependent 
vasodilatation was abolished in the presence of a relatively low concentration 
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of TEA (0.5 mM)  (Honing et al., 2001), a concentration used to inhibit KCa 
channels. In human penile isolated resistance arteries, CNP produced an 
endothelium-independent hyperpolarization and concentration-dependent 
vasorelaxation which was sensitive to the blockade of the Na+/K+-pump, Kir, 
SKCa, IKCa and BKCa (Kun et al., 2008). Further studies using cANF4-23 as a 
selective NPR-C agonist resulted in concentration-dependent vasorelaxation, 
suggesting the presence of NPR-C receptors in these arteries (Kun et al., 
2008). In human resistance arteries from omental fat, the CNP-induced 
vasorelaxation in the presence of L-NAME and indomethacin were 
significantly attenuated in the presence of M372049, a selective NPR-C 
receptor antagonist (Moyes et al., 2014).  
 After more than two decades of studies on CNP, due to the conflicting 
results presented by different research groups using various species of study 
and different vascular bed, a direct comparison or a definitive role for CNP as 
a factor for EDH-type response is still not possible and remains to be 
determined in future studies (Luksha et al., 2009; Sandow & Tare, 2007). 
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1.3.2 Epoxyeicosatrienoic acids (EETs) 
Apart from prostacyclin, other metabolites of arachidonic acid (AA) produced 
by endothelial cells include epoxyeicosatrienoic acids (EETs) which are 
derived from the cytochrome P450-dependent pathways (Edwards et al., 2010; 
Rosolowsky & Campbell, 1993). These EETs consist of four different 
regioisomers including 5,6-EET; 8,9-EET; 11,12-EET and 14,15-EET and 
have been proposed to be factors for EHD-type responses (Figure 1.3)  
(Campbell et al., 1996; Weston et al., 2005). An early study on bovine 
coronary arteries demonstrated that AA  caused endothelium-dependent 
vasorelaxation (Rosolowsky & Campbell, 1993). Further work by the same 
group found that the relaxations to AA and EET were attenuated by the 
presence of high potassium, TEA and charybdotoxin leading to their 
conclusion that EET is a factor for EDH-type response (Campbell et al., 1996). 
 
 
 
 
 
 
 
 
 
Figure 1.3 Different cytochrome P450 metabolites of arachidonic acid 
including 5,6-EET; 8,9-EET; 11,12-EET and 14,15-EET that have been 
proposed to be a factor for EDH-mediated response. EET, epoxyeicosatrienoic 
acids. 
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Other studies have reported that 11,12-EET hyperpolarizes bovine, 
porcine and guinea-pig coronary smooth muscle cells (Campbell et al., 1996; 
Eckman et al., 1998; Edwards et al., 2000). In guinea-pig coronary arteries, the 
hyperpolarization and potency of the AA- and 11,12-EET-induced 
vasorelaxations were significantly reduced in the presence of iberiotoxin, 
indicating that the BKCa channels play a role in the EET-induced EDH-type 
response (Eckman et al., 1998). In porcine coronary smooth muscle cells, 
hyperpolarization to 11,12-EET was essentially abolished in the presence of 
iberiotoxin (Edwards et al., 2000). Using selective EET antagonists, Weston et 
al, (2005) reported that in PCAs, bradykinin-induced EET release involved 
ERWK WKH µFODVVLFDO¶ ('+-type response (activation of endothelial SKCa and 
IKCa) and activation of the iberiotoxin-sensitive BKCa channels.  
In mouse isolated mesenteric arteries, the effects of 11,12-EET-induced 
vasorelaxation and hyperpolarization were both endothelium-dependent and ±
independent (Earley et al., 2009). These vasorelaxant and hyperpolarization 
responses were significantly reduced when either both SKCa and IKCa channels 
were blocked together or when BKCa was blocked (Earley et al., 2009). When 
all three KCa channels were blocked, the 11,12-EET-induced hyperpolarization 
was completely abolished, whereas the vasorelaxation was nearly abolished 
(Earley et al., 2009). In human isolated coronary arterioles (HCAs), the 
presence of both SKCa and IKCa inhibitors significant reduced the AA-induced 
vasorelaxation (Zheng et al., 2013b). The AA-induced vasorelaxation was 
essentially abolished in the presence of high potassium, indicating that in 
HCAs, the AA-induced vasorelaxation involved the EDH-type response 
(Miura & Gutterman, 1998; Zheng et al., 2013b).  
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1.3.3 Hydrogen Peroxide (H2O2) 
Hydrogen peroxide (H2O2) is one of the many reactive oxygen species (ROS) 
generated within the endothelium following stimulation by agonists such as 
acetylcholine and bradykinin or stimuli such as shear stress (Matoba et al., 
2003; Matoba et al., 2000; Miura et al., 2003). Other ROS generated within the 
endothelium include nitric oxide (NO), peroxynitrite (ONOO -), superoxide 
anions (O2-) and hydroxyl radicals (OH-) (Brandes & Mugge, 1997; Edwards et 
al., 2010; Gryglewski et al., 1986; Shimokawa, 2010).  The precursor of H2O2, 
superoxide anions, can be generated within the endothelium from sources such 
as eNOS, NADPH oxidases (Nox), xanthine oxidase, cyclooxygenases, 
lipoxygenases, CYP450 epoxygenases and mitochondria (Edwards et al., 
2010; Shimokawa & Morikawa, 2005). Through uncoupling of eNOS, 
superoxide anions can be generated as by-product from the catalysis of L-
arginine to NO (Figure 1.2) (Matoba et al., 2000). The generated superoxide 
anions can then form H2O2 either by spontaneous dismutation or catalysed by 
superoxide dismutase (SOD) (Faraci & Didion, 2004). Alternatively, 
superoxide can also react with endothelial NO to form ONOO - (Figure 1.2) 
(Gryglewski et al., 1986). Therefore, the second major function of SOD is to 
prolong the half-life of NO protecting NO and NO-mediated signalling in the 
blood vessels (Faraci & Didion, 2004; MacKenzie et al., 1999; Shimokawa, 
2010).  
In tissues, another significant source of intracellular ROS is the 
NADPH oxidase enzymes where superoxide anions are formed through 
reduction of O2 using NADPH or NADH as an electron donor (Chen et al., 
2012; Paravicini & Touyz, 2008). To date, seven different Nox isoforms have 
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been identified including Nox1-5, Duox1 and Duox2 (Paravicini & Touyz, 
2008), but within the vasculature, only Nox1, Nox2, Nox4 and Nox5 isoforms 
have been reported to be involved in many cardiovascular diseases such as 
hypertension, atherosclerosis, stroke, diabetes  and ischaemia-reperfusion 
damage (Kleinschnitz et al., 2010; Paravicini & Touyz, 2008; Streeter et al., 
2013; Wingler et al., 2011).  
In rat aortic smooth muscle cells, it has been shown that Nox1 produces 
primarily superoxide, while Nox4 produces mainly H2O2 (Dikalov et al., 
2008). In transgenic mice overexpressed with endothelial Nox4, a significantly 
higher amount of H2O2 has been detected in the aortic homogenates compared 
to the control (Ray et al., 2011). The blood pressures in the Nox4 
overexpressed mice were significantly lower compared to the WT before and 
after chronic treatment of angiotensin II (1.1 mg/kg/day)  (Ray et al., 2011). In 
experiments using isolated aortae, the ACh-induced vasorelaxation was 
enhanced in the Nox4 overexpressed transgenic mice compared to the WT 
littermate mice and the enhancement was abolished by catalase, indicating that 
the enhancement is attributed to H2O2 (Ray et al., 2011). Hence, these authors 
concluded that the increase in endothelial Nox4 activity may provide beneficial 
effects to the vascular tone as opposed to the functional effects of Nox1 and 
Nox2 (Ray et al., 2011).  
In a different study, a higher level of Nox4 proteins has been detected 
in ischaemic brain samples taken from stroke patients and mice (Kleinschnitz 
et al., 2010). In this study, Kleinschnitz et. al. (2010)  reported that 
pharmacological inhibition with the NADPH oxidase inhibitor, VAS2870, but 
not apocynin, given in vivo 2 h and 12 h post-stroke mimicked the 
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neuroprotective effects observed in Nox4 knock-out mice where the ROS 
formation and brain infarct volume were reduced with significant improvement 
in neurological function (Kleinschnitz et al., 2010). Given the fact that whilst 
endothelial Nox4 overexpressed mice provide beneficial effects on the vascular 
tone (Ray et al., 2011), the same Nox isoform, Nox4, seems to be the major 
source of oxidative stress after acute stroke, having a detrimental effect in the 
brain (Kleinschnitz et al., 2010). Therefore, the role of Nox4 generated H2O2 
within the vasculature may provide contradictory effects depending on the 
experimental conditions and vascular beds (Kleinschnitz et al., 2010; Streeter 
et al., 2013).  
H2O2 was first reported to hyperpolarize smooth muscle cells and 
produce concentration-dependent vasorelaxation in PCAs in 1991 (Beny & 
von der Weid, 1991). However, due to the lack of effect to bradykinin and 
substance P-induced endothelium-dependent hyperpolarization in the presence 
of catalase, Bény and van der Weid concluded that the EDH-type response 
induced by bradykinin or substance P and H2O2 may be of two different 
entities (Beny & von der Weid, 1991). A later study in rabbit iliac arteries 
similarly reported that catalase had no effect on the ACh- and A23187-induced 
hyperpolarization, but significantly inhibited the vasorelaxation to both 
compounds, leading  the authors to conclude that, endogenous H2O2 is not a 
hyperpolarizing factor, but is a relaxing factor (Chaytor et al., 2003). Further 
studies in various vascular beds, including porcine and human coronary 
arterioles, human and murine mesenteric arteries and murine aortae, H2O2 has 
been reported to act as a vasodilator (Beny & von der Weid, 1991; Liu et al., 
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2011; Matoba et al., 2002; Matoba et al., 2003; Miura et al., 2003; Ohashi et 
al., 2012).  
Early studies in bovine isolated pulmonary arteries and PCAs reported 
that H2O2±induced endothelium-independent vasorelaxation through activation 
of soluble guanylyl cyclase producing cGMP (Burke & Wolin, 1987; 
Hayabuchi et al., 1998). However, a study from a different group failed to 
demonstrate the involvement of cGMP in the H2O2-induced response in PCAs 
(Barlow & White, 1998). Instead they have reported that H2O2-induced 
hyperpolarization and relaxation through potassium channels and large 
conductance calcium-activated K+ channels (BKCa) (Barlow & White, 1998). 
Other studies in human coronary arterioles and PCAs similarly reported that 
BKCa channels play a role in the H2O2-induced vasorelaxation (Hayabuchi et 
al., 1998; Liu et al., 2011; Miura et al., 2003). However, this observation was 
not universal as studies from other laboratories reported that inhibition of BKCa 
channels had no effect on the H2O2-induced vasorelaxation in mouse 
mesenteric arteries (Ellis et al., 2003; Matoba et al., 2000). Nonetheless, 
studies in a variety of different vessels including PCAs, murine mesenteric 
arteries and aortae, human mesenteric arteries and coronary arterioles and 
canine coronary arteries all came to the same conclusion that K+ channels play 
a role in the H2O2-induced response as the H2O2-induced vasorelaxation was 
sensitive to high potassium and/or tetrabutylammonium (Ellis et al., 2003; 
Matoba et al., 2002; Matoba et al., 2003; Matoba et al., 2000; Miura et al., 
2003; Ohashi et al., 2012; Rogers et al., 2006; Thengchaisri & Kuo, 2003). In 
small mesenteric arteries from mice, Matoba et al. (2000) reported that the 
ACh±induced EDH-type response was sensitive to catalase and the formation 
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of endothelial H2O2 was detected using confocal microscope with 
dichlorodihydrofluorescein diacetate (DCF) dye. Therefore, they concluded 
that H2O2 is a factor for EDH-type response in murine small mesenteric arteries 
(Matoba et al., 2000). Similarly in porcine coronary microvessels, Matoba and 
colleagues have provided further evidence that H2O2 acts as a factor for EDH-
type response by demonstrating that bradykinin-induced EDH-type 
vasorelaxation is sensitive to catalase and the production of endothelial H2O2 
was detected using electron spin resonance method (Matoba et al., 2003). They 
have also reported that exogenous H2O2 hyperpolarizes and relaxes vascular 
smooth muscle through K+ channels (Matoba et al., 2003). In human coronary 
arterioles, endogenous H2O2 induced by shear stress have been reported to be a 
factor for EDH-type response (Miura et al., 2003).  
Conversely, a study from another laboratory using small mesenteric 
arteries isolated from WT or type II diabetic mice failed to demonstrate that 
H2O2 plays a role in the ACh-induced EDH-type vasorelaxation (Ellis et al., 
2003). In the same arteries, although the H2O2-induced vasorelaxation was 
abolished by high potassium (60 mM), inhibition of the Na+/K+-ATPase, Kir, 
Kv or the KCa channels had no effects on the H2O2-induced vasorelaxation 
(Ellis et al., 2003). This is in contrast with other studies where, in human 
coronary arterioles, the H2O2-induced vasorelaxation was sensitive to apamin 
(SKCa channel inhibitor) and charybdotoxin (Miura et al., 2003), while in rat 
and canine coronary arteries, the H2O2-induced vasorelaxation was sensitive to 
4-aminopyridine (Kv channel blocker) (Rogers et al., 2006). Hence, it is 
possible that the response to H2O2 may vary between species, vascular beds 
and experimental conditions (Edwards et al., 2010; Thakali et al., 2006). 
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1.3.4 Potassium (K+) ions, Calcium-activated Potassium (KCa) Channels 
and Transient Receptor Potential (TRP) Channels 
$V GHVFULEHG DERYH LQ WKH µFODVVLFDO¶ ('+ SDWKZD\ DFWLYDWLRQ RI WKH
endothelial SKCa and IKCa channels causes efflux of K+ ions into the 
extracellular space (Figure 1.4) (Edwards et al., 1998; Edwards & Weston, 
2004; Weston et al., 2005). In rat hepatic arteries, the concentration of K+ 
detected in the myoendothelial space was raised to ~6 mM in ACh (10 µM)-
induced hyperpolarization (Edwards et al., 1998). In these vessels, the increase 
in K+ concentration in the myoendothelial space is abolished in the presence of 
apamin plus charybdotoxin, inhibitors of the SKCa, IKCa and BKCa channels 
(Edwards et al., 1998). In endothelial cells from PCA, hyperpolarization 
induced by bradykinin (in the presence of L-NAME and indomethacin) was 
significantly inhibited by TRAM-39 and apamin, inhibitors of the IKCa and 
SKCa channels respectively (Weston et al., 2005). This residual 
hyperpolarization was completely abolished in the additional presence of 
iberiotoxin, an inhibitor of the BKCa channel, indicating that all three channels 
are involved in the EDH-type response (Weston et al., 2005).  
In human coronary arterioles, flow-induced vasodilatation and 
hyperpolarization were abolished in the presence charybdotoxin suggesting 
that KCa channels play a role in the shear stress-induced endothelium-
dependent vasorelaxation (Miura et al., 2001). 
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Figure 1.4 Hypothesized schematic diagram of the EDH-type mediated 
vasorelaxation signalling at the myoendothelial contact sites involving 
endothelial cell projections through internal elastic lamina (IEL). Senadheera 
et al. (2012) reported that in rat mesenteric artery, TRPC3 channels, 
intermediate-conductance calcium-activated potassium channels (IKCa), gap 
junction connexins and 1,4,5-triphosphate receptor (IP3R) occur in close 
proximity within the endothelial cell projections. Ca2+ influx from TRPC3 
channels or Ca2+ release from IP3-sensitive stores activates endothelial SKCa 
and IKCa channels, followed by K+ efflux and activation of Kir and Na+/K+ 
ATPases on the vascular smooth muscle. TRPV4 channels have also been 
shown to play a role in endothelium-dependent vasorelaxation. Figure adapted 
from Edwards et al. (2010) and Senadheera et al. (2012). 
 
The efflux of K+ ions from the endothelium will, in turn, activate the 
Na+/K+-ATPase pump and Kir channels on the vascular smooth muscle leading 
to hyperpolarization and relaxation of the smooth muscle (Edwards et al., 
1998). In rat hepatic and mesenteric arteries, Edwards et al. (1998) reported 
that extracellular K+ mimics the effect of EDH-type response, hyperpolarizing 
and relaxing vascular smooth muscle. These EDH-type responses were 
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abolished by the presence of ouabain (Na+/K+-ATPase inhibitor) and barium 
(Kir channel blocker) leading to their conclusion that K+ is likely to be factor 
for EDH-type response via activation of the Na+/K+-ATPase and Kir channels 
(Edwards et al., 1998). This conclusion was further supported by studies 
conducted on other vascular beds including human thyroid arteries, rat middle 
cerebral arteries and PCAs (Beny & Schaad, 2000; McNeish et al., 2005; 
Torondel et al., 2004). However, studies from other laboratories using rat 
hepatic arteries, human subcutaneous arteries, PCAs, guinea-pig carotid and 
coronary arteries reported that K+ is unlikely to be a factor for EDH-type 
responses and that ouabain and/or barium had no effect on the ACh- or 
bradykinin-induced hyperpolarization (Coleman et al., 2001; Quignard et al., 
1999). This leads to the proposal that in vessels where activation of the 
Na+/K+-ATPase and Kir channels were not involved, electronic signalling were 
transferred from the endothelial cells to the smooth muscle cells via gap 
junctions (Figure 1.4) (Chaytor et al., 2003; Edwards et al., 2000; for a review 
see Griffith, 2004; Harris et al., 2000).  Further details about the involvement 
of gap junctions in EDH-mediated responses will be discussed later (Section 
1.3.5). 
As mentioned briefly in Section 1.2, studies have now provided 
evidence that TRP channels play a role in regulation of vascular tone (Earley & 
Brayden, 2010; Sukumaran et al., 2013). In murine isolated mesenteric 
arteries, the vasorelaxation and hyperpolarization of the EDH-type response 
induced by ACh were significantly reduced (~75%) in TRPV4 knockout mice 
compared to the WT mice (Earley et al., 2009). Furthermore, this group of 
researchers demonstrated that the 11,12-EET-induced vasorelaxation and 
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hyperpolarization were completely abolished in TRPV4 KO mice compared to 
the control (Earley et al., 2009). In human isolated coronary arterioles (HCAs), 
AA-induced vasorelaxation was significantly reduced in the presence of 
RN1734, a selective TRPV4 antagonist (Zheng et al., 2013b). Whereas, in 
TRPV4 overexpressed HCAECs, all four of the different AA metabolites; 5,6-
EET; 8,9-EET; 11,12-EET and 14,15-EET were less potent than AA in 
activation of TRPV4 channels (Zheng et al., 2013b).  
In rat mesenteric artery endothelial cells, physical and functional 
interaction between TRPV4 and SKCa channels have been reported (Ma et al., 
2013). Using inhibitors of the TRPV4 and SKCa channels, RN1734 and apamin 
respectively, Ma et al. (2013) demonstrated that the membrane potential and 
relaxation to ACh in rat isolated mesenteric arteries were significantly 
attenuated. Both inhibitors have been shown to reduce the local blood flow in 
ex vivo PHVHQWHULF DUWHULDO EHG LQGXFHG E\ Į-PDD (activator of TRPV4 
channels) and ACh (Ma et al., 2013).  This group of researchers also reported 
that the BKCa channels expressed in the vascular smooth muscle cells isolated 
from rat aortae are physically associated with TRPC1 channels where influx of 
Ca2+ through TRPC1 activates BKCa which then leads to membrane 
hyperpolarization (Kwan et al., 2009).  
A different study has reported that TRPC3 channels are involved in 
endothelial NO release in PCAs (Huang et al., 2011). In rat mesenteric arteries, 
blocking SKCa, IKCa or TRPC3 channel individually using pharmacological 
inhibitors significantly reduced the ACh-induced, EDH-type vasorelaxation 
(Senadheera et al., 2012). The residual relaxation was completely abolished in 
the presence of either a combination of  SKCa and TRPC3 channel antagonists 
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or a combination of  IKCa and TRPC3 channel antagonists (Senadheera et al., 
2012). Immunohistochemical studies have demonstrated that ~73% of these 
TRPC3 channels are expressed in the internal elastic lamina (IEL) hole sites 
with about three-fold higher frequency than the expression of myoendothelial 
gap junctions (MEGJs)  (Figure 1.4) (Senadheera et al., 2012). Therefore, the 
authors concluded that in rat mesenteric artery, Ca2+ influx through TRPC3 
channels facilitates EDH-type response through activation of endothelial SKCa 
and IKCa channels.  
A different study conducted by the same research group comparing 
isolated third order uterine radial arteries from pregnant rats with age-matched 
non-pregnant rats reported that the EDH-type activity is enhanced in vessels 
from pregnant rats (Senadheera et al., 2013). These authors suggested that the 
increase in EDH-type activity in vessels from pregnant rats could be related to 
the increase in expression and activity of TRPV4 channels (Senadheera et al., 
2013). However, a reduction in the incidence of MEGJs in pregnant rats was 
also reported (Senadheera et al., 2013). As opposed to rat cremaster arterioles 
where TRPV4 channels and IKCa channels have been reported to cluster within 
the endothelial cell projection microdomain (Bagher et al., 2012), TRPV4 
channels in radial arteries from both pregnant or non-pregnant rats were not 
expressed near the IEL (Senadheera et al., 2013). Therefore, the roles of TRP 
or KCa channels may vary between species and vascular bed under study.  
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1.3.5 Myoendothelial Gap Junctions (MEGJs) 
As previously mentioned  (Section 1.2), increases in intracellular calcium in 
the endothelium activate endothelial SKCa and IKCa channels which in turn 
hyperpolarize VSMCs either through release of K+ ions from these channel 
leading to  activation of VSMCs Kir channel and ouabain-sensitive Na+/K+ 
ATPase pump (Edwards et al., 1998; Edwards et al., 2010) or through 
electrical signalling via myoendothelial gap junctions (de Wit & Griffith, 
2010; Edwards et al., 2010). Gap junctions have been reported to facilitate 
communication between endothelial cells, between VSMCs and between 
endothelial cells and VSMCs (Edwards et al., 2010). 
Gap junctions are made up of two docking hemichannels or connexons 
which allow passage of small molecules or second messenger of less than 1 
kDa to diffuse through (de Wit & Griffith, 2010; van Kempen & Jongsma, 
1999). Each connexon is composed of six connexins (Cx), transmembrane 
proteins. Within the vasculature, expression of Cx37, Cx40, Cx43 and Cx45 
subunits has been detected in the endothelial and/or VSMCs (Chaytor et al., 
2003; Hill et al., 2002; Kerr et al., 2012; Lang et al., 2007; Luksha et al., 2009; 
van Kempen & Jongsma, 1999). However, the expression and distribution of 
different connexin proteins varies between vascular bed and species of studied 
(Hill et al., 2002; Luksha et al., 2009; van Kempen & Jongsma, 1999). Hill et 
al. (2002) reported that the number of MEGJs increased with decreasing vessel 
size in rat mesenteric arteries, while Sandow et al. (2002) detected MEGJs in 
rat mesenteric arteries but not femoral arteries.  
In functional studies, non-VHOHFWLYH JDS MXQFWLRQ LQKLELWRUV Į-
glycyrrhetinic acid, carbenoxolone and palmitoleic acid have been reported to 
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inhibit the endothelium-dependent, EDH-type vasorelaxation in rat isolated 
mesenteric arterial bed, human myometrial arteries, omental arteries and veins 
isolated from pregnant women, suggesting that gap junctional communications 
play a role in the EDH-type response (Hammond et al., 2011; Harris et al., 
2000; Kenny et al., 2002b). Similarly, in PCAs, Gap 27, a connexin mimetic 
peptide, significantly reduced the substance P- and bradykinin-induced 
hyperpolarization demonstrating the involvement of gap junctional 
communication in the EDH-type response (Edwards et al., 2000). 
A different study using different Cx-mimetic peptide 37,43Gap27, 
40Gap27 and 43Gap26 to disrupt intercellular communication by targeting 
Cx37, Cx40 and Cx43 of the MEGJs in rabbit isolated iliac arteries 
demonstrated these peptides had no effect on the A23187-induced EDH-type 
vasorelaxation when used alone (Chaytor et al., 2003). However, in the 
presence of all three peptides in combination, the potency of A23187-induced 
EDH-type response was significantly reduced confirming that more than one 
Cx subtype are involved in the gap junctional communications (Chaytor et al., 
2003; Luksha et al., 2009). Furthermore, the presence of all three peptides in 
combination abolished the ACh- and A23187-induced hyperpolarization 
(Chaytor et al., 2003). Similarly, the presence of all three peptides essentially 
abolished the bradykinin-induced EDH-type vasorelaxation in resistance 
arteries isolated from subcutaneous fat of healthy pregnant women (Lang et al., 
2007). In addition, immunohistochemistry confirmed the expression of Cx37, 
Cx40 and Cx43 proteins in resistance arteries isolated from subcutaneous fat of 
healthy pregnant women (Lang et al., 2007), omental arteries and veins 
isolated from healthy pregnant women (Hammond et al., 2011) and in iliac 
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arteries isolated from rabbit (Chaytor et al., 2003).  Interestingly, in the 
presence of all three Cx-mimetic peptides, the additional presence of catalase 
abolished the A23187-induced vasorelaxation in resistance arteries isolated 
from subcutaneous fat of healthy pregnant women (Lang et al., 2007). In a 
different study, the presence of carbenoxolone and catalase produced a greater 
inhibition compared to when used alone in bradykinin-induced EDH-type 
response in omental arteries and veins isolated from healthy pregnant women 
(Hammond et al., 2011). These authors proposed that gap junctional 
communication and endogenous H2O2 compensate each other in the EDH-type 
response (Hammond et al., 2011).  
As mentioned in Section 1.3.4, MEGJs have been reported to cluster in 
the endothelial cell projection within the internal elastic lamina space (IEL) 
(Figure 1.4) (Kerr et al., 2012; Sandow et al., 2002). In rat mesenteric arteries, 
studies have demonstrated that endothelial IKCa channels and Na+/K+-ATPase 
are highly expressed in the endothelial cell projections and are co-localised 
with MEGJs specifically Cx37 and Cx40 proteins (Dora et al., 2008; Sandow 
et al., 2006). Similarly, endothelial IKCa channels and Cx37 proteins were 
detected within the IEL which corresponds with the functional study where 
presence of carbenoxolone and TRAM-34 essentially abolished the 
bradykinin-induced EDH-type response in human mesenteric arteries (Chadha 
et al., 2011). See Section 1.3.4 for discussion on interactions between MEGJs 
and TRP channels. 
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1.4 Physiological relevance of EDH-type responses 
In the vasculature, endothelial cells play an important role in maintaining 
vascular homeostasis, exerting both vasodilatation and vasoconstrictor effects 
on the VSMCs to control blood pressure (Durand & Gutterman, 2013). The 
EDH-type responses have been reported to play a role under physiological 
FRQGLWLRQV HLWKHU LQ KHDOWK RU LQ GLVHDVH DFWLQJ DV D µEDFN-XS¶ V\VWHP IRU 12
see Section 1.6) (Durand & Gutterman, 2013; McCulloch et al., 1997; Yang et 
al., 2007). In humans, the contribution of different types of endothelium-
derived vasodilators varies with age and under certain physiological conditions 
such as pregnancy (Al-Shaer et al., 2006; Durand & Gutterman, 2013; Miura 
et al., 2001; Yang et al., 2007).  
A preliminary study of flow-induced vasodilatation in human isolated 
coronary microvessels from different age groups demonstrated that in vessels 
isolated from children (age 0-18) vasodilatation was mainly mediated by 
prostaglandins, and the contribution of prostaglandin reduces with age as the 
role of NO increases (Zinkevich et al., 2010). However, in disease, human 
coronary arterioles isolated from adults with coronary artery disease showed a 
reduction in the flow-induced vasodilatation with an increase in EDH-type 
responses to compensate the loss of NO (Miura et al., 2001). A later study 
conducted by the same research group reported that endothelium-dependent 
H2O2 plays a role in the flow-induced vasodilatation in human coronary 
arterioles from patients with heart disease (Miura et al., 2003). 
In vascular responses measuring forearm blood flow of healthy human 
subjects, ACh-induced vasodilatation was significantly lower in elderly 
subjects compared to young subjects and the reduction in vasodilatation was 
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attributed to the loss of NO (Al-Shaer et al., 2006). In addition to that, a 
reduction in the human forearm blood flow to an endothelium-independent 
vasodilator, sodium nitroprusside was reported in healthy elderly subject 
compared to the young subjects suggesting that vascular dysfunction occurred 
with the aging process (Al-Shaer et al., 2006).  
 The other physiological condition which alters the contribution of 
endothelium-dependent vasorelaxation is during pregnancy (Yang et al., 
2007). A previous study demonstrated an enhancement in the bradykinin-
induced vasorelaxation in resistance arteries from normotensive pregnant 
women compared to non-pregnant women (Knock & Poston, 1996). In the 
presence of NO synthase inhibitor, no differences between both groups were 
detected in the bradykinin-induced vasorelaxation suggesting a greater role for 
NO in resistance arteries from pregnant women (Knock & Poston, 1996). In 
isolated resistance arteries from women with pre-eclampsia, the bradykinin-
induced vasorelaxation was significantly reduced compared to women with 
normotensive pregnancy (Knock & Poston, 1996). The presence of NO 
synthase inhibitor further reduced the bradykinin-induced vasorelaxation in 
arteries from women with pre-eclampsia, with a greater reduction in the 
endothelium-dependent vasorelaxation compared to arteries from 
normotensive pregnancy (Knock & Poston, 1996). A different study in human 
isolated myometrial arteries from women with normotensive pregnancy 
demonstrated that gap junctional communications play a role in the EDH-type 
response (Kenny et al., 2002b) with a greater EDH-type responses compared 
to non-pregnant women and in pre-eclampsia (Kenny et al., 2002a).  
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1.5 Sex differences in the EDH-type responses  
Studies have reported that the cardiovascular risk in premenopausal women is 
significantly lower compared to age-matched men or postmenopausal women 
and sex differences in vascular function have been suggested for the 
differences in risk (Lerner & Kannel, 1986; McCulloch & Randall, 1998; 
Villar et al., 2008). Previous studies in rat isolated mesenteric arteries and in 
mesenteric arterial bed have demonstrated a greater EDH-type response in 
females compared to males (McCulloch & Randall, 1998; White et al., 2000). 
This was further confirmed by a study using eNOS and COX-1 double 
knockout mice, where the mean arterial pressure in females was unaffected 
whereas in males there was a significant increase in the blood pressure 
compared to the WT control (Scotland et al., 2005). Similarly, in pressurised 
rat isolated mesenteric arteries, a greater ACh-induced EDH-type response was 
observed in females compared to males and the enhancement in EDH-type 
response in females was attributed to the apamin-sensitive SKCa channels 
(White et al., 2000).  
Sex differences in the EDH-type response in the vasculature have been 
implicated with the sex hormone, oestrogen which has been shown to exert a 
cardioprotective effect (Gilligan et al., 1994; Tagawa et al., 1997; Villar et al., 
2008). A previous study in PCAs reported that 18-22 h incubation with ȕ-
estradiol significantly enhanced endothelium-dependent, A23187-induced 
vasorelaxation in female and castrated male pigs (Bell et al., 1995). Similarly 
in rat mesenteric arteries, A23187-induced EDH-type vasorelaxation and 
hyperpolarization were essentially abolished in ovariectomised female rats and 
WKH UHVSRQVHV ZHUH UHVWRUHG LQ ȕ-estradiol treated rats (Liu et al., 2002). 
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)XUWKHU VWXGLHV XVLQJ WKH JDS MXQFWLRQ LQKLELWRU Į-GA have demonstrated 
that the impairment in the EDH-type responses in ovariectomised rats were 
associated with the loss of gap junction communication with a significant 
reduction in expression of connexin 43 proteins (Liu et al., 2002). In forearm 
EORRG IORZ UHVSRQVHV RI SRVWPHQRSDXVDO ZRPHQ DFXWH WUHDWPHQW ZLWK ȕ-
estradiol enhanced the endothelium-dependent, ACh-induced vasodilatation 
(Gilligan et al., 1994; Tagawa et al., 1997).  
 ,Q 3&$V IURP IHPDOH SLJV LQFXEDWLRQ ZLWK ȕ-estradiol for 24 h 
significantly reduced superoxide anion production measured using lucigenin-
enhanced chemiluminescence technique (Cox et al., 2005). Therefore, another 
possibility which may contribute to sex differences in the vascular function is 
the oxidative stress level in the vasculature. In rat isolated aortae with intact 
endothelium, a higher superoxide level was detected in blood vessels from 
males compared to females (Brandes & Mugge, 1997; Kerr et al., 1999). This 
conclusion was further supported by a study conducted on human subjects 
where a greater oxidative stress has been reported in healthy young men 
compared to premenopausal women (Ide et al., 2002). 
Studies in diabetic or hypertensive animals similarly reported sex 
differences in endothelial function (Han et al., 2014; Loria et al., 2014). For 
instance, in mesenteric arteries and thoracic aortae from streptozotocin (STZ)-
induced diabetic rats, both males and females demonstrated impairment in the 
endothelium-dependent vasorelaxation compared to their age-matched controls 
(Han et al., 2014; Zhang et al., 2012b). However, after 8 weeks of STZ 
treatment, the impairment of the endothelium-dependent vasorelaxation in the 
mesenteric arteries were greater in females compared to males and this was 
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attributed to the shift in the relative contribution of EDH-type responses to 
NO-mediated responses in both sexes (Zhang et al., 2012b).  
In spontaneously hypertensive rats (SHRs), the ACh-induced 
vasorelaxation was significantly reduced in aortae from male animals 
compared to the WKY control whereas in females, no differences in the 
endothelium-dependent vasorelaxation were detected between the SHRs 
compared to the WKY control (Loria et al., 2014). However, differences in the 
functional response between SHRs and WKY in males cannot be explained by 
the expression and activity of the NOS proteins as a higher expression level of 
NOS3 proteins has been detected in aortae from the SHRs and no differences 
in the NOS activity was detected (Loria et al., 2014). These authors suggested 
that the reduction in the endothelium-dependent vasorelaxation in aortae from 
male SHRs could be related to the increased production of ROS which reduces 
the bioavailability of NO (Loria et al., 2014). On the other hand, in small 
mesenteric arteries, an increased in ACh-induced NO production was reported 
in SHRs from both sexes compared to the WKY control (Loria et al., 2014).  
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1.6 EDH-type responses and cardiovascular diseases 
In cardiovascular diseases, endothelial dysfunction has been reported, where 
the release of NO is compromised (Angulo et al., 2003; Feletou & Vanhoutte, 
2009; Gilligan et al., 1994). In many studies, EDH-type response has been 
proposed to be enhanced in diseases DFWLQJ DV D µEDFN XS¶ V\VWHP WR
compensate for the loss of NO in the endothelium (Feletou & Vanhoutte, 2009; 
Katz & Krum, 2001; McCulloch et al., 1997; Miura et al., 2001).  However, in 
some studies, a reduction in both the NO and EDH-type vasorelaxations were 
reported in disease state including diabetes in man (Angulo et al., 2003), rat 
(Brondum et al., 2010; Fukao et al., 1997; Leo et al., 2011; Ma et al., 2013; 
Schach et al., 2014) and murine models (Fitzgerald et al., 2007; Makino et al., 
2008), but this observation could possibly be species, vascular bed or vessel 
size specific (Angulo et al., 2003; Fitzgerald et al., 2007; Fitzgerald et al., 
2005). Therefore, future work involving tissue and disease specific 
pharmacological intervention to improve either the NO or the EDH-type 
mediated response is required. 
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1.6.1 Atherosclerosis 
As mentioned in Section 1.3.3, NADPH oxidase-derived ROS have been 
linked to development of atherosclerosis forming lesion in the intima layer of 
the blood vessels (Lassegue & Clempus, 2003). To study the role of Nox2 in 
development of atherosclerosis, plaque formation along the aortae of 
Nox2/ApoE double KO were compared with age-matched ApoE KO mice 
(Judkins et al., 2010). In this study, the area of atherosclerotic lesion formed in 
the aortae of the Nox2/ApoE double KO mice were ~50% less than the lesion 
formed in age-matched ApoE KO mice indicating that Nox2 protein 
contributes to formation of atherosclerotic lesion (Judkins et al., 2010). The 
superoxide production in the aortae of the Nox2/ApoE double KO mice was 
also significantly reduced with an increase in NO bioavailability when 
compared with the ApoE KO mice (Judkins et al., 2010).  
As CNP has been reported to be a factor for EDH-type mediated 
response (Chauhan et al., 2003; Hobbs et al., 2004; Honing et al., 2001; Kun et 
al., 2008; Wei et al., 1994), ecCNP KO mice have been developed to further 
characterise the effects of endothelial CNP in maintaining vascular 
homeostasis (Moyes et al., 2014). To study the effects of CNP on development 
of atherosclerosis, the entire aorta of ecCNP KO/ApoE KO mice were 
compared to CNP WT/ApoE KO mice (Moyes et al., 2014). The development 
of atherosclerotic plaque, particularly at the aortic arch and abdominal aortae, 
was accelerated in ecCNP/ApoE double KO mice from both sexes compared to 
the WT (Moyes et al., 2014). The development of atherosclerotic plaques 
subsequently caused formation of aortic arch or abdominal aortic aneurysms 
observed in about 50% of the male double KO mice (Moyes et al., 2014). 
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1.6.2 Diabetes 
A high prevalence of erectile dysfunction has been reported in diabetic patients 
and this was attributed to endothelial dysfunction associated with diabetes 
(Angulo et al., 2003). In diabetic patients, impaired endothelial function leads 
to a reduction in endothelium-dependent vasorelaxation in the human corpus 
cavernosum and in penile resistance arteries (Angulo et al., 2003). Consistent 
with a previous study where Shimokawa et al. (1996) have reported that the 
EDH-type responses increase with decreasing vessel size (Shimokawa et al., 
1996), Angulo et al. (2003) reported that the ACh-induced vasorelaxation in 
human corpus cavernosum is mainly mediated by NO whereas in penile 
resistance arteries, both the NO- and EDH-type responses play a role in the 
ACh-induced vasorelaxation. In diabetic patients, a reduction in the ACh-
induced NO-mediated vasorelaxation has been reported in human corpus 
cavernosum, whereas in the resistance arteries, reduction in both NO and 
EDH-type mediated vasorelaxations have been observed (Angulo et al., 2003).   
Similarly, in rat model of Type I diabetes (streptozotocin-induced) or 
Type II Zucker diabetic fatty (ZDF) rats, the ACh-induced EDH-type 
vasorelaxation and hyperpolarization in small mesenteric arteries were 
significantly reduced (Brondum et al., 2010; Fukao et al., 1997). A later study 
reported that the basal release of NO and ACh-induced NO-mediated response 
were also impaired in mesenteric arteries from streptozotocin-induced diabetic 
rat (Leo et al., 2011). These authors suggested that the impairment of the NO-
mediated vasorelaxation in the diabetic rat could be associated with the up-
regulation of Nox2 protein expression where an increased production of 
superoxide has been detected in the diabetic arteries (Leo et al., 2011). Despite 
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reporting an impairment in the SKCa and IKCa-channel mediated EDH-type 
responses in the mesenteric arteries from diabetic rats, an increased in the SKCa 
and IKCa proteins expression were observed (Leo et al., 2011). These authors 
suggested that the impairment in the EDH-type response could be related to 
other downstream microdomain signalling such as MEGJ communications 
(Leo et al., 2011). In contrast, a study from a different laboratory using 
primary cultured mesenteric artery endothelial cells reported that the 
impairment in the EDH-type response in streptozotocin-induced diabetic rats is 
a result of reduction in the expression level of SKCa and TRPV4 proteins (Ma 
et al., 2013). Here, the discrepancy between the expression level of SKCa 
reported by Leo et al. (2011) and Ma et al. (2013) could be due to differences 
in experimental condition where cultured cells were used in the experiment 
conducted by Ma et al. (2013).  
In thoracic aortae isolated from streptozotocin-induced diabetic rats, a 
significant reduction in ACh-induced vasorelaxation has been reported where 
the EDH-type vasorelaxation was completely abolished in both the diabetic 
and control group (Csanyi et al., 2007). These authors concluded that there 
was no up-regulation of the EDH-type responses in the diabetic rat group. 
However, as mentioned above, the lack of EDH-type response in both the 
control group and the diabetic rat group could be due to the size of vessel used 
where the EDH-type response plays a greater role in smaller vessels, hence no 
EDH-type responses were observed in larger vessels (Shimokawa et al., 1996). 
Therefore, the discrepancies in findings between studies from different 
research groups could be due to differences in experimental conditions, species  
studied, type of vessels used, or age of animal used (Fitzgerald et al., 2007).   
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 In coronary arteries isolated from streptozotocin-induced diabetic mice, 
significant reductions in ACh-induced vasorelaxation and EDH-type mediated 
response were reported (Makino et al., 2008). These authors reported that the 
reduction in ACh-induced vasorelaxation can be associated with the decrease 
in expression of Cx37 and Cx40 in the coronary arteries from diabetic mice 
where the gap junction communication was also reported to be attenuated 
using Lucifer-Yellow assay (Makino et al., 2008). In mesenteric arteries from 
non-diabetic mice, the ACh-induced vasorelaxation was mainly mediated by 
EDH-type response (Fitzgerald et al., 2007). After 7 days of exposure to 
streptozotocin (representing early stages of diabetes mice), Fitzgerald et al. 
(2007) reported that the NO activity is up-regulated to compensate the loss of 
EDH-type responses in the mesenteric arteries to maintain the vascular 
function. Similarly, a reduction in the functional and expression of Cx40 
protein and Cx40 mRNA level were reported in mesenteric arteries from type 
II diabetic ZDF rats (25-week-old) (Young et al., 2008). Furthermore, a 
reduction in Cx37 but not Cx43 protein and mRNA level was reported in the 
homogenates from the diabetic samples (Young et al., 2008).  
 Interestingly, similar to Type 1 diabetic rats where an increase in IKCa 
proteins have been reported (Leo et al., 2011), a different study using 
mesenteric arteries from 18-week-old ZDF rats similarly demonstrated an 
increase in IKCa mRNA and protein expression levels (Schach et al., 2014). 
Indeed, a previous study reported that NS309 (1 µM), a selective SKCa and 
IKCa channel activator can restore the ACh-induced endothelium-dependent 
and EDH-type mediated vasorelaxation in mesenteric arteries from ZDF rats 
(Brondum et al., 2010). These authors reported no differences in protein 
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expression of SKCa channels between ZDF and ZL rats and suggested that the 
endothelial dysfunction in ZDF rats is due to changes in the vascular function 
rather than changes in the protein expression level (Brondum et al., 2010). 
 
1.6.3 Hypertension  
Early studies have shown that inhibition of NOS increases blood pressure in 
mice and further knockout of the eNOS gene in mice abolished the ACh-
induced vasorelaxation in the aortae (Huang et al., 1995). The mean arterial 
pressure in eNOS KO mice was also significantly higher than the WT mice 
(Huang et al., 1995; Shesely et al., 1996). Other study using SKCa/IKCa-
deficient mice reported that the mean arterial pressure was significantly higher 
than the WT mice indicating that the SKCa/IKCa channels, which is involved in 
WKH µFODVVLFDO¶ ('+ SDWKZD\ SOD\ D UROH LQ UHJXODWLRQ RI EORRG SUHVVXUH DQG
vascular tone (Brahler et al., 2009).  
In monocytes from SHRs, an upregulation of TRPC3 channel 
expression level with significant increase in calcium influx compared to 
normotensive Wistar-Kyoto rats (WKY) has been previously reported (Liu et 
al., 2005). Similarly, in VSMCs and aortic tissues from SHRs, there was an 
increase in TRPC3, but not TRPC6, expression level when compared to the 
WKY (Liu et al., 2009). The increase in TRPC3 expression level in the 
VSMCs from SHRs was reported to be associated with the increased in 
angiotensin II-induced calcium influx and with a significantly greater 
angiotensin II-induced contraction compared to the normotensive WKY (Liu et 
al., 2009). Long term in vivo treatment in these SHRs for 4 weeks with 
telmisartan, an angiotensin II AT1 receptor antagonist, but not amlodipine, a 
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calcium channel blocker significantly reduces the TRPC3 expression level (Liu 
et al., 2009). Results from these animal studies were in agreement with studies 
using isolated vascular endothelium of preglomerular arteries from patients 
with malignant hypertension, where a higher level of TRPC3 protein 
expression has been reported (Thilo et al., 2009). Therefore, TRPC3 channels 
could be of potential target for future drug treatment of hypertension.  
In human studies, a significantly higher amount of plasma H2O2 
production was reported in subjects with essential hypertension compared to 
normotensive subjects (Lacy et al., 2000). This observation may be related to 
the NADPH oxidase pathway where a different study using human resistance 
arteries (<300 µM in diameter) isolated from subcutaneous fat reported that the 
angiotensin II-induced ROS generation was significantly greater in VSMCs 
isolated from hypertensive patients compared to normotensive subjects and 
this ROS formation was sensitive to DPI, an inhibitor of the NADPH oxidases 
(Touyz & Schiffrin, 2001). Therefore, apart from the NO-mediated pathway, 
the EDH-type responses or the NADPH oxidase pathway may be potential 
targets for treatment of hypertension.  
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1.7 Aims  
Although previous studies have demonstrated clear sex differences in 
endothelial function, most current cardiovascular studies are conducted on 
either male only animals or animals from both sexes.  This could be one of the 
possible explanations for contradictory findings between studies. Therefore, 
the principal aim of the present study was to elucidate whether the effects of 
sex in PCAs from male and female pigs contribute to any differences on 
endothelium-dependent vasorelaxation.  
In the present study, bradykinin, an endothelium-dependent 
vasorelaxant was mainly used in isometric tension studies in the presence of 
various inhibitors. In some studies, Western immunoblotting was used to 
compare protein expression levels in PCAs from male and female pigs. The 
aims of the present study include the following; 
º In preliminary studies, the effects of various endothelium-dependent 
agents including substance P, carbachol and bradykinin on PCAs were 
investigated. Next, sex differences in the EDH-type response were investigated 
using L-NAME and indomethacin to inhibit the synthesis of nitric oxide and 
prostacyclin. The study was then extended to investigate if endogenous H2O2, 
gap junction communications, SKCa and/or IKCa channels play a role in 
endothelium-dependent and EDH-type responses in PCAs from male and 
female pigs.  
º As H2O2 has been detected in various pathological states and has been 
reported to be a factor for EDH-type response, present study examined the 
mechanism of action of exogenous H2O2 on PCAs using various potassium 
channel inhibitors.  
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º Hyperoxic gassing conditions have been regularly used in isometric 
tension studies. High amount of superoxide generated in the buffer may 
influence pharmacological responses. Here, the effects of the antioxidant, 
Tiron® on endothelium-dependent vasorelaxation were examined under 
different gassing conditions (95% O2/5% CO2 or 95% air/5% CO2) in PCAs 
from male and female pigs.  
º One of the sources for generation of endogenous H2O2 is through the 
NADPH oxidase (Nox) system. Previous studies have reported greater 
oxidative stress in males compared to females. Therefore, sex differences in 
the role of Nox-generated ROS in the endothelium-dependent and EDH-type 
responses were investigated.  
º Given that TRP channels have been reported to play a role in 
endothelium-dependent vasorelaxation, sex differences in the role of TRP 
channels in endothelium-dependent, EDH-type responses and H2O2-induced 
vasorelaxation in PCAs from male and female pigs were examined in the 
present study using a range of selective and non-selective TRP channel 
antagonists.  
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2.1 Introduction 
Regulation of vascular tone is controlled by endothelium-derived relaxants 
including nitric oxide (NO) (Furchgott & Zawadzki, 1980; Palmer et al., 
1987), prostacyclin (PGI2) (Moncada et al., 1976) and endothelium-dependent 
hyperpolarization (EDH)-type mechanisms (Edwards et al., 2010; Feletou & 
Vanhoutte, 2013; Taylor & Weston, 1988). As mentioned under Section 1.2 
about the two different categories of EDH-type responses, this aim of this 
chapter was to examine the role of different factor(s) which have been 
proposed to be putative factor for EDH-type response released by bradykinin 
including K+ ions which is mediated through the SKCa and IKCa  channels, 
myoendothelial gap junction communications and hydrogen peroxide (H2O2) 
(Edwards et al., 2010; Hayabuchi et al., 1998; Shimokawa, 2010; Yada et al., 
2003). H2O2 has been reported to act as a factor responsible for EDH in 
porcine coronary arteries, human, murine and rat mesenteric arteries (Matoba 
et al., 2002; Matoba et al., 2003; Matoba et al., 2000; Wheal et al., 2012) (for 
a review see Shimokawa, 2010). However, the responses to H2O2 may vary 
between species, vascular beds and experimental conditions (Chaytor et al., 
2003; Gluais et al., 2005b; Lucchesi et al., 2005). 
Cardiovascular risk in men and postmenopausal women is higher than 
premenopausal women and sex differences in endothelial function have been 
suggested (McCulloch & Randall, 1998; Villar et al., 2008). To date, most 
studies on endothelial function have been conducted on either arteries from 
male animals only (Edwards et al., 1998; Garry et al., 2009; Harris et al., 
2000; Leung et al., 2006; Matoba et al., 2003) or from both sexes (Chadha et 
al., 2011; Edwards et al., 2000; Huang et al., 2011; Quignard et al., 1999; 
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Yang et al., 2003). However, previous studies have demonstrated clear sex 
differences in vascular function of the EDH-mediated pathways (for review see 
Feletou & Vanhoutte, 2006; Villar et al., 2008). EDH-type responses have 
been reported to be up-regulated to compensate for the loss of NO (McCulloch 
et al., 1997; Wheal et al., 2012; Yada et al., 2003) and this compensation was 
greater in females compared to males (McCulloch & Randall, 1998; White et 
al., 2000). Furthermore, in endothelial NO synthase and cyclo-oxygenase-1 
(eNOS/COX- GRXEOH NQRFNRXW PLFH µ('+ PLFH¶ WKH PDOH PLFH ZHUH
hypertensive while female mice were normotensive with greater endothelium-
dependent vasorelaxation in female mice (Scotland et al., 2005). However, in 
rat cerebral arteries, the EDH-type responses were greater in males compared 
to females (Sokoya et al., 2007). In a previous study on mesenteric arteries 
from rats, the EDH-type responses in females were partly dependent on 
increased expression of Cx43, which was driven by oestrogen (Liu et al., 
2002).  
The aim of this chapter was to investigate the roles and relative 
contributions of NO, PGI2 and EDH-type responses in porcine isolated 
coronary arteries (PCAs). The study was then extended to investigate the 
effects of sex differences on endothelium-dependent vasorelaxation of PCAs, 
specifically the role of gap junction communications, endogenous H2O2 and 
calcium-activated potassium channels in bradykinin-induced vasorelaxation. 
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2.2 Materials and methods 
2.2.1 Preparation of rings of distal PCAs  
Hearts from male and female pigs (large white hybrid pigs, 4-6 months old, 
weighing ~ 50 kg) were collected from a local abattoir and transported to the 
laboratory in ice-FROG PRGLILHG .UHEV¶-Henseleit solution (118 mM NaCl, 4.8 
mM KCl, 1.1 mM MgSO4, 25 mM NaHCO3, 1.2 mM KH2PO4, 11.6 mM D-
glucose, 1.25 mM CaCl2) previously gassed with 5% CO2 and 95% O2. The 
distal part of the coronary artery was then dissected and placed in 2% w/v 
)LFROO LQ .UHEV¶-Henseleit solution for overnight storage at 4°C. The 2% w/v 
Ficoll component was added to minimise osmotic swelling. The following day, 
tissues were finely dissected, cleaned of adherent connective and fatty tissues. 
PCAs were then cut into rings of about 2 mm in length and mounted in a 
multichannel wire myograph (Model 610M, DMT, Aarhus N, Denmark) 
)LJXUH  ILOOHG ZLWK  PO .UHEV¶-Henseleit solution gassed with 95% O2/5% 
CO2 and maintained at 37°C.  
 
 
Figure 2.1 A multichannel wire myograph. 
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Here, the distal part of the PCAs was used because it has previously 
been reported that the EDH response is greater with decreasing vessels size 
(Shimokawa et al., 1996) and the number of myoendothelial gap junctions 
appears to be greater in the distal part of the rat mesenteric arteries compared 
to the proximal (Sandow & Hill, 2000). The mean vessel size of PCAs from 
female pigs (0.86 ± 0.02 mm) did not differ significantly from the mean vessel 
size of male pigs (0.89 ± 0.02 mm) (2-WDLOHG XQSDLUHG 6WXGHQW¶V t-test). 
Seasonal variations in pig responses were not factored into the present study 
design but each set of experiment has been carried out with an internal, 
contemporaneous control.  
 
2.2.2 Wire myography  
To determine the basal optimal tension, vessels mounted in the wire myograph 
were placed at baseline tensions from 9.81 mN to 68.67 mN and were left to 
equilibrate for approximately 30 min. Tension was measured and recorded 
using a PowerLab recording system (ADInstruments, Oxfordshire, UK). After 
30 min of equilibration, contractile responses to 60 mM KCl were determined 
and were analysed.  
Subsequent vessels were then set at a baseline tension of 24.5 mN 
which was the optimal tension for KCl contraction and left to equilibrate for 
approximately 30 min. The vessels were then challenged with the addition of 
60 mM KCl twice and following this the vascular tone was then raised to about 
50-80% of the second KCl contraction tone by the addition of the thromboxane 
A2 mimetic, U46619 (1 nM - 90 nM). Once stable tone was achieved, 
concentration-response curves to carbachol (1 nM ± 10 µM) and two different 
46 
 
endothelium-dependent vasorelaxants, substance P (0.01 nM ± 3 nM) and 
bradykinin (0.01 nM ± 1 µM), or the nitric oxide donor, sodium nitroprusside 
(10 nM ± 30 µM) or NS309, (6,7-Dichloro-1H-indole-2,3-dione 3-oxime), a 
positive modulator of SKCa and IKCa channels (Brondum et al., 2010; 
Dalsgaard et al., 2009; Leuranguer et al., 2008a) (0.1 µM  ±  0.1 mM) were 
constructed. To examine the selectivity of NS309, some experiments were pre-
contracted with 60 mM KCl with their respective controls raised to the same 
tone with U46619.  
All inhibitors were incubated with the tissues for 1 h before pre-
FRQWUDFWLRQ ZLWK 8 H[FHSW IRU H[SHULPHQWV ZLWKȕ-estradiol (Bell et al., 
1995; Cox et al., 2005; Teoh & Man, 2000) which were incubated for 2 h (1 
nM) or 4 h (1 µM). Vasorelaxation to bradykinin was studied in the absence or 
presence of NG-nitro-L-arginine methyl ester (L-NAME) (300 µM) which is a 
NO synthase inhibitor to determine the NO-mediated component (Randall & 
Griffith, 1991). Indomethacin (10 µM) was used to inhibit the synthesis of 
prostanoids. In some experiments polyethylene glycol (PEG)-catalase (300 
Uml-1) (Hedegaard et al., 2011) was added to eliminate intracellular hydrogen 
peroxide. To study the role of gap junctions, non-selective gap junction 
inhibitors carbenoxolone (100 µM) (Harris et al., 2002; Tang & Vanhoutte, 
2008) and Į-glyF\UUKHWLQLF DFLG Į-GA) (100 µM) (Kenny et al., 2002b; 
Matoba et al., 2003) were used. Apamin (500 nM) and TRAM-34 (10 µM) 
(Gluais et al., 2005a), small (SKCa) and intermediate (IKCa) - calcium activated 
potassium channel inhibitors, respectively, were used to study the role of K+ 
channels in the bradykinin- induced vasorelaxation.  
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The concentration of U46619 used was significantly higher in the 
presence of L-NAME, indomethacin with carbenoxolone in PCAs from males 
and females (P<0.01) and in the presence of 18Į-GA in PCAs from males 
(P<0.05) (Table 2.1A). The concentration of U46619 used was also 
significantly higher in the presence of L-NAME, indomethacin with 18Į-GA 
in females (P<0.01) or in the presence of 1 µM 17ȕ-estradiol in males (P<0.05) 
(Table 2.1A). The concentration of U46619 used was the same under all other 
conditions (Table 2.1A and 2.2A). The level of tone achieved with U46619 
was the same under all conditions in PCAs from males and females (Table 
2.1B and 2.2B). 
 
A Concentration of 
U46619 (nM) 
 
L-NAME, indomethacin 
Control Inhibitor Control Inhibitor 
PEG-Catalase Male 11.0 ± 1.6 12.8 ± 4.1 15.6 ± 1.8 16.5 ± 3.0 
Female 15.6 ± 2.2 15.1 ± 1.8 28.6 ± 7.7 18.9 ± 3.3 
Carbenoxolone Male 11.1 ± 2.0 103 ± 34 15.0 ± 1.5 308 ± 116** 
Female 14.0 ± 2.4 173 ± 69 26.6 ± 7.1 3386 ± 1752** 
Į-GA Male 18.5 ± 2.7 77.8 ± 26.2* 20.8 ± 2.2 40.7 ± 5.3 
Female 17.7 ± 1.9 41.3 ± 11.6 23.0 ± 1.9 59.3 ± 8.7** 
1nM ȕ-
estradiol Male   
14.7 ± 1.8 15.5 ± 3.8 
0ȕ-
estradiol   7.83 ± 1.54 10.9 ± 1.2* 
 
Table 2.1 Summary of (A) concentration of U46619 used (nM) in the presence 
or absence of 300 µM L-NAME and 10 µM indomethacin with or without 300 
UmL-1 PEG-FDWDODVH 0FDUEHQR[RORQH 0Į-GA, 1 nM or 1 µM 
17ȕ-estradiol in porcine coronary arteries from male and female pigs. Data are 
expressed as mean ± S.E.M. of 6-15 experiments. *P<0.05, **P<0.01; one-
ZD\ $129$ IROORZHG E\ %RQIHUURQL¶V post hoc test or 2-tailed, paired 
6WXGHQW¶V t-test. 
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B      % KCl response  
L-NAME, 
indomethacin 
Control Inhibitor Control Inhibitor 
PEG-Catalase Male 68.8 ± 3.5 70.9 ± 2.1 66.1 ± 3.0 65.9 ± 3.0 Female 68.8 ± 3.0 71.2 ± 3.9 67.4 ± 3.3 69.9 ± 2.7 
Carbenoxolone Male 71.4 ± 4.3 67.3 ± 3.4 69.7 ± 3.3 55.7 ± 4.6 Female 68.7 ± 3.2 64.3 ± 2.6 67.4 ± 3.3 55.4 ± 7.4 
Į-GA Male 65.8 ± 5.6 70 ± 6.2 63.67 ± 7.8 62.83 ± 5.0 Female 58.7 ± 4.0 64.0 ± 4.1 60.8 ± 3.2 67.0 ± 5.3 
1nM 17ɴ-
estradiol Male   
53.2 ± 0.6 56.8 ± 2.2 
1µM 17ɴ-
estradiol   58.0 ± 3.4 63.5 ± 5.9 
 
Table 2.1 Summary of (B) the levels of tone achieved with U46619 expressed 
in percentage to the second KCl-induced tone in the presence or absence of 
300 µM L-NAME and 10 µM indomethacin with or without 300 UmL-1 PEG-
FDWDODVH  0 FDUEHQR[RORQH  0 Į-GA, 1 nM or 1 µM 17ȕ-
estradiol in porcine coronary arteries from male and female pigs. Data are 
expressed as mean ± S.E.M. of 6-15 experiments. 
 
A Concentration 
of U46619 (nM) 
L-NAME, indomethacin 
Control TRAM-34 Apamin Apamin, TRAM-34 
Male 12.1 ± 1.3 16.7 ± 4.5 11.6 ± 1.7 11.8 ± 1.7 
Female 19.0 ± 3.3 12 ± 2.7 21.3 ± 6.6 18.7 ± 3.6 
 
B  U46619-
induced tone (% 
KCl response)  
L-NAME, indomethacin 
Control TRAM-34 Apamin Apamin, TRAM-34 
Male 72.0 ± 4.6 66.3 ± 5.2 75.9 ± 4.8 67.8 ± 4.4 
Female 79.2 ± 5.4 67.0 ± 7.7 73.1 ± 7.5 66.3 ± 5.9 
 
Table 2.2 Summary of (A) concentration of U46619 used (nM) and (B) the 
levels of tone achieved with U46619 expressed in percentage to the second 
KCl-induced tone in the presence or absence of 300 µM L-NAME and 10 µM 
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indomethacin with or without 10 µM TRAM-34 and/or 500 nM apamin in 
porcine coronary arteries from male and female pigs.  
2.2.3 Western Blotting 
Western Blot studies were carried out to determine the relative expression 
levels of connexin 37, 40, 43 and IKCa between PCAs from male and female 
pigs. PCAs from male and female pigs were finely dissected and cut into rings 
of about 1 cm in length. Vessels were then gassed with 5% CO2 and 95% O2 in 
.UHEV¶-Henseleit solution at 37°C for 1 h. The method described below is the 
result of substantial method development including different batches of 
antibodies and different lysis buffers. Results of these developments are 
included in the Appendix B. For detailed contents of the buffers and chemicals 
used for Western blot, please refer to Appendix A. 
Segments (designated F1 - F5 for samples from females and M1 - M5 
for samples from males) were homogenised on ice in lysis buffer (80 mM 
VRGLXP ȕ-glycerophosphate, 20 mM imidazole, 1 mM dithiothreitol, 1 mM 
sodium fluoride, pH7.6) containing protease inhibitor cocktail (Calbiochem, 
VWR International Ltd, Lutterworth, Leicestershire, UK). Protein 
concentrations of the supernatants were determined by Bradford method 
(Bradford, 1976) using bovine serum albumin (BSA) to generate the standard 
curve (2, 1, 0.5, 0.25, 0.125, 0 mg/mL). In duplicates, 10 µL of supernatants 
(diluted 1:5 or 1:10) followed by 40 µL of Bradford reagent (Bio-Rad, Hemel 
Hempstead, Hertfordshire, UK) were added into a 96-well plates. 150 µL of 
distilled water was then added into each well to make up a final total volume 
of 200 µL. The intensity of the absorbance value of 595 nm was then measured 
using a SpectraMAX 340 PC microplate reader (Molecular Devices, 
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Wokingham, Berkshire, UK). Protein concentrations of the samples were 
extrapolated from the BSA standard curve.  
Samples (F1-F5 and M1-M5) were diluted 1:1 in 2x Laemmli sample 
buffer and heated at 95°C for 5 min. After centrifugation at 13,000x g for 1 
min, 5 µg of protein were loaded on a 4-20% Mini-PROTEAN TGX precast 
gel (Bio-Rad, Hemel Hempstead, Hertfordshire, UK). Gel was run at 100 V for 
5 min followed by 175 V for 45 min in 1X electrophoresis buffer (Appendix 
A) and was then  transferred onto nitrocellulose membrane (GE Healthcare, 
Little Chalfont, Buckinghamshire, UK) using a Bio-Rad mini-transblot at 100 
V for 1 h in transfer buffer (Appendix A). The nitrocellulose membrane was 
then blocked with 5% w/v non-fat milk (The Co-Operative instant dried 
skimmed milk, Manchester, UK) in tris-buffered saline containing 0.1% 
Tween 20 (TBS-T) for 1 h at room temperature with shaking before overnight 
incubation with mouse monoclonal anti-Cx-43 antibody (C8093 Sigma-
Aldrich) (1:1000) and mouse monoclonal anti-myosin light chain (MLC) 
antibody (M4401 Sigma-Aldrich) (1:500) diluted in 5% w/v non-fat milk at 
4°C with shaking. The immunoblot was then washed three times for 15 min 
each wash with TBS-T then incubated with secondary antibody IRDye 800CW 
Goat anti-mouse IgG (1:10,000) (LI-COR Biosciences, Cambridge, UK) 
diluted in 5% w/v non-fat milk for 1 h at 37°C. This was followed by another 
three times 15 min washing with TBS-T buffer. The immunoblot was then 
visualised using a LI-COR Odyssey Infrared Imaging Scanner and densities of 
the bands were determined using Odyssey (Application Software Version 3.0 
LI-COR Biosciences, Cambridge, UK). 
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Due to the high concentration of proteins required for all other 
antibodies, samples (designated F6-F10 and M6-M10) were prepared in a 
slightly modified protocol. Samples (F6-F10 and M6-M10) were homogenised 
on ice in lysis buffer (20 mM Tris, 1 mM EGTA, 320 mM sucrose, 0.1% 
Triton X100, 1 mM sodium fluoride, 10 mM sRGLXP ȕ-glycerophosphate, 
pH7.6) containing protease inhibitor cocktail (Calbiochem) followed by 
centrifugation at 3,000x g for 5 min at 4°C (Hermle LaborTechnik Z216MK, 
Wehingen, Germany). Supernatant of the samples were then solubilised in 6x 
solubilisation buffer and diluted to 1 mg/ml of protein with 1x solubilisation 
buffer. Samples were then heated at 95°C for 5 min followed by centrifugation 
at 13,000x g for 1 min before loading to the precast gel.  
The amounts of protein concentration loaded with the respective 
dilution of antibody used were as followed; for connexin 40, 10 µg of PCAs 
samples with 20 µg of pig kidney (PK) lysate used as positive control were 
incubated with rabbit polyclonal anti-connexin 40 - aminoterminal end 
antibody (ab38580 Abcam®, Cambridge, UK) (1:100) and mouse monoclonal 
anti-GAPDH antibody (G8795 Sigma-Aldrich) (1:40,000).  For connexin 37, 
15 µg of PCAs samples with 20 µg of pig (PK) and rat (RK) kidney lysate 
used as positive controls were incubated with rabbit polyclonal anti-GJA4 
antibody (C15878 Assay Biotech, Stratech Scientific Limited,  Suffolk, UK) 
(1:500) and mouse monoclonal anti-ȕ-Actin antibody (A2228 Sigma-Aldrich) 
(1:40,000). For IKCa, 15 µg of PCAs samples with 10 µg of pig kidney lysate 
used as positive control were incubated with mouse polyclonal anti-KCNN4 
antibody (H00003783-B01P Abnova, Taipei, Taiwan) (1:500) and mouse 
monoclonal anti-GAPDH antibody (G8795 Sigma-Aldrich) (1:40,000). For all 
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antibodies, the blocking and washing steps used were as described above and 
the same secondary antibody, IRDye® 800CW Goat anti-mouse IgG (1:10 000) 
(LI-COR Biosciences, Cambridge, UK) were used for anti-mouse antibody and 
IRDye® 680LT Goat anti-rabbit IgG (1:10 000) (LI-COR Biosciences, 
Cambridge, UK) for anti-rabbit antibody. 
 
2.2.4 Polymerase chain reaction (PCR) amplification of the Sry gene for 
sex identification 
2.2.4.1 DNA extraction from porcine tissue 
Tissue samples were collected from respective pig hearts used for myograph 
and Western Blot study. In between each sample, the scissors and forceps were 
rinsed with 70% industrial methylated spirit (IMS) followed by plenty of Mili-
Q water to minimised contamination between samples. DNA samples for the 
polymerase chain reaction amplification (PCR) was extracted from 
approximately 2 mm3 of respective heart tissue using 200 µL of lysis buffer 
(50 mM KCl, 10 mM Tris-HCl pH8.3, 0.45% v/v Nonidet P40, 0.45% v/v 
Tween 20 - filtered through a 0.2 µm Sartorius Minisart® filter) and digested 
with 5 µL proteinase K (20 mg/ml). Samples were incubated at 37°C for 3 h 
until tissues were fully degraded. Samples were then heated to 95°C for 10 min 
in a heating block to inactivate proteinase K. Method was adapted from Bryja 
& Koneân (2003). 
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2.2.4.2 PCR amplification of the pig tissues for sex identification 
Primers that amplify the 163-bp region of the Sry gene were adapted from 
Pomp et. al.,  ZLWK WKH ¶ XSVWUHDP SULPHU 65<%- ¶-
TGAACGCTTTC AT TGTGTGGTC-¶ DQG ¶ GRZQVWUHDP SULPHU 65<%-3 
¶-AGGAGGCA CAGA GGCTACAGGC±¶ 7Ke 447/445-bp region of the 
Zfy-Zfx genes taken from Aasen & Medrano (1990) were used as positive 
control for successful PCR amplification (Bryja & Koneân, 2003; Henrique-
Silva et al., 2007; Pomp et al., 1995) - ¶ XSVWUHDP SULPHU ¶-
ATAATCACATGG AGAGCCACAAGCT-¶ DQG ¶ GRZQVWUHDP SULPHU ¶-
GCACTTCTTTGG TATCTGAGAAAGT-¶ For PCR analysis of a 
successful amplification in male samples, bands representing Zfy-Zfx (positive 
control) and Sry band should be visible while in female samples only the Zfy-
Zfx (positive control) band should be detected. The Zfy-Zfx band should be 
fainter in males compared to females because of the competing Sry 
amplification system in males. 
The amplifications were performed in the following conditions: 1 µL 
SRYB primers, 1 µL Zfy-Zfx primers, 200 µM dNTPs, 1 U Phusion DNA 
polymerase, and 5 µL of tissue lysate in a 50 µL reaction volume (method 
adapted from PCR guidelines from NEB Phusion® High-Fidelity DNA 
polymerase). All reaction was assembled on ice and the Phusion DNA 
polymerase was added last to prevent any primer degradation caused by 
exonuclease activity. The cycling conditions were 30 cycles of denaturation at 
98 °C (1 min), annealing at 54°C (1 min) and extension at 72°C (1 min). The 
PCR amplifications were performed in SensoQuest Thermocycler (Geneflow 
Limited, Staffordshire, UK). Following PCR amplifications, 5 µL samples 
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were mixed with 5 µL of distilled H2O and 2 µL 6x loading buffer and 10 µL 
of samples were loaded into a 1.5% ethidium bromide stained agarose gel. 
 
2.2.4.3 Optimisation of the PCR conditions using purified or unpurified 
DNA samples, varying annealing temperature and concentration of 
magnesium chloride 
To optimise the PCR protocol, a range of annealing temperatures (42°C, 45°C, 
50°C, 54°C) and different concentrations of MgCl2 were examined (1.5 mM, 
2.0 mM, 2.5 mM). PCR amplification using purified and unpurified DNA 
samples were also compared. DNA samples were purified using DNeasy 
Tissue Kit (Qiagen, Manchester, UK) following protocol from the DNeasy 
Tissue Kit Handbook. Briefly, 180 µL tissue lysate was added with 200 µL AL 
buffer, votexed and incubated at 70°C for 10 min. 200 µL of ethanol was then 
added and sample was vortex and transferred to a spin column and centrifuged 
at 8000 rpm for 1 min (GenFuge 24D, Progen, Mexborough, UK). Flow 
through were discarded and 500 µL AW1 buffer was added and sample was 
centrifuged again at 8000 rpm for 1 min. Flow through was discarded and 500 
µL of AW2 buffer were added and sample was centrifuged at 13 000 rpm for 3 
min. The spin column was then transferred to a 1.5 mL Eppendorf and 200 µL 
AE buffer were added into the spin column and incubated at room temperature 
for 1 min. Purified DNA sample was finally eluted by centrifuging at 8000 rpm 
for 1 min and concentration of DNA was measured using NanoDrop 2000 
spectrophotometer (Thermo Scientific, Fisher Scientific UK Ltd, 
Loughborough, UK).   
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2.2.4.4 The effects of running singleplex or duplex PCR amplification 
The Sry gene was amplified in either singleplex or duplex PCR reaction using 
two sets of primers. In singleplex reaction, amplification of the two sets of 
primers was carried out in separate PCR tube whereas in a duplex PCR 
amplification, the 447/445-bp regions of the Zfy-Zfx genes were co-amplified 
with the SRYB primers. 
 
2.2.5 Statistical analysis 
Data are presented as mean percentage relaxation of U46619-induced tone 
with standard error of the mean (S.E.M.) and n being the number of separate 
animals. The concentration-response curves were fitted to a sigmoidal curve 
with a variable slope using four-parameter logistic equation in GraphPad Prism 
(Version 6, GraphPad Software, La Jolla, California, USA). The maximum 
percentage relaxation (Rmax) and the negative log of concentration required to 
produce half the maximal relaxation of the induced tone (EC50) were calculated 
by fitting the data to the logistic equation:  
R   =     Rmax   AnH       
                                          EC50nH + AnH 
where R is the reduction in tone, Rmax is the maximum vasorelaxation of the 
established tone, A is the concentration of the vasorelaxant. nH is the slope 
function and EC50 is the concentration of the vasorelaxant required to produce 
half the maximal relaxation (McCulloch & Randall, 1998). Data were analysed 
using 2-WDLOHG SDLUHG RU XQSDLUHG 6WXGHQW¶V t-test to compare differences 
between 2 groups (tissue segments from the same animal). In 3 or more 
groups, one-way ANOVA was used and significant differences between 
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JURXSV ZHUH GHWHFWHG E\ %RQIHUURQL¶V post hoc test. P-values of less than 0.05 
were considered statistically significant. 
  
2.2.6 Drugs and chemicals 
All drugs were purchased from Sigma-Aldrich (Poole, Dorset, UK) except for 
apamin and NS309 from Tocris Bioscience (Bristol, UK). Stock solutions of 
carbachol, substance P, sodium nitroprusside, NG-nitro-L-arginine methyl ester 
(L-NAME), PEG-catalase, carbenoxolone, and apamin were dissolved in 
distilled water. Stock solution of indomethacin was dissolved in absolute 
ethanol whereas TRAM- Į-glycyrrhetinic acid and NS309 were dissolved 
in DMSO. 10 mM stock solution of bradykinin was made in water while ȕ-
estradiol and U46619 thromboxane A2-mimetic were made in ethanol. All 
further dilutions of the stock solutions were made using distilled water except 
for NS309 which was further diluted with DMSO to 10 mM, 30% DMSO to 1 
mM and distilled water to 0.1 mM. Primers for PCR amplifications were 
ordered from Eurofins Genomics (Ebersberg, Germany). 
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2.3 Results 
2.3.1 Optimal tension in porcine distal coronary arteries (PCAs) for 
contractile responses 
Segments of porcine distal coronary arteries mounted in a wire myograph were 
subjected to increasing amounts of tension. Tissue segments were then allowed 
to recover before the contractile responses to 60 mM KCl were measured. 
Initially an increase in the contractile response was observed with a mean 
maximum contraction of 22.0 ± 5.0 mN obtained at tension set at 19.6 mN. 
The response obtained with 60 mM KCl then decreased with increasing 
amounts of tension applied (Figure 2.2). Based on these observations, the 
average of 24.5 mN tension was used in subsequent experiments.  
 
Figure 2.2 The effects of increasing tension (mN) on the contractile response 
to 60 mM KCl in porcine distal coronary arteries from male and female pigs. 
Data points are expressed as a change in tension (mN) and are mean ± S.E.M. 
of 3-12 experiments. 
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2.3.2 Vascular effects of carbachol, substance P, bradykinin and sodium 
nitroprusside in porcine distal coronary arteries (PCAs) 
Carbachol produced concentration-dependent contractions with a pEC50 of 
6.36 ± 0.31 and a maximum response (Rmax) of 143 ± 43%, n=5 (Figure 2.3). 
In contrast, substance P produced concentration-dependent vasorelaxations 
with an Rmax of 86.6 ± 8.1% (pEC50 = 9.71 ± 0.12, n=4) (Figure 2.4A). 
Similarly bradykinin also produced relaxations described by Rmax of 99.9 ± 
5.4% and pEC50 = 8.57 ± 0.14 (n=4) (Figure 2.4B). Sodium nitroprusside 
(SNP) caused a concentration-dependent vasorelaxation with an Rmax of 107 ± 
13% and pEC50 = 6.46 ± 0.21 (n=5) (Figure 2.4C).  
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Figure 2.3 Log concentration-response curve to carbachol in U46619 pre-
contracted porcine coronary arteries from male and female pigs. Data are 
expressed as a percentage change from the U46619-induced tone and are mean 
± S.E.M. of 5 experiments. 
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Figure 2.4 Log concentration-response curves for the vasorelaxant effects of 
(A) substance P, (B) bradykinin and (C) sodium nitroprusside in U46619 pre-
contracted porcine coronary arteries from male and female pigs. Data are 
expressed as a percentage change from the U46619-induced tone and are 
means ± S.E.M. of 4-5 experiments. 
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2.3.3 The effects of L-NAME and removal of the endothelium on 
bradykinin-induced vasorelaxation in PCAs from male and female pigs 
In PCAs from pigs of either sex, bradykinin produced concentration-dependent 
vasorelaxations. Under control conditions the maximum bradykinin-induced 
vasorelaxation was 89.7 ± 3.3% with pEC50 = 8.46 ± 0.08 (n=12). In the 
presence of 300 µM L-NAME (Figure 2.5) the responses to bradykinin were 
significantly inhibited such that the maximum relaxation was reduced to 53.4 ± 
4.7% (P<0.01) (pEC50 = 7.99 ± 0.17, n=12). The presence of 300 µM L-
NAME also significantly shifted the curve 3-fold to the right (P<0.05). 
Removal of the endothelium abolished the bradykinin-induced vasorelaxation 
and a small contraction (12.9 ± 4.0%) was uncovered (pEC50 = 7.67 ± 0.70, 
n=4) (Figure 2.5). 
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Figure 2.5 Log concentration-response curves to bradykinin in the absence and 
presence of 300µM L-NAME or endothelium denuded tissue in U46619 pre-
contracted porcine coronary arteries from male and female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 4-12 experiments. **P< 0.01; 2-tailed, paired SWXGHQW¶V t-test. 
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2.3.4 The effects of L-NAME and/or cyclooxygenase inhibitor 
indomethacin on bradykinin-induced vasorelaxation in PCAs from male 
and female pigs 
In PCAs from either sex, the presence of L-NAME alone significantly 
inhibited the maximum bradykinin-induced vasorelaxation from 89.7 ± 3.3% 
(pEC50 = 8.46 ± 0.08, n=12) under control conditions to 53.4 ± 4.7% (pEC50 = 
7.99 ± 0.17, n=12) (P<0.0001) in the presence of L-NAME (Figure 2.6). The 
presence of indomethacin alone had no effect on the bradykinin-induced 
vasorelaxation producing an Rmax of 89.5 ± 2.9% (pEC50 = 8.23 ± 0.07, n=11) 
and the additional presence of indomethacin to L-NAME had no further effects 
on the Rmax or pEC50 of the bradykinin-induced vasorelaxation compared to L-
NAME alone, producing an Rmax of 63.5 ± 7.4% (pEC50 = 7.58 ± 0.20, n=12). 
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Figure 2.6 Log concentration-response the vasorelaxant effects of bradykinin 
in the absence or presence of 300 µM L-NAME and/or 10 µM indomethacin in 
U46619 pre-contracted porcine coronary arteries from male and female pigs.  
Data are expressed as a percentage change from U46619-induced tone and are 
mean ± S.E.M. of 11-12 experiments. ****P<0.0001; one-way ANOVA 
IROORZHG E\%RQIHUURQL¶V post hoc test. 
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2.3.5 The effects of sex on EDH-type vasorelaxations 
In PCAs from male and female pigs, bradykinin produced comparable, 
concentration-dependent vasorelaxant effects (Figure 2.7A) described by Rmax 
of 91.4 ± 3.4% and pEC50 of 8.50 ± 0.08 (n=8 in females) and Rmax of 91.9 ± 
3.4% and pEC50 of 8.38 ± 0.08 (n=12 in males). In either sex, the presence of 
L-NAME and indomethacin significantly reduced the bradykinin-induced 
vasorelaxation compared to controls. The reduction in vasorelaxation was 
significantly (P<0.05) greater in males (Rmax = 45.0 ± 7.9%, pEC50 = 7.33 ± 
0.27, n=11) compared to females (Rmax = 66.8 ± 6.2%, pEC50 = 7.65 ± 0.16, 
n=8). The bradykinin-induced vasorelaxation in arteries from both male and 
female pigs was shifted significantly to the right in the presence of L-NAME 
and indomethacin compared to their respective control responses (P<0.05). 
Original traces showing the tissue responses with increasing concentrations of 
bradykinin are shown in Figure 2.7B and C. 
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Figure 2.7 (A) Log concentration-response curves for the vasorelaxant effects 
of bradykinin in the absence or presence of 300 µM L-NAME and 10 µM 
indomethacin in U46619 pre-contracted porcine coronary arteries from male 
and female pigs. Data are expressed as a percentage change from U46619-
induced tone and are mean ± S.E.M. of 8-12 experiments. Original traces 
showing the responses to increasing concentration of bradykinin in the (A) 
absence or (B) presence of L-NAME and indomethacin *P<0.05, 
****P<0.0001; one-ZD\ $129$IROORZHG E\%RQIHUURQL¶V post hoc test. 
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2.3.6 The effects of 1 Q0 ȕ-estradiol in the presence of L-NAME and 
indomethacin on bradykinin-induced vasorelaxation in PCAs from male 
pigs 
To examine if the enhanced EDH-mediated vasorelaxation to bradykinin 
observed in PCAs from female pigs was due to exposure to oestrogen, this 
study explored WKH DFXWH HIIHFWV RI H[SRVXUH WR ORZ FRQFHQWUDWLRQ RI ȕ-
estradiol (1 nM) in the presence of L-NAME and indomethacin on PCAs from 
PDOH SLJV +HUH WKH SUHVHQFH RI ȕ-estradiol had no effects on the 
bradykinin-induced vasorelaxation such that the Rmax under control condition 
was 71.2 ± 9.4% (pEC50 = 7.79 ± 0.29, n=6) compared to a maximum 
relaxation of 68.5 ± 6.7% (pEC50 = 7.66 ± 0.20, n=6) in the presence of 1 nM 
ȕ-estradiol (Figure 2.8). 
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Figure 2.8 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME, 10 µM indomethacin and 1 
Q0 ȕ-estradiol (2 h incubation) in U46619 pre-contracted porcine coronary 
arteries from male pigs. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 6 experiments.  
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2.3.7 The effects of 1 µM 1ȕ-estradiol in the presence of L-NAME and 
indomethacin on bradykinin-induced vasorelaxation in PCAs from male 
pigs 
$V WKH H[SRVXUH WR  Q0 RI ȕ-estradiol had no effect on the bradykinin-
induced vasorelaxation in the presence of L-NAME and indomethacin, a 
KLJKHU FRQFHQWUDWLRQ RI ȕ-estradiol (1 µM) was used. As some of the 
individual concentration-response curve did not achieve a defined Rmax, data 
were analysed at each individual concentration. At 10 nM and 30 µM of 
EUDG\NLQLQ WKH SUHVHQFH RI  0 ȕ-estradiol significantly inhibited the 
vasorelaxation (n=6) (Figure 2.9).  
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Figure 2.9 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME, 10 µM indomethacin and 1 
µM ȕ-estradiol (4 h incubation) in U46619 pre-contracted porcine coronary 
arteries from male pigs. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 6 experiments. *P<0.05; 2-
tailed, SDLUHG6WXGHQW¶V t-test.   
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2.3.8 The effects of L-NAME, indomethacin and PEG-catalase on 
bradykinin-induced vasorelaxation in PCAs from male and female pigs 
In PCAs from females, treatment with 300 UmL-1 PEG-catalase alone (Figure 
2.10A) significantly reduced the vasorelaxation to bradykinin (Rmax = 70.8 ± 
4.7%, pEC50 = 8.23 ± 0.13, n=9) compared to an Rmax of 87.3 ± 2.6% (pEC50 = 
8.46 ± 0.06, n=15) under control conditions (P<0.05). However, in the 
presence of L-NAME and indomethacin (Rmax = 54.7 ± 5.8%, pEC50 = 7.92 ± 
0.2, n=9) no further inhibition was observed in the additional presence of 300 
UmL-1 PEG-catalase (Rmax = 52.1 ± 4.6%, pEC50 = 7.63 ± 0.15, n=14).  
Treatment of PCAs from males with 300 UmL-1 PEG-catalase (Figure 
2.10B) did not affect the vasorelaxation to bradykinin (Rmax = 82.7 ± 5.3%, 
pEC50 = 8.05 ± 0.13, n=10) compared to control (Rmax = 86.1 ± 3.5%, pEC50 = 
8.34 ± 0.09, n=14). The presence of L-NAME and indomethacin in male PCAs 
significantly reduced the vasorelaxant responses to bradykinin (Rmax = 48.2 ± 
9.3%, pEC50 = 7.26 ± 0.30, n=10) but the additional presence of 300 UmL-1 
PEG-catalase did not cause further reduction in the bradykinin-induced 
vasorelaxation (Rmax = 47.2 ± 15.8%, pEC50 = 7.07 ±0.50, n=11). A further 
experiment conducted in the presence of 600 UmL-1 PEG-catalase had no 
effect on the Rmax or EC50 of the bradykinin-induced vasorelaxation (Figure 
2.10C), such that in the presence of 600 UmL-1 PEG-catalase the Rmax = 95.3± 
6.6% (pEC50 = 7.63 ±0.11, n=4) and Rmax = 42.9± 12.5% (pEC50 = 7.62 ±0.53, 
n=4) in the additional presence of L-NAME and indomethacin.  
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Figure 2.10 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 300 µM L-NAME, 10 µM 
indomethacin or 300 UmL-1 PEG-catalase in U46619 pre-contracted porcine 
coronary arteries from (A) female and (B) male pigs or with (C) 600 UmL-1 
PEG-catalase in males. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 4-15 experiments. *P<0.05; 
one-ZD\$129$IROORZHG E\%RQIHUURQL¶V post hoc test. 
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2.3.9 The effects of L-NAME, indomethacin and carbenoxolone on 
bradykinin-induced vasorelaxation in PCAs from male and female pigs. 
In PCAs from females, treatment with carbenoxolone alone did not affect 
vasorelaxation to bradykinin such that the maximum relaxation in controls was 
87.1 ± 2.8% (pEC50 = 8.48 ± 0.07, n=14) compared to a response of 81.6 ± 
5.9% (pEC50 = 8.38 ± 0.17, n=8) in the presence of carbenoxolone (Figure 
2.11A). However, in the presence of L-NAME and indomethacin, addition of 
carbenoxolone further reduced the maximum relaxation to bradykinin from 
54.7 ± 5.8% (pEC50 = 7.92 ± 0.20, n=9) in the presence of L-NAME and 
indomethacin to a response of 31.1 ± 4.1% (pEC50 = 7.62 ± 0.23, n=7) in the 
presence of carbenoxolone in combination with L-NAME and indomethacin 
(P<0.01). 
In PCAs from males, the presence of carbenoxolone alone or in 
combination with L-NAME and indomethacin did not affect vasorelaxation to 
bradykinin (Figure 2.11B).  The responses to bradykinin in the presence of 
carbenoxolone alone (Rmax = 81.5 ± 5.7%, pEC50 = 8.20 ± 0.14, n=6) were 
comparable with the responses to bradykinin under control conditions (Rmax = 
87.7 ± 5.3%, pEC50 = 8.17 ± 0.12, n=9). Similarly, in the presence of L-NAME 
and indomethacin (Rmax = 51.7 ± 10.3%, pEC50 = 7.06 ± 0.28, n=7) the 
responses to bradykinin did not differ significantly in the additional presence 
of carbenoxolone (Rmax = 44.2 ± 3.1%, pEC50 = 7.54 ± 0.11, n=6). 
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Figure 2.11 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 300 µM L-NAME, 10 µM 
indomethacin or 100 µM carbenoxolone in U46619 pre-contracted porcine 
coronary arteries from (A) female and (B) male pigs. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 6-14 
experiments. **P<0.01; one-way ANOVA followed by BonferURQL¶V post hoc 
test. 
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2.3.10 The effects of L-1$0( LQGRPHWKDFLQ DQG Į-glycyrrhetinic acid 
on bradykinin-induced vasorelaxation in PCAs from male and female pigs 
7KH SUHVHQFH RI Į-glycyrrhetinic acid (Rmax = 97.9 ± 2.0%, pEC50 = 8.46 ± 
0.04, n=6) in PCAs from female pigs did not affect the bradykinin-induced 
vasorelaxation compared to the control (Rmax = 99.3 ± 2.8%, pEC50 = 8.61 ± 
0.06, n=6) (Figure 2.12A). In the presence of L-NAME and indomethacin 
(Rmax = 88.2 ± 4.9%, pEC50 = 7.95 ± 0.09, n=6), adGLWLRQRIĮ-glycyrrhetinic 
acid (Rmax = 88.4 ± 4.4%, pEC50 = 7.60 ± 0.07, n=6) significantly shifted the 
curve to the right by 2.2-fold (P<0.05). 
,Q 3&$V IURP PDOH SLJV WKH SUHVHQFH RI Į-glycyrrhetinic acid (Rmax 
= 96.0 ± 3.7%, pEC50 = 8.69 ± 0.08, n=6) alone had no effect on the 
bradykinin-induced vasorelaxation compared to the control (Rmax = 101.9 ± 
2.5%, pEC50 = 8.80 ± 0.06, n= )LJXUH% Į-glycyrrhetinic acid in the 
presence of L-NAME and indomethacin (Rmax = 81.3 ± 6.2%, pEC50 = 8.10 ± 
0.14, n=6) had no effect on the bradykinin-induced vasorelaxation compared to 
L-NAME and indomethacin (Rmax = 82.7 ± 7.8%, pEC50 = 8.04 ± 0.18, n=6). 
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Figure 2.12 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 300 µM L-NAME, 10 µM 
indomethacin or  0 Į-JO\F\UUKHWLQLF DFLG Į-GA) in U46619 pre-
contracted porcine coronary arteries from (A) female and (B) male pigs. Data 
are expressed as a percentage change from U46619-induced tone and are mean 
 6(0 RI  H[SHULPHQWV ,Q IHPDOH 3&$V SUHVHQFHRI Į-GA in L-NAME 
and indomethacin significantly shifted the bradykinin-induced vasorelaxation 
curve 2.2-fold to the right (P<0.05; one way ANOVA followed by 
%RQIHUURQL¶V post hoc test).  
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2.3.11 The effects of L-NAME, indomethacin, TRAM-34 and/or apamin 
on bradykinin-induced vasorelaxation in PCAs from male and female pigs 
In PCAs from females, treatment with TRAM-34 in the presence of L-NAME 
and indomethacin significantly inhibited the maximum relaxation to 
bradykinin from Rmax of 87.5 ± 2.7% (pEC50 = 7.6 ± 0.05, n=5) to Rmax of 58.4 
± 7.9% (pEC50 = 7.5 ± 0.2, n=5) (Figure 2.13A) (P<0.0001). Similarly, the 
maximum relaxation to bradykinin was significantly inhibited by apamin in the 
presence of L-NAME and indomethacin such that the Rmax was reduced to 72.2 
± 10.5% (pEC50 = 7.6 ± 0.2, n=5) (P<0.01). The maximum relaxation to 
bradykinin was further inhibited with a combination of TRAM-34 and apamin 
in the presence of L-NAME and indomethacin (Rmax = 26.6 ± 3.7%, pEC50 = 
7.2 ± 0.2, n=6) (P<0.0001) (Figure 2.13A). 
In PCAs from males, vasorelaxation produced at 1 µM of bradykinin 
was used for statistical analysis instead of Rmax because the maximum 
relaxation was not fully defined in some of the groups. Treatment with TRAM-
34 in the presence of L-NAME and indomethacin (52.4 ± 9.5%, n=11) had no 
effect on the bradykinin-induced vasorelaxation at 1 µM bradykinin compared 
to L-NAME and indomethacin (63.3 ± 7.9%, n=11) (Figure 2.13B). In 
contrast, addition of apamin alone significantly inhibited the vasorelaxation 
produced at 1 µM bradykinin (39.8 ± 9.7%, n=11) (P<0.05) compared to L-
NAME and indomethacin. Similarly, combination of TRAM-34 and apamin in 
the presence of L-NAME and indomethacin (27.0 ± 4.7%, n=11) significantly 
inhibited the vasorelaxation produced at 1 µM bradykinin compared to L-
NAME and indomethacin (P<0.01) but vasorelaxation in these arteries did not 
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differ significantly with the apamin, L-NAME and indomethacin treated 
arteries. 
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Figure 2.13 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME, 10 µM indomethacin, 500 
nM apamin and/or 10 µM TRAM-34 in U46619 pre-contracted porcine 
coronary arteries from (A) female and (B) male pigs. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 5-11 
experiments. *P<0.05, **P<0.01, ****P<0.0001; one-way ANOVA followed 
E\%RQIHUURQL¶V post hoc test.  
 
 
74 
 
2.3.12 The effects of L-NAME, indomethacin and apamin and/or TRAM-
34 on NS309-induced vasorelaxation in PCAs from male and female pigs 
To further determine if there are sex differences in the functional role of the 
IKCa channels in PCAs from male and female pigs, NS309, a selective SKCa 
and IKCa channels activator (Leuranguer et al., 2008a) was used in the 
presence of apamin and/or TRAM-34. In PCAs from female pigs in the 
presence of L-NAME and indomethacin, NS309 produced an Rmax of 117 ± 3% 
(pEC50 = 5.81 ± 0.05, n=6) and treatment with apamin had no effect on the 
NS309-induced vasorelaxation (Rmax = 114 ± 3%, pEC50 = 5.74 ± 0.05, n=6) 
(Figure 2.14A). Similarly, in PCAs from male pigs, in the presence of L-
NAME and indomethacin, apamin no effect on the Rmax or pEC50 values on 
NS309-induced vasorelaxation (Rmax = 116 ± 3%, pEC50 = 5.82 ± 0.05, without 
apamin; Rmax = 117 ± 3%, pEC50 = 5.73 ± 0.05; with apamin, n=6) (Figure 
2.14B). In PCAs from male pigs, in the presence of L-NAME and 
indomethacin, the addition of TRAM-34 did not affect responses to NS309 
such that Rmax = 113 ± 4% and pEC50 = 5.84 ± 0.06 (n=6) in the absence and 
Rmax = 112 ± 5% and pEC50 = 5.91 ± 0.10 (n=6) in the presence of TRAM-34 
(Figure 2.14C).  
Further experiments with PCAs from male pigs in the presence of L-
NAME and indomethacin with both apamin and TRAM-34 had no effect on 
the NS309-induced vasorelaxation (Figure 2.14D) compared to the control. 
The Rmax was 119 ± 5% (pEC50 = 5.83 ± 0.90, n=6) under control conditions 
and Rmax of 119 ± 5% (pEC50 = 5.86 ± 0.91, n=6) in the presence of apamin 
and TRAM-34. On the other hand, in PCAs from female pigs, the presence of 
L-NAME, indomethacin and both apamin and TRAM-34 significantly 
75 
 
inhibited the NS309-induced vasorelaxation (Figure 2.14E) at 0.3 µM of 
NS309 (P<0.05) with no significant differences in Rmax between control (Rmax 
of 115 ± 6%, pEC50 = 5.96 ± 0.12, n=10) and in the presence of apamin and 
TRAM-34 (Rmax of 115 ± 4%, pEC50 = 5.72 ± 0.07, n=10).  
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Figure 2.14 Log concentration-response curves for the vasorelaxant effects of 
NS309 in the presence of 300 µM L-NAME, 10 µM indomethacin and 500 nM 
apamin in U46619 pre-contracted porcine coronary arteries from (A) female 
and (B) male pigs. Data are expressed as a percentage change from U46619-
induced tone and are mean ± S.E.M. of 6 experiments.  
 
76 
 
-7 -6 -5 -4
- 1 2 0
- 9 0
- 6 0
- 3 0
0
M a le
L o g  M  [N S 3 0 9 ]
R
e
la
x
a
ti
o
n
(%
 
U
46
61
9-
in
du
c
e
d 
to
n
e
)
L -N A M E , in do m eth ac in  (n = 6)
L -N A M E , in do m ethac in ,
T R A M -3 4  (n = 6 )
C
3
6
9
120
-7 -6 -5 -4
- 1 2 0
- 9 0
- 6 0
- 3 0
0
M a le
L o g  M  [N S 3 0 9 ]
R
e
la
x
a
ti
o
n
(%
 
U
4
66
1
9-
in
du
c
e
d 
to
n
e
)
L -N A M E , in do m eth ac in  (n = 6)
L -N A M E , in do m ethac in ,
T R A M -3 4 , ap a m in  (n = 6)
D
3
6
9
120
-7 -6 -5 -4
- 1 2 0
- 9 0
- 6 0
- 3 0
0
F e m a le
L o g  M  [N S 3 0 9 ]
R
e
la
x
a
ti
o
n
(%
 
U
46
61
9-
in
du
c
e
d 
to
n
e
)
L -N A M E , ind om ethac in  (n= 10)
L -N A M E , in do m ethac in ,
T R A M -3 4 , ap am in  (n = 1 0)
E
*
3
6
9
120
 
Figure 2.14 Log concentration-response curves for the vasorelaxant effects of 
NS309 in the presence of 300 µM L-NAME, 10 µM indomethacin and 10 µM 
TRAM-34 in U46619 pre-contracted porcine coronary arteries from (C) male 
pigs or in the presence of both apamin and TRAM-34 in (D) male and (E) 
female pigs. Data are expressed as a percentage change from U46619-induced 
tone and are mean ± S.E.M. of 6-10 experiments. *P<0.05; 2-tailed, paired 
6WXGHQW¶V t-test. 
77 
 
2.3.13 The effects of 60 mM KCl or U46619-induced tone on NS309-
induced vasorelaxation in PCAs from female pigs 
Additional experiments to examine the selectivity of NS309 were carried out 
by pre-contracting vessels with either 60 mM KCl or U46619 in the presence 
of L-NAME and indomethacin (Figure 2.15A). Vessels pre-contracted with 
either U46619 or KCl produced a similar maximum relaxation to NS309 such 
that the Rmax for U46619 pre-contracted vessels was 113 ± 3% compared to 
Rmax of 116 ± 3% in vessels pre-contracted with KCl. However, vessels pre-
contracted with KCl significantly shifted the NS309-induced vasorelaxation 
curve 8.1-fold to the right (P<0.001) compared to vessels pre-contracted with 
U46619 (Figure 2.15A) (pEC50 = 5.67 ± 0.04, pre-contracted with U46619; 
pEC50 = 4.76 ± 0.02, pre-contracted with KCl, n=6). See Figure 2.15B for 
original trace showing responses to NS309. 
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Figure 2.15 (A) Log concentration-response curves for the vasorelaxant 
effects of NS309 in the presence of 300 µM L-NAME and 10 µM 
indomethacin pre-contracted with either U46619 or 60 mM KCl in porcine 
coronary arteries from female pigs. Presence of 60 mM KCl significantly 
shifted the NS309-induced vasorelaxation 8.1-fold to the right (P<0.001; 2-
tailed, SDLUHG6WXGHQW¶V t-test).  Data are expressed as a percentage change from 
U46619- or KCl-induced tone and are mean ± S.E.M. of 6 experiments. (B) 
Original trace showing the responses to increasing concentration of NS309, a 
selective SKCa and IKCa channels activator. 
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2.4 Determination of expressions of Connexins 37, 40 and 43 and IKCa in 
PCAs from male and female pigs via Western blotting  
Western Blot analysis demonstrated the presence of connexin 43 (Figure 
2.16A), connexin 40 (Figure 2.17A) and IKCa (Figure 2.19A), but connexin 37 
(Figure 2.18) proteins were not detected in PCAs from male and female pigs. 
Further quantitative analysis based on the ratio of the protein band intensities 
to their respective loading control showed no significant differences between 
PCAs from male and female pigs in connexin 43:MLC (Figure 2.16B), 
connexin 40:GAPDH (Figure 2.17B),  and IKCa:GAPDH (Figure 2.19B). In 
Figure 2.17A and 2.18 the presence of the red lower band below 37 kDa is a 
non-specific band produced by the secondary antibody, IRDye® 680LT Goat 
anti-rabbit IgG (1:10 000) (LI-COR Biosciences, Cambridge, UK) (Figure 
2.17C). For connexin 40 (Figure 2.17A), no bands were observed at 40 kDa in 
the absence of the primary antibody (Figure 2.17C). 
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Figure 2.16 (A) Connexin 43 (43 kDa) and MLC (18 kDa) expression levels in 
5 µg of porcine coronary artery samples (PCAs) from female (F1-F5) and male 
(M1±M5) pigs. (B) Ratio of the expression levels of connexin 43 to MLC in 
male and female PCAs based on the intensities of their bands. Data are 
expressed in the ratio of Cx43 to MLC intensities bands and are mean ± S.E.M. 
of 5 PCAs. 
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Figure 2.17 (A) Connexin 40 (40 kDa) and GAPDH (~37 kDa) expression 
levels in 10 µg of porcine coronary artery samples (PCAs) from female (F6±
F10) and male (M6±M9) pigs with 20 µg of pig kidney (PK) lysate as positive 
control. (B) Ratio of the expression levels of Cx40 to GAPDH in male and 
female PCAs based on the intensities of their bands. (C) Blot incubated with 
secondary antibody alone demonstrating that the lower band slightly above 25 
kDa is a non-specific band produced by the secondary antibody, IRDye® 
680LT Goat anti-rabbit IgG with no bands observed at 40 kDa in the absence 
of the primary antibody. Data are expressed in the ratio of Cx40 to GAPDH 
intensities bands and are mean ± S.E.M. of 4-5 PCAs. 
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Figure 2.18 &RQQH[LQ  a N'D DQG ȕ-actin (42 kDa) expression levels in 
15 µg of porcine coronary artery samples from female (F7±F9) and male (M6±
M8) pigs with 20 µg of pig (PK) and rat kidney (RK) lysate as positive 
controls.       
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Figure 2.19 (A) IKCa (47.5 kDa) and GAPDH (~37 kDa) expression levels in 
15 µg of porcine coronary artery samples (PCAs) from female (F6±F10) and 
male (M6±M10) pigs with 10 µg of pig kidney (PK) lysate as positive control. 
(B) Ratio of the expression levels of IKCa to GAPDH in male and female PCAs 
based on the intensities of their bands. Data are expressed in the ratio of IKCa 
to GAPDH intensities bands and are mean ± S.E.M. of 5 PCAs. 
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2.5 Polymerase chain reaction (PCR) amplification of the Sry gene 
for sex identification in pigs 
2.5.1 The effects of DNA purification on PCR of the Sry gene 
Preliminary work demonstrated that purified DNA samples (Figure 2.20B) 
produced a sharper Zfy/Zfx band (447 bp) compared to unpurified samples 
(Figure 2.20A) and that PCR amplification of the Sry band (163 bp) in DNA 
VDPSOHV IURP SLJV¶ KHDUW ZLWK PDOH DQG female samples from rat liver (MK and 
FK) as positive control was unsuccessful. Failure of the PCR amplification in 
rat liver could be due to species differences as the primers were based on 
porcine DNA sequence.  
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Figure 2.20 PCR amplification of the Sry gene for sex identification in porcine 
heart tissue using (A) unpurified and (B) purified DNA samples. Upper band 
(445 bp) corresponds to the positive control Zfy/Zfx PCR product and (B) 
purified samples produced a sharp and strong band compared to (A) unpurified 
samples. However, amplification of the Sry band (163 bp) was unsuccessful 
under both conditions. Lane m = DNA ladder, MK = liver from male rat and 
FK = liver from female rat were used as positive controls for the Sry gene but 
no band was observed, this could possibly be due to species differences as the 
Sry primers for PCR amplification were based on porcine.  
 
 
 
 
 
 
A 
B 
447/445 bp 
(Zfy/Zfx) 
447/445 bp 
(Zfy/Zfx) 
F       M      M       M      M     M     MK     FK     m 
m     FK     MK    M      M     FK     MK     M     M 
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2.5.2 Optimisation of the PCR conditions varying the annealing 
temperature and magnesium chloride concentration 
As the PCR amplification of the Sry gene was successful, a range of annealing 
temperatures and different concentrations of magnesium chloride were 
examined. Figure 2.21 demonstrates that the annealing temperature of 54°C 
appeared to be the optimised condition for PCR amplification, a temperature 
previously used by Brya & Koneân (2003) for sex identification.  
 
Figure 2.21 Varying annealing temperatures for confirmation of the Sry PCR 
DPSOLILFDWLRQ LQ SXULILHG '1$ VDPSOHV IURP IHPDOH ) DQG PDOH 0 SLJV¶
heart tissues. Lane 1 (marker), lanes 2-3 (PCR amplification of female DNA in 
duplex was unsuccessful), lanes 4-11 (two different male DNA samples 
annealed under different temperature and 54°C appeared to produce the 
strongest band). 
 
 
 
 
 
 
163 bp (Sry)? 
m     54      54     42    45     50     54     42      45     50     54    
F       F                   M                                M 
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Next, different concentrations of magnesium chloride were examined in 
singleplex or duplex PCR reaction using purified DNA samples from male 
pigs.  Figure 2.22 demonstrated no differences in the Zfy-Zfx band between 1.5 
- 2.5 mM of magnesium chloride concentrations and that amplification of the 
Sry band was unsuccessful either in singleplex or duplex form. It was later 
GLVFRYHUHG WKDW WKH ¶ GRZQVWUHDP SULPHU RUGHUHG ZDV QRW FRQYHUWHG DQG
inverted, contributing to the failure in amplifying the Sry band. New primer 
was re-ordered for subsequent experiments.  
 
Figure 2.22 Varying magnesium chloride concentrations for confirmation of 
the Sry/Zfy-Zfx PCR amplification in singleplex (1-6) or duplex (7-8) using 
SXULILHG '1$ VDPSOHV IURP PDOH SLJV¶ KHDUW WLVVXHV /DQH  PDUNHU
singleplex of Zfy/Zfx PCR amplification (1, 3, 5) and singleplex of Sry PCR 
amplification (2, 4, 6). Upper band (447 bp) corresponds to the positive control 
of the Zfy/Zfx PCR product but the lower faint band (~250 bp) do not 
correspond to the Sry PCR product. Amplification of the Sry gene was 
XQVXFFHVVIXO EHFDXVH WKH ¶ GRZQVWUHDP SULPHU ZDV QRW LQYHUWHG DQG
converted. New primer was ordered for subsequent experiments.  
 
 
 
 
 
447/445 bp 
(Zfy/Zfx) 
m       1         2        3        4         5        6        7         8 
1.5 mM        2 mM         2.5 mM 1.5 mM 2 mM  
87 
 
2.5.3 The effects of running singleplex or duplex PCR amplification 
Using a new set of primers, PCR amplification of the Sry/Zfy-Zfx genes were 
carried out in singleplex or duplex using purified DNA samples from male and 
female pigs (Figure 2.23). Results demonstrated that running Zfy-Zfx in 
singleplex form a stronger band compared to duplex with no differences in the 
visibility of the Sry band. Figure 2.23 also demonstrates that the Sry band was 
stronger in males compared to females (last two lanes).  
         
Figure 2.23 Confirmation of Sry/Zfy-Zfx PCR amplification in singleplex or 
GXSOH[ XVLQJ SXULILHG '1$ VDPSOHV IURP PDOH 0 DQG IHPDOH ) SLJV¶ KHDUW
tissues. Lane 1 (marker), lane 2-3 PCR amplification in singleplex and lane 4-6 
PCR amplification in duplex. Upper band (447 bp) corresponds to the positive 
control of the Zfy/Zfx PCR product. Lane 4 and 5 were DNA samples from two 
different male pigs extracted on separate days. The 163 bp band visualised was 
stronger in males compared to females. 
 
 
 
duplex singleplex 
m         M         M         M         M         F 
163 bp (Sry) 
447/445 bp 
(Zfy/Zfx) 
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2.5.4 PCR amplification of the Sry gene for sex identification in pig tissue 
samples collected from hearts used for myograph and Western Blot study 
8VLQJ SXULILHG '1$ VDPSOHV IURP PDOH DQG IHPDOH SLJV¶ KHDUW WLVVXH ZKLFK
correspond to the PCAs used for Western Blotting and myography studies, 
PCR amplification of the Sry (Figure 2.24A) and Zfy-Zfx (Figure 2.24B) were 
conducted in singleplex. Figure 2.24A demonstrated that the Sry band was 
detected in all male DNA samples (n=7) and not in female DNA samples (n=6) 
collected on separate days.  
Figure 2.25 demonstrated that the Sry band (163 bp) was detected in 
five out of six male DNA samples and not in the female samples (n=7). In the 
female DNA samples, seven out of the eight PCR amplification were 
successful, using the Zfy-Zfx band as positive control for successful PCR 
(Bryja & Koneân, 2003; Pomp et al., 1995) and the Sry band was absence in 
the female samples.  
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Figure 2.24 Confirmation of (A) Sry and (B) Zfy-Zfx in singleplex PCR 
DPSOLILFDWLRQ XVLQJ SXULILHG '1$ VDPSOHV IURP PDOH DQG IHPDOH SLJV¶ KHDUW
tissue which correspond to the porcine coronary arteries used for Western 
blotting and myography studies. Lane m = marker, M = male and F = female. 
Upper band (447 bp) corresponds to the positive control of the Zfy/Zfx PCR 
product. Singleplex PCR amplification of the Zfy/Zfx in B was from the same 
samples as A except for the last two lanes in B where the Sry primers were 
added and here the 163 bp band detected was stronger in males compared to 
females.  
 
 
 
 
A 
447/445 bp 
(Zfy/Zfx) 
163 bp  
(Sry) m    M    M   M   M   M   M    M    F     F    F     F    F     F    F   M 
B 
m    M    M     M     M    M     M    M     F      F      F      F     F      F    
163 bp  
(Sry) 
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Figure 2.25 Confirmation of Sry/Zfy-Zfx PCR amplification in duplex using 
unpurified '1$ VDPSOHV IURP PDOH DQG IHPDOH SLJV¶ KHDUW WLVVXH ZKLFK
correspond to the porcine coronary arteries used in Western blotting and 
myography studies. Lane m = marker, M = male and F = female. Upper band 
(447 bp) corresponds to the positive control of the Zfy/Zfx PCR product and 
appears fainter in the males compared to females due to competing Sry 
amplification system in the males.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
447/445 bp 
(Zfy/Zfx) 
163 bp  
(Sry) 
m     M    M   M   M    M    M     F     F     F     F     F     F     F     F    
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2.6 Discussion  
In PCAs from either sex, bradykinin produced a concentration-dependent 
vasorelaxation with a maximum relaxation of almost 90% and this relaxation 
was abolished with the removal of endothelium. This indicates that the 
vasorelaxation to bradykinin in porcine isolated coronary arteries is 
endothelium-dependent and a similar observation had been previously reported 
by Nagao & Vanhoutte (1992). Treatment with indomethacin alone had no 
effect on the bradykinin-induced vasorelaxation, whereas treatment with L-
NAME alone significantly reduced the maximum vasorelaxation to bradykinin 
in PCAs from either sex. This result demonstrated that the endothelium-
derived nitric oxide plays a significant role in the endothelium-dependent 
relaxation to bradykinin. In the presence of L-NAME, a residual relaxation was 
observed in the present study and this relaxation was insensitive to the 
presence of indomethacin. The substantial proportion of bradykinin-induced 
vasorelaxation which is insensitive to NO synthase inhibition and 
cyclooxygenase inhibition is attributed to endothelium-derived 
hyperpolarization (EDH)-type response (Edwards et al., 2010; McCulloch et 
al., 1997; Taylor & Weston, 1988).  
In the second part of the study, a significant sex difference in the EDH-
mediated response induced by bradykinin was demonstrated. Specifically, the 
EDH responses were more prominent in females compared to males. Similar 
conclusions have been made in previous studies including isolated mesenteric 
arteries from rats (McCulloch & Randall, 1998; White et al., 2000), mesenteric 
DUWHULHV IURP µ('+ PLFH¶ H126&2;-1 double knockout mouse) as well as 
an in vivo VWXG\ ZLWK µ('+ PLFH¶ (Scotland et al., 2005). However, another 
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study in PCAs reported that the presence of L-NAME and indomethacin did 
not show any significant sex differences in the endothelium-dependent 
vasorelaxation to bradykinin (Barber & Miller, 1997). This difference could 
possibly be due to the size of the vessels used. In the present study, small distal 
PCAs, where EDH is believed to be more prominent in endothelium-dependent 
relaxations (Shimokawa et al., 1996), were used.  However, in the study 
conducted by Barber et al., (1997), the size of the vessels used was not 
reported.  
To examine if the enhanced EDH-type relaxation in PCAs from female 
pigs could be influenced ex vivo by oestrogen levels, the present study 
examined the effects of low concentrations (1 nM) and high concentrations (1 
0 ȕ-estradiol on bradykinin-induced EDH-type relaxation in PCAs from 
male pigs. Treatment with 1 Q0 ȕ-estradiol for 2 h in the presence of L-
NAME and indomethacin had no effect on the bradykinin-induced 
vasorelaxation. A similar result has previously been reported, where acute 
exposure (20 min) of 1 Q0ȕ-estradiol or 24 h exposure to 1 nM ± 100 nM 
ȕ-estradiol in PCAs from either sex had no effect on the bradykinin-induced 
vasorelaxation (Cox et al., 2005; Teoh & Man, 2000). However, in the present 
VWXG\ H[SRVXUH WR KLJK FRQFHQWUDWLRQV RI ȕ-estradiol (1 µM) for 4 h 
significantly inhibited the bradykinin-induced EDH-type relaxation in PCAs 
from male pigs. This is in contrast to a previous study in isolated carotid 
DUWHULHV IURP PDOH UDEELWV ZKHUH FKURQLF WUHDWPHQW  ZHHNV RI ȕ-estradiol 
had no effect on the acetylcholine-induced EDH-type responses in control 
animals, but significantly enhanced the EDH-type responses in 
hypercholesterolaemic animals (Ghanam et al., 2000). Here, the mechanism in 
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ZKLFK  0 ȕ-estradiol inhibited the EDH-mediated response remains 
unclear and is beyond the scope of the present study. The sex of the PCAs used 
in the present study was confirmed by PCR amplification of the Sry (sex-
determining region Y) gene.  
The present study also demonstrates that NO plays a greater role in 
PCAs from male pigs compared to female pigs. This could possibility be due 
to higher expression levels of eNOS in males compared to females as a 
previous study in rat thoracic aortae reported that the gene expression levels of 
eNOS mRNA is higher in male rats compared to female rats (Kerr et al., 
1999). However, expression levels of eNOS alone do not necessarily translate 
to activity and function of NO because NO availability decreases rapidly as it 
reacts with superoxide anion (O2-) forming peroxynitrite (Figure 2.26A) (Kerr 
et al., 1999).  
Another relevant endogenous mediator is H2O2, formed by spontaneous 
dismutation or catalysed by superoxide dismutase (SOD) (Figure 2.26B) 
(Shimokawa, 2010). H2O2 on its own has previously been reported to produce 
a concentration-dependent vasorelaxation in PCAs (Matoba et al., 2003) and 
studies have reported that H2O2 is an EDH mediator (Edwards et al., 2008; 
Hammond et al., 2011; Matoba et al., 2002; Matoba et al., 2003; Matoba et al., 
2000; Shimokawa & Morikawa, 2005) or modulator (Wheal et al., 2012). 
Therefore, the present study investigated the effects of sex differences in 
endothelium-derived H2O2. Here, the presence of PEG-catalase alone 
significantly reduced the vasorelaxation to bradykinin in PCAs from females, 
but not males. This result suggests that endogenous H2O2 plays a significant 
role in the responses induced by bradykinin in PCAs, but only in female pigs. 
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Conversely, in the presence of L-NAME and indomethacin, PEG-catalase did 
not affect the bradykinin-induced vasorelaxation in PCAs from both sexes, 
indicating that H2O2 does not play a significant role in the EDH-mediated 
pathway in distal PCAs. These findings differ from a previous study conducted 
on the male porcine coronary arteries where they have concluded that H2O2 is 
an EDH mediator (Matoba et al., 2003). In their study, porcine coronary 
microvessels (250 - 300 µm in diameter) were used and endothelium-
dependent vasorelaxations to bradykinin were insensitive to indomethacin and 
L-NAME, which also differs from the findings in the present study. These 
differences, or at least that in the absence of NO/PGI2, could be due to the 
difference in vessel size used. In the present study, experiments were repeated 
with a higher concentration of PEG-catalase (600 Uml-1) in PCAs from males, 
but no further inhibition of the bradykinin-induced vasorelaxation was 
observed. Thus, the possibility that insufficient PEG-catalase concentration 
was used can be excluded. Endothelium-derived H2O2 can be generated from 
superoxide anion (O2 -) as a by-product from the catalysis of L-arginine to NO 
by endothelial NO synthase (eNOS) (Figure 2.26A) (Heinzel et al., 1992). 
Previous studies have reported that L-NAME caused a reduction in O2± 
generation (Kerr et al., 1999) and inhibition of H2O2 formation (Heinzel et al., 
1992). Therefore, it is possible that formation of endogenous H2O2 in distal 
PCAs used in the present study is dependent on the eNOS system where 
formation of H2O2 is inhibited in the presence of L-NAME. However, it should 
be noted that all present experiments were conducted in the presence of both L-
NAME and indomethacin, therefore the involvement of the cyclo-oxygenase or 
prostanoid pathway in the effect of H2O2 cannot be ruled out.   
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On the other hand, in the NO-mediated response, a higher level of NO 
in PCAs from males could have reacted with superoxide forming peroxynitrite 
rather than H2O2, as it has been previously reported that the reaction of 
superoxide with NO is three to four times faster than with SOD (Wolin, 2009).  
This could be a possible explanation as to why H2O2 did not play a role in the 
NO-mediated pathway in males. As for the response observed in PCAs from 
female pigs where endothelium-derived H2O2 plays a role in the NO-mediated 
bradykinin-induced vasorelaxation, it is possible that a higher level of SOD is 
present in the endothelial cells in females leading to H2O2 formation. A 
previous study in mitochondria isolated from rat brain and liver showed higher 
expression and activities of manganese-SOD (Mn-SOD) and glutathione 
peroxidase in females compared to males, therefore providing a protective 
effect in females during oxidative stress (Borras et al., 2003). However, further 
studies to determine the SOD levels and activity are required. Also, as 
superoxide anions in blood vessels can be generated from a few different 
pathways (Wolin, 2009) including NAPDH oxidase, it is possible that there are 
sex differences in the upstream reaction. Previous studies in age-matched rat 
aortae (Brandes & Mugge, 1997) and in young healthy human subjects (Ide et 
al., 2002) concluded that males experience a greater oxidative stress compared 
to females and this is attributed to the increased production of O2 ± and reduced 
activity/availability of O2 ± scavengers.   
Next, the role of gap junctional communication in male and female 
arteries was investigated as it has been reported that gap junctions play a role 
in the EDH-type response. Here, the effects of two different inhibitors 
(carbenoxolone and Į-glycyrrhetinic acid) were examined either alone or in 
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combination with L-NAME and indomethacin against bradykinin-induced 
vasorelaxation. In PCAs from male and female pigs, the presence of 
carbenoxolone or Į-glycyrrhetinic acid alone had no effect on 
vasorelaxation to bradykinin indicating that gap junctional communication 
does not play a significant role in the NO-mediated response. Conversely, in 
the EDH pathway, carbenoxolone significantly reduced the maximum 
relaxation to bradykinin in PCAs from female but not male pigs. The 
inhibitory effects of both carbenoxolone and Į-glycyrrhetinic acid in the 
presence of L-NAME and indomethacin confirm that gap junction 
communication plays a significant role in the EDH responses induced by 
bradykinin in PCAs from female pigs, but not male pigs. The finding in PCAs 
from female pigs concur with previous studies on isolated myometrial arteries 
and subcutaneous resistance arteries from pregnant women (Kenny et al., 
2002b; Lang et al., 2007) while the finding in PCAs from male pigs is in 
DJUHHPHQW ZLWK D SUHYLRXV VWXG\ XVLQJ Į-glycyrrhetinic acid in PCAs from 
male pigs (Matoba et al., 2003). Gap junctions have been reported to play a 
role in both NO-dependent and EDH-mediated endothelium-dependent 
vasorelaxation in mesenteric arteries and thoracic aortae from male rabbits 
(Chaytor et al., 1998), human mesenteric arteries (Chadha et al., 2011) and 
PCAs of unspecified sex (Edwards et al., 2000). However, another study 
conducted on PCAs of unspecified sex using three different types of gap 
MXQFWLRQ LQKLELWRUV Į-glycyrrhetinic acid, 1-heptanol and Gap27) had no 
effect on the EDH response (Yang et al., 2003). In the NO-dependent 
responses of the present study, the difference in findings could be due to the 
difference in the size and/or type of vascular tissue used or species differences 
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(Feletou & Vanhoutte, 2006). The inconsistency of findings for the role of gap 
junctions in all previous studies could possibly be due to the unspecified sex 
used (Chadha et al., 2011; Yang et al., 2003). As Cx43 has previously been 
implicated in EDH-mediated relaxations (Lang et al., 2007), the present study 
investigated whether the differential expression of this protein could explain 
the difference in the sensitivity to gap junction inhibition. However, the 
Western Blot analysis for Cx43 protein in PCAs from male and female pigs 
did not detect any differences in the expression level of this gap junction 
protein, indicating that expression per se does not contribute to the sex 
differences observed. Further Western Blot analysis on other subtypes of 
connexin proteins that have been previously identified in blood vessels 
(Chaytor et al., 2003; de Wit & Griffith, 2010; Lang et al., 2007) showed no 
differences in the expression level of Cx40 proteins and Cx37 proteins were 
not detected in PCAs from male or female pigs. Therefore, the differences in 
EDH-mediated responses between PCAs from male and female pigs may be 
due to differences in gap junctional communication, rather than expression of 
gap junction proteins. For example, it could be that the calcium-activated 
potassium channels (Kca) (Chadha et al., 2011; Gluais et al., 2005a), which are 
located near the myoendothelial gap junctions differentially influence gap 
junctional communication between the sexes.  
Given the potential differences in KCa-channel activity between sexes, 
the effects of apamin, the small conductance calcium-activated potassium 
channel (SKCa) blocker, and TRAM-34, an inhibitor of intermediate 
conductance calcium-activated potassium (IKCa) channels on EDH-mediated 
responses (Chadha et al., 2011; Edwards et al., 2010; Gluais et al., 2005a; 
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Yang et al., 2003) were examined. The present study demonstrated that in the 
EDH-mediated response, IKCa channels play a role only in PCAs from female 
pigs, while the SKCa channels play a role in both sexes. This is in agreement 
with a previous study conducted on carotid arteries from male guinea-pigs 
where TRAM-34 alone had no effect on endothelium-dependent 
hyperpolarization, but apamin significantly inhibited acetylcholine-evoked 
hyperpolarization (Gluais et al., 2005a). Furthermore, another study examining 
sex differences in EDH-mediated responses reported that apamin had the same 
effect on the maximum relaxation to acetylcholine in male and female rat 
mesenteric arteries (White et al., 2000), which is comparable to the present 
study. Taken together, the present study demonstrates that gap junctional 
communication and IKCa channels play a role in the EDH-mediated response in 
PCAs from female pigs, but not male pigs. Interestingly, previous studies using 
immunohistochemistry with specific antibodies have shown that IKCa channels 
are found co-localised with myoendothelial connexin proteins with their 
functionality being related to the EDH-mediated activity (Chadha et al., 2011; 
Sandow et al., 2006). A previous study in male obese rats demonstrated an 
upregulation in IKCa and MEGJ expression and activity to compensate for the 
loss of NO-mediated responses as observed in age-matched control male rats 
(Chadha et al., 2010). However, Western Blot analysis in the present study for 
IKCa expression level showed no differences between PCAs from male and 
female pigs.      
In order to determine whether there is a difference in the function of 
IKCa channels between males and females, NS309 was used as a potent and 
selective SKCa and IKCa channel activator (Leuranguer et al., 2008a). NS309 
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produced a comparable concentration-dependent vasorelaxation in PCAs from 
male and female pigs. Blocking SKCa channels specifically with apamin had no 
effect on the NS309-induced vasorelaxation in either male or female pigs. 
Further experiments blocking IKCa channels specifically with TRAM-34 also 
had no effect on the NS309-induced vasorelaxation. This finding is in line with 
a previous study measuring the membrane potential of guinea pig carotid 
arteries where NS309 (10 µM)-induced hyperpolarization was not significantly 
affected by TRAM-34 or apamin alone in the presence of L-NAME and 
indomethacin. It is therefore possible that when either SKCa or IKCa channels 
are blocked separately there is a compensatory response involving the other 
KCa channels activated by NS309. However, blocking both SKCa and IKCa 
channels together had little effect on the NS309-induced vasorelaxation, 
although there was slight inhibition at 0.3 µM in PCAs from female pigs. 
These data suggest that NS309 is not mediating relaxation through SKCa or 
IKCa channels in the PCAs and therefore cannot be used to determine if there is 
a difference in the activity of these channels between males and females. 
Additional experiments to investigate the selectivity of NS309 using high 
potassium demonstrated that at higher concentration of NS309 (>3 µM) other 
vasorelaxation pathway may be involved. This observation is in line with 
previous studies where loss of selectivity for IKCa and SKCa has been reported 
at higher concentrations of NS309 (Dalsgaard et al., 2009; Kroigaard et al., 
2012). Furthermore, it has been reported that NS309 inhibits voltage-
dependent calcium-channels (Morimura et al., 2006). Therefore in the present 
study, use of NS309 as a selective activator of SKCa and IKCa is questionable 
and may not be suitable to draw any conclusion to support the bradykinin-
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induced vasorelaxation findings. NS309 is a more potent and selective SKCa 
and IKCa activator compared to other activators such as 1-EBIO (Leuranguer et 
al., 2008a) or DCEBIO (Morimura et al., 2006). 
In summary, the present study confirmed that bradykinin is an 
endothelium-dependent vasorelaxant, stimulating the release of NO- and EDH-
type mediated responses in PCAs. The second part of the study demonstrates 
that both NO and EDH-type responses contribute significantly towards the 
endothelium-dependent vasorelaxation induced by bradykinin in male and 
female isolated distal PCAs. Clear sex differences in endothelial function have 
been demonstrated where the EDH-type responses play a greater role in PCAs 
from female compared to male pigs. In PCAs from female pigs, endogenous 
H2O2 plays a role in the bradykinin-induced vasorelaxation. Furthermore, gap 
junctional communication and the IKCa channels appear to be more important 
in the EDH-mediated pathway in PCAs from female pigs and these could be 
compensation for the diminished response of NO-mediated pathway in PCAs 
from female pigs. The sex differences in endothelial function demonstrated in 
the present study may contribute to the cardiovascular protective effects 
observed in females (Figure 2.26B). 
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Figure 2.26 Hypothesized mechanism of action of sex differences in 
endothelial function to bradykinin-induced vasorelaxation in porcine coronary 
arteries from (A) male and (B) female pigs. Present study demonstrated a clear 
sex differences in endothelial function where only in PCAs from female pigs 
have greater EDH-mediated responses specifically the gap junction 
communication whereas endogenous H2O2 play a role in the NO-mediated 
pathway in female pigs. Figure adapted from Shimokawa (2010). 
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3.1 Introduction  
In Chapter 2, endogenous H2O2 has been reported to plays a role in the 
endothelium-dependent vasorelaxation in porcine distal coronary arteries 
(PCAs) from female but not male pigs. Other studies have reported that 
endothelium-derived H2O2 is a factor for EDH-type response in mouse, rat and 
human mesenteric arteries (Matoba et al., 2002; Matoba et al., 2000; Wheal et 
al., 2012), human coronary arterioles (Miura et al., 2003), porcine coronary 
microvessels (Matoba et al., 2003) and in canine coronary arteries (Yada et al., 
2003).  
Studies measuring membrane potential of vascular smooth muscle cells 
(VSMCs) from PCAs have also shown that exogenously applied H2O2 
hyperpolarizes and relaxes the smooth muscle (Beny & von der Weid, 1991; 
Matoba et al., 2003).  Elevation of H2O2 has been reported in various 
pathological states including ischaemia and reperfusion of rat brain, where up 
to 100 µM of H2O2 was detected (Hyslop et al., 1995). In human, plasma 
levels of the H2O2 detected in subjects with essential hypertension (3.36 ± 0.15 
µM, n=74) were significantly higher than in normotensive subjects (3.00 ± 
0.09 µM, n=162) (Lacy et al., 2000). High levels of H2O2 (>0.5 mM) have 
been reported to cause tissue injury in organ bath experiments (Ellis et al., 
2003; Walia et al., 2000), however the role of endothelial Nox4-derived H2O2 
remains contradictory as both protective (Ray et al., 2011; Schroder et al., 
2012) and damaging effects on vascular function have been reported 
(Montezano & Touyz, 2012). Therefore, further understanding of the 
mechanism of action of H2O2 may be beneficial for the development of new 
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strategies in treatment or prevention of diseases related to oxidative stress 
(Burgoyne et al., 2013). 
Studies of H2O2 in a variety of different vessels and species have 
demonstrated that H2O2 acts as a vasorelaxant via activation of potassium 
channels on the vascular smooth muscle (Barlow & White, 1998; Ellis et al., 
2003; Hayabuchi et al., 1998; Matoba et al., 2002; Matoba et al., 2003; 
Matoba et al., 2000; Miura et al., 2003; Ohashi et al., 2012; Rogers et al., 
2007; Rogers et al., 2006; Thengchaisri & Kuo, 2003; Wheal et al., 2012). 
However, inconsistencies in results have been reported when more specific 
potassium channel blockers were used. For example, use of iberiotoxin, 
charybdotoxin and/or apamin to inhibit large, intermediate and small-
conductance calcium activated potassium channels significantly reduce the 
H2O2-induced vasorelaxation in porcine coronary arteries (Hayabuchi et al., 
1998) and human coronary arterioles (Miura et al., 2003) but not in murine 
small mesenteric arteries (Ellis et al., 2003). The other discrepancy in results is 
the role of cGMP in the H2O2-mediated relaxation where some studies (Burke 
& Wolin, 1987; Hayabuchi et al., 1998) have demonstrated that blocking the 
guanylyl cyclase pathway inhibits H2O2-induced vasorelaxation but this is not 
universally supported (Barlow & White, 1998; Ellis et al., 2003; Miura et al., 
2003; Thengchaisri & Kuo, 2003).  
The aim of this chapter was to investigate the mechanism of action of 
exogenously applied H2O2 on PCAs, and specifically the involvement of 
potassium channels.  This was then extended to investigate the role of the 
ouabain-sensitive 3Na+/2K+-pump in the H2O2-induced vasorelaxation in 
PCAs.  
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3.2 Materials and Methods 
3.2.1 Preparation of rings of distal PCAs 
Tissues were set up as previously described in Chapter 2. 
3.2.2 Wire myograph study  
As previously described in Chapter 2, after 30 min of equilibration, the tissue 
response to 60 mM KCl was determined twice. The vascular tone was then 
raised to about 50-90% of the second KCl contraction with U46619 (1 nM - 50 
µM), a thromboxane A2-mimetic, or with KCl (60 mM) to examine the role of 
H2O2 as a factor for EDH. Once stable tone was achieved, concentration-
response curves to H2O2 (1 µM - 1 mM), bradykinin (0.01 nM - 1 µM), sodium 
nitroprusside (SNP) (10 nM - 10 µM) or verapamil (1 nM - 10 µM) were 
constructed. In some experiments where the vascular tone could not be 
maintained due to the effects of the inhibitors and slow response of the test 
drug, a single concentration response was examined instead (100 µM H2O2 or 
300 nM forskolin). Vasorelaxation to H2O2 was studied in the presence of NG-
nitro-L-arginine methyl ester (L-NAME) (300 µM), a NO synthase inhibitor 
and indomethacin (10 µM), a cyclooxygenase inhibitor to define EDH-type 
response. To study the role of the endothelium in H2O2-induced 
vasorelaxation, the endothelium of the vessels was removed mechanically by 
rubbing the lumen gently with stainless-steel forceps. PEG-catalase (300 Uml-
1) was added to eliminate intracellular H2O2 and carbenoxolone (100 µM) 
(Harris et al., 2002; Tang & Vanhoutte, 2008) was used as a non-selective gap 
junction inhibitor to examine the role of gap junctions. To inhibit potassium 
(K+) channels, tetraethylammonium (TEA) (10 mM) (Ellis et al., 2003; 
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McCulloch et al., 1997; Rogers et al., 2007; Uhiara et al., 2009) was used. 
Glibenclamide (1 µM) (Miura et al., 2003) was used as an ATP-sensitive K+ 
channel (KATP) inhibitor and 4-aminopyridine (4-AP) (1 mM) (Ellis et al., 
2003) was used as a voltage-gated K+ channel (KV) inhibitor. Barium chloride 
(30 µM) (Edwards et al., 1998) was used as an inwardly rectifying K+ channel 
(Kir) inhibitor.  Apamin (500 nM) (Weston et al., 2005), TRAM-34 (10 µM) 
(Gluais et al., 2005a) and iberiotoxin (100 nM) (Edwards et al., 2000; Rogers 
et al., 2007), small (SKCa), intermediate (IKCa) and large (BKCa) conductance 
calcium-activated potassium channel inhibitors respectively were used to study 
the role of selective K+ channels in the H2O2-induced vasorelaxation. In some 
preparations, paxilline (300 nM or 1 µM) (Wilson et al., 2000) was used as a 
potent inhibitor of the BKCa channels. Ouabain (500 nM) (Beny & Schaad, 
2000) was used to inhibit the sodium-potassium pump activity and 1H-[1,2,4] 
Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 µM) (Ellis et al., 2003; 
Hayabuchi et al., 1998; Li et al., 1998) was used to selectively inhibit soluble 
guanylyl cyclase activity. 2,4-dichlorobenzamil (DCB) (10 µM) was used as a 
Na+/Ca2+ exchanger inhibitor while KB-R7943 (10 µM)  was used as a 
selective inhibitor of the reverse mode of the Na+/Ca2+ exchanger (Coleman & 
Khalil, 2002).  
The concentration of U46619 used was significantly lower in the 
presence of L-NAME, indomethacin with ouabain ± barium (P<0.0001) or in 
endothelium denuded vessels (P<0.05) whereas the U46619 concentration used 
was significantly higher in the presence of glibenclamide (P<0.01) or KB-
R7943 (P<0.01) the in PCAs from females (Table 3.1A). The level of tone 
achieved with U46619 was the same under all conditions in PCAs from female 
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pigs except for in the presence of ouabain ± barium (P<0.05) or in the presence 
of KB-R7943 or 100 µM DCB (P<0.05) (Table 3.1A). The concentration of 
U46619 used was significantly lower in the presence of L-NAME, 
indomethacin with ouabain (P<0.0001) or 4-AP (P<0.05) in PCAs from males 
(Table 3.1B). The level of tone achieved with U46619 was the same under all 
conditions in PCAs from male pigs except for in the presence of high K+ 
(P<0.01) (Table 3.1B). 
As K+ has been previously reported to be a factor responsible for EDH, 
acting via activation of the 3Na+/2K+ ATPase (Edwards et al., 1998), the effect 
of 100 µM and 1 mM H2O2, 500 nM ouabain and endothelium denudation on 
KCl-induced vasorelaxation (0 ± 20 mM KCl added at the interval of 2 - 5 
min) in K+-IUHH .UHEV¶-Henseleit solution substituted with equimolar NaCl 
(Gallo et al., 2010; Harris et al., 2000) were examined. At the end of each 
experiment, successful removal of the endothelium was confirmed by 100 nM 
Substance P. All inhibitors were added 1 h before pre-contraction with 
U46619. 
To further examine the effects of H2O2 on the KCl-induced contraction, 
vessels were pre-incubated with 100 µM or 1 mM H2O2 for 30 min or 1 h 
IROORZHG E\ ZDVKLQJ RXW ZLWK .UHEV¶-Henseleit solutions for 1 h before being 
subjected to the third 60 mM KCl response. To study the effects of ouabain 
and H2O2 on Ca2+-induced contraction, calcium-IUHH .UHEV¶-Henseleit 
solutions were used. Vessels were pre-incubated with 500 nM ouabain or 100 
µM H2O2 for 1 h followed by the addition of 60 mM KCl. Once stable tone 
was achieved, concentration-response curves to calcium re-introduction (1 µM 
± 10 mM) were constructed.  
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A                   Female 
U46619-induced 
tone (% KCl 
response) 
Concentration of 
U46619 (nM) 
L-NAME, 
indomethacin 
Control 69.0 ± 5.2 20.0 ± 3.0 
Barium 63.6 ± 7.2 13.0 ± 2.6 
Ouabain 100 ± 6* 3.83 ± 1.96**** 
Barium, ouabain 106 ± 10* 0.33 ± 0.21**** 
Endothelium 
denuded 82.4 ± 15.9 10.0 ± 0* 
L-NAME, 
indomethacin 
Control 71.7 ± 3.0 16.7 ± 3.3 
High K+ 105 ± 6.7 60 mM KCl 
TEA 90.8 ± 16.7 7.7 ± 1.5 
Glibenclamide 68.5 ± 4.8 32.5 ± 4.4** 
 
Control 67.3 ± 6.7 17.5 ± 3.2 
Iberiotoxin 97.5 ± 5.4 13.8 ± 2.4 
ODQ 65.3 ± 8.1 16.3 ± 2.4 
Iberiotoxin, ODQ 67.8 ± 9.0 17.0 ± 3.7 
 
Control 56.3 ± 1.7 16.8 ± 0.2 
300nM Paxilline 61.3 ± 10.8 14.7 ± 1.5 
 
Control 54.2 ± 2.1 10.6 ± 1.9 
1µM Paxilline 61.0 ± 6.6 10.4 ± 1.6 
L-NAME, 
indomethacin 
Control 72.8 ± 4.0 18.2 ± 4.2 
10 µM DCB 71.4 ± 5.6 17.8 ± 1.4 
10 µM KB-R7943 53.8 ± 2.1* 94.0 ± 26.0** 
500 nM ouabain 87.6 ± 5.9 0.60 ± 0.24 
L-NAME, 
indomethacin 
Control 71.0 ± 6.5 35.0 ± 6.3 
100 µM DCB 43.0 ± 5.5* 3074 ± 1339 
 
B                     Male U46619-induced tone (% KCl response) 
Concentration of 
U46619 (nM) 
L-NAME, 
indomethacin 
Control 69.7 ± 6.1 16.7 ± 2.3 
Ouabain 83.0 ± 5.1 0.83 ± 0.54**** 
4-AP 64.0 ± 9.9 8.4 ± 1.9* 
High K+ 103 ± 2.0** 60 mM KCl 
 
Table 3.1 Summary of U46619 concentration used (nM) and the levels of tone 
achieved with U46619 expressed in percentage to the second KCl-induced tone 
in porcine coronary arteries from (A) female and (B) male pigs. Data are 
expressed as mean ± S.E.M. of 3-9 experiments. *P<0.05, **P<0.01, 
****P<0.0001; one-ZD\$129$ IROORZHGE\%RQIHUURQL¶V post hoc test or 2-
WDLOHG SDLUHG6WXGHQW¶V t-test.  
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3.2.3 Atomic absorption spectrophotometric determination of 3Na+/2K+ 
ATPase activity  
The methodology for measuring rubidium-uptake using atomic absorption 
spectrophotometry (Perkin-Elmer, Coventry, UK) to study the sodium-
potassium pump activity was adapted from Longo et al., (1991). Finely 
dissected PCAs, cleaned of adherent connective and fatty tissues, were cut 
open longitudinally. PCA segments were then cut into 1.0 - 1.5 cm in length 
and placed into 6-well plates pre-filled with 3 PO .UHEV¶-Henseleit solution 
previously gassed with 5% CO2 and 95% O2. Test agents (500 nM or 10 mM 
ouabain, 10 µM, 100 µM or 1 mM H2O2) were added into the respective wells 
and plates were incubated at 37°C in a shaker for 30 min. After 30 min, 
.UHEV¶-Henseleit solution was replaced with K+-IUHH .UHEV¶-Henseleit solution 
containing 4 mM RbCl with respective inhibitors and incubated at 37°C in a 
shaker for an additional 30 min. Arteries were then rapidly washed three times 
with ice-cold 0.2 M MgSO4 then stored at -20°C until further assay. Frozen 
segments were fixed with 2 mL fixative (containing 50% ethanol, 49% 
distilled water and 1% acetic acid) and left to evaporate in a fume hood 
overnight. Intracellular Rb+ was then extracted in 2 mL of distilled water and 
the Rb+ content was determined with flame photometry on an atomic 
absorption spectrometer using wavelength of 780 nm. Rb+-uptake levels were 
interpolated from a standard Rb+ curve and individual PCA reading was 
divided by the wet weight of the respective artery segment. 
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3.2.4 Statistical analysis 
Data for the functional studies were presented and analysed as described in 
Chapter 2. In data where the Rmax were not achieved, data were analysed using 
the response generated at the highest concentration of vasorelaxant or at each 
individual concentration of vasorelaxant. Results of the Rb+-uptake 
experiments were analysed using one-way ANOVA followed by DunnetW¶V
multiple comparison test against the control.  
 
3.2.5 Drugs and chemicals 
All drugs were purchased from Sigma-Aldrich (Poole, Dorset, UK) unless 
otherwise indicated. Apamin, KB-R7943, paxilline and forskolin were 
purchased from Tocris Bioscience (Bristol, UK) and 2,4-dichlorobenzamil 
(DCB) from Enzo Life Sciences (Exeter, UK). All drugs were dissolved in 
distilled water except for indomethacin which was dissolved in absolute 
ethanol and TRAM-34, glibenclamide, DCB and KB-R7943 were dissolved in 
DM62 7($ ZDV GLVVROYHG GLUHFWO\ LQWR .UHEV¶-Henseleit solution. Stock 
solutions of bradykinin and U46619 were made to 10 mM and H2O2 to 100 
mM with distilled water. All further dilutions of the stock solutions were made 
using distilled water. 
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3.3 Results 
3.3.1 The effects of L-NAME, indomethacin, carbenoxolone and PEG-
catalase on H2O2±induced vasorelaxation in PCAs from female pigs 
H2O2 (1 µM±1 mM) produced concentration-dependent vasorelaxations in 
PCAs from females with an Rmax of 100 ± 16% (pEC50 = 4.18 ± 0.20, n=4) 
under control conditions. The presence of PEG-catalase
 
significantly reduced 
the Rmax for relaxation to H2O2 to 41.2 ±14.5% (pEC50 = 4.00 ± 0.48, n=4) 
(P<0.05)
 
but did not affect the potency (Figure 3.1). Relaxations to H2O2 were 
unaffected by the presence of L-NAME and indomethacin (pEC50 = 4.00 ± 
0.05, n=6) or carbenoxolone (pEC50 = 4.08 ± 0.12, n=4) (Figure 3.1). 
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Figure 3.1 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the absence or presence of 300 µM L-NAME, 10 µM indomethacin, 
100 µM carbenoxolone or 300 Uml-1 PEG-catalase in U46619 pre-contracted 
porcine coronary arteries from female pigs. Data are expressed as a percentage 
change from U46619-induced tone and are mean ± S.E.M. of 4-6 experiments. 
* P<0.05; one-ZD\ $129$IROORZHG E\%RQIHUURQL¶V post hoc test. 
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3.3.2 The effects of potassium channel inhibitors on hydrogen peroxide ±
induced vasorelaxation in PCAs from male or female pigs 
In PCAs from female pigs, in the presence of L-NAME and indomethacin, 
removal of the endothelium or pre-treatment of vessels with 30 µM barium 
chloride had no effect on the H2O2-induced vasorelaxation (n=5) (Figure 
3.2A). The presence of 500 nM ouabain significantly inhibited the H2O2-
induced vasorelaxation (n=6) (P<0.0001) and this was not significantly altered 
by the additional presence of barium chloride (n=5) (Figure 3.2A). In the 
presence of L-NAME and indomethacin, 10 mM TEA significantly inhibited 
the relaxation at 100 µM H2O2 (P<0.05) (n=6) (Figure 3.2B). High 
extracellular KCl (60 mM) essentially abolished the relaxation to H2O2 at 
concentrations up to 300 µM (n=5) (Figure 3.2B). The presence of 1 µM 
glibenclamide had no effect on the H2O2-induced vasorelaxation (n=6) (Figure 
3.2B). 
In Chapter 2, sex differences in the role of endogenous H2O2 in PCA in 
bradykinin-induced vasorelaxation were reported, therefore, here the effects of 
H2O2-induced vasorelaxation in PCAs from male pigs were examined. Under 
control conditions there were no sex differences between the H2O2-induced 
vasorelaxation where the relaxation produced at 1 mM of H2O2 in male PCAs 
was 98 ± 2% (n=9) (Figure 3.2C). Again, the presence of ouabain or 60 mM 
KCl significantly inhibited the H2O2-induced vasorelaxation producing a 
relaxation of 32 ± 5% (n=6) and 52 ± 9% (n=5) respectively at 1 mM H2O2 
(P<0.0001). Pre-treatment with 1 mM 4-AP had no effect on the 
vasorelaxation (n=4) (Figure 3.2C). For original trace see Figure 3.2D. 
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Figure 3.2 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the presence of 300 µM L-NAME, 10 µM indomethacin with (A) 
removed endothelium, 30 µM barium chloride and/or 500 nM ouabain (B) 60 
mM KCl, 10 mM TEA or 1 µM glibenclamide in U46619 pre-contracted 
porcine coronary arteries from female pigs and (C) 500 nM ouabain, 1 mM 4-
AP or 60 mM KCl in PCAs from male pigs. Data are expressed as a percentage 
change from U46619-induced tone and are mean ± S.E.M. of 4-9 experiments. 
*P<0.05, ****P<0.0001; one-ZD\ $129$ IROORZHGE\%RQIHUURQL¶V post hoc 
test. 
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Figure 3.2 (D) Original traces showing the responses to U46619 pre-
contracted porcine coronary arteries and responses to increasing concentration 
of hydrogen peroxide. 
 
3.3.3 The effects of soluble guanylyl cyclase inhibitor (ODQ) and selective 
BKCa channel inhibitors on hydrogen peroxide (H2O2)±induced 
vasorelaxation in PCAs from female pigs 
In PCAs from females, the soluble guanylyl cyclase inhibitor 10 µM ODQ had 
no effect on the H2O2-induced vasorelaxation (n=4) (Figure 3.3A). As no 
effect was observed in the presence of ODQ, a further experiment to examine 
the effects of ODQ was carried with a concentration-response curve to sodium 
nitroprusside (SNP). At 10 µM SNP, the relaxation was significantly reduced 
from 104 ± 2% to 18.5 ± 10.3% (n=3) in the presence of 10 µM ODQ (P<0.01) 
(Figure 3.3B).  
The presence of 100 nM iberiotoxin, an inhibitor of the BKCa channels 
alone (n=4) or in combination with ODQ (n=5) had no effect on the H2O2-
induced vasorelaxation (Figure 3.3A). Further experiments with paxilline (300 
nM or 1 µM), a potent BKCa inhibitor, similarly had no effects on the H2O2-
induced vasorelaxation (n=3-5) (Figure 3.3C and D respectively).  
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Figure 3.3 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the absence or presence of (A) 100 nM iberiotoxin and/or 10 µM ODQ 
in U46619 pre-contracted porcine coronary arteries (PCAs) from female pigs. 
(B) Log concentration-response curves for the vasorelaxant effects of SNP in 
the absence or presence of 10 µM ODQ in PCAs from female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 3-5 experiments. ** P<0.01; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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Figure 3.3 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the absence or presence of (C) 300 nM paxilline or (D) 1µM paxilline 
in U46619 pre-contracted porcine coronary arteries from female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 3-5 experiments.  
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3.3.4 The effects of selective SKCa and IKCa channel inhibitors on hydrogen 
peroxide (H2O2)±induced vasorelaxation in PCAs from female pigs 
To examine the effects of IKCa and SKCa channels on H2O2-induced 
vasorelaxation in the presence of L-NAME and indomethacin, 10 µM TRAM-
34 and 500 nM apamin were used as their respective inhibitors (Figure 3.4). 
Here, presence of TRAM-34 and/or apamin had no effects on the H2O2-
induced vasorelaxation (n=6) (Figure 3.4).  
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Figure 3.4 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the presence of 300 µM L-NAME, 10 µM indomethacin, 10 µM 
TRAM-34 and/or 500 nM apamin in U46619 pre-contracted porcine coronary 
arteries from female pigs. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 6 experiments.  
 
3.3.5 The effects of L-NAME and indomethacin in the absence or presence 
of sodium-calcium exchangers (DCB or KB-R7943) on H2O2 ±induced 
vasorelaxation in PCAs from either sex 
Next, the role of Na+/Ca2+ exchanger (NCX) in the H2O2±induced 
vasorelaxation was investigated as Hinata et al. (2007) have previously 
reported that H2O2 activates NCX in isolated guinea-pig cardiac ventricular 
myocytes. Here, in the presence of L-NAME and indomethacin, neither 10 
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µM DCB nor 10 µM KB-R7943 had any effect on the responses to a single 
concentration of H2O2 (100 µM) (n=5) (Figure 3.5A) in PCAs. The presence 
of 500 nM of ouabain significantly inhibited the relaxation to 100 µM H2O2 
(relaxation at 100 µM H2O2 = 82.7 ± 12.2%, control; 5.03 ± 3.3%, ouabain, 
n=5) (P<0.05) (Figure 3.5A). Increasing the concentration of DCB to 100 µM 
did not alter the relaxation to 100 µM H2O2 (n=5) (Figure 3.5B).  
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Figure 3.5 Single concentration-responses to 100 µM H2O2 in the presence of 
300 µM L-NAME, 10 µM indomethacin and (A) 10 µM DCB or KB-R7943 
using 500 nM ouabain as a positive control and (B) higher concentration of 
DCB (100 µM) in U46619 pre-contracted porcine coronary arteries from either 
sex. Data are expressed as a percentage change from U46619-induced tone and 
are mean ± S.E.M. of 5 experiments. *P<0.05; one-way ANOVA followed by 
%RQIHUURQL¶V post hoc test.   
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3.3.6 The effects of ouabain in the absence or presence of L-NAME and 
indomethacin on bradykinin-induced vasorelaxation in PCAs from male 
or female pigs 
Next, the effects of ouabain on U46619 pre-contracted porcine coronary 
arteries PCAs from males and females against concentration-response curve to 
bradykinin were examined as a previous study has reported that bradykinin 
stimulate release of H2O2 in PCAs (Matoba et al., 2003). In PCAs from 
females, the presence of L-NAME and indomethacin significantly reduced the 
relaxation at 1 µM bradykinin (relaxation at 1 µM bradykinin = 101 ± 1%, 
control; 70.1 ± 10.8%, L-NAME, indomethacin, n=7) (P<0.01) (Figure 3.6A). 
The presence of ouabain, both in the absence and presence of L-NAME and 
indomethacin essentially abolished the bradykinin-induced vasorelaxation 
(n=7) (P<0.0001) (Figure 3.6A). 
Similarly in PCAs from males, L-NAME and indomethacin 
significantly reduced the relaxation at 1 µM bradykinin (relaxation at 1 µM 
bradykinin = 90.2 ± 5.6%, control; 61.0 ± 13.1%, L-NAME, indomethacin, 
n=5) (P<0.05). The presence of ouabain in the absence or presence of L-
NAME and indomethacin abolished the bradykinin-induced vasorelaxation 
(n=5) (P<0.001) (Figure 3.6B).  
 
121 
 
lo g  M  [b ra d y k in in ]
R
e
la
x
a
ti
o
n
(%
 
U
4
66
1
9-
in
du
c
e
d 
to
n
e
)
- 1 1 - 1 0 - 9 - 8 - 7 - 6
- 9 0
- 6 0
- 3 0
0
C o n tro l (n = 7 )
L -N A M E , in do m eth ac in  (n = 7)
O u a ba in  (n = 7)
L -N A M E , ind o m eth ac in , o u ab a in  (n= 7)
F e m a leA
****
**
****
0
lo g  M  [b ra d y k in in ]
R
e
la
x
a
ti
o
n
(%
 
U
46
61
9-
in
du
c
e
d 
to
n
e
)
- 1 1 - 1 0 - 9 - 8 - 7 - 6
- 9 0
- 6 0
- 3 0
0
C o n tro l (n = 5 )
L -N A M E , in do m eth ac in  (n = 5)
O u a ba in  (n = 5)
L -N A M E , ind o m eth ac in , o u ab a in  (n= 5)
M a leB
*
***
****
0
3 0
6 0
9 0
 
Figure 3.6 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence or absence of 300 µM L-NAME, 10 µM 
indomethacin and/or 500 nM ouabain in U46619 pre-contracted porcine 
coronary arteries from (A) female or (B) male pigs. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 5-7 
experiments. *P<0.05, **P<0.01 ***P<0.001 and ****P<0.0001; one-way 
$129$IROORZHG E\%RQIHUURQL¶V post hoc test. 
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3.3.7 The effects of ouabain on responses to endothelium-independent 
vasorelaxants in PCAs from female pigs 
To investigate the selectivity of 500 nM ouabain on vasorelaxation, responses 
to verapamil, were determined in its presence. Ouabain did not affect the 
verapamil-induced vasorelaxation (n=5) (Figure 3.7A). On the other hand, in 
the presence of L-NAME and indomethacin, 500 nM ouabain significantly 
inhibited the SNP-induced vasorelaxation (n=6) (P<0.05) (Figure 3.7B). Using 
a single concentration of forskolin (300 nM), the presence of 500 nM ouabain 
significantly inhibited the vasorelaxation after 2 h (relaxation to 300 nM 
forskolin = 93.6 ± 12.2%, without ouabain; 62.9 ± 10.2%, with ouabain, n=5) 
(P<0.05) (Figure 3.7C). 
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Figure 3.7 Log concentration-response curves for the vasorelaxant effects of 
(A) verapamil (B) SNP and (C) a single concentration response to 300 nM 
forskolin in the absence or presence of 500 nM ouabain in U46619 pre-
contracted porcine coronary arteries from female pigs. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 5-6 
experiments. *P<0.05, **P<0.01, ***P<0.001; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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3.3.8 3Na+/2K+ pump activity as assessed by atomic absorption 
spectrophotometry in PCAs from female pigs 
Measurement of the 3Na+/2K+ ATPase activity using atomic absorption 
spectrophotometry in PCAs from female pigs showed that the presence of 10 
µM ouabain significantly reduced the rubidium (Rb+)-uptake in PCAs from 
13.9 ± 1.0 µmol mg-1 of tissue wet weight to 3.1 ± 0.3 µmol mg-1 of tissue wet 
weight (n=9-10) (P<0.0001) (Figure 3.8A). The presence of 10 µM or 100 µM 
H2O2 had no effect on Rb+-uptake, but at 1 mM H2O2, Rb+-uptake was 
significantly reduced to 8.2 ± 0.6 µmol mg-1 of tissue wet weight (n=7-9) 
(P<0.0001). The addition of 500 nM ouabain further reduced the Rb+-uptake to 
3.6 ± 0.4 µmol mg-1 of tissue wet weight (n=9) (P<0.0001) (Figure 3.8A).  
In a separate experiment, Rb+-uptake was significantly reduced by 1 
mM of H2O2 from 12.9 ± 1.5 µmol mg-1 of tissue wet weight under control 
conditions to 7.1 ± 0.7 µmol mg-1 of tissue wet weight (n=10) (P<0.01). A 
lower concentration of ouabain (500 nM) also significantly inhibited the Rb+-
uptake to 3.8 ± 0.5 µmol mg-1 of tissue wet weight (n=10) (P<0.001) (Figure 
3.8B). 
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Figure 3.8 Measurement of rubidium (Rb+)-uptake (30 min incubation time) in 
PCAs from female pigs to determine the activity of Na+/K+ pump in the 
presence of (A) 500 nM or 10 µM ouabain, various concentrations of H2O2 (10 
µM, 100 µM or 1 mM) and (B) 1 mM H2O2 or 500 nM ouabain using atomic 
absorption spectrophotometer used in a flame emission mode. Data are 
expressed as rubidium-uptake in µmol mg-1 of tissue wet weight and are mean 
± S.E.M. of 7-10 experiments. ** P<0.01, *** P<0.001 and **** P<0.0001; 
one-ZD\ $129$ IROORZHG E\ 'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW FRPSDUHG
to the control. 
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3.3.9 The effects of 100 µM or 1 mM H2O2 on KCl-induced contraction in 
PCAs from either sex 
To examine if the exposure of H2O2 impaired the ability of PCAs to contract 
again to 60 mM KCl, different concentrations of H2O2 (100 µM or 1 mM) were 
incubated with the vessels. Exposure to 100 µM H2O2 for 1 h had no effect on 
the KCl-induced contraction (n=6) (Figure 3.9A). On the other hand, exposure 
to 1 mM H2O2 for 1 h (7.48 ± 0.96g, control; 4.33 ± 0.83g, 1 mM H2O2, n=5) 
(Figure 3.9B), but not 30 min (n=4) (Figure 3.9C), significantly reduced the 60 
mM KCl-induced contraction (P<0.01). Figure 3.10A and B show the 
responses of PCAs on exposure to 100 µM H2O2 and 1 mM H2O2 respectively 
under basal tone. 
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Figure 3.9 The effects of (A) 100 µM H2O2 or 1 mM H2O2 for 1 h or 30 min 
on KCl-induced contraction in PCAs from either sex. Data are expressed as 
absolute KCl-induced contraction and are mean ± S.E.M. of 4-6 experiments. 
**P<0.01; 2-WDLOHG SDLUHG6WXGHQW¶V t-test.  
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Figure 3.10 Original traces showing the responses to exposure of (A) 100 µM 
H2O2 and (B) 1 mM H2O2 on PCAs under basal tone.  
 
3.3.10 The effects of 500 nM ouabain, 100 µM H2O2 on Ca2+ re-
introduction in PCAs from either sex 
As previous studies have reported that ouabain induces intracellular calcium 
oscillations in rat proximal tubule cells and increases calcium concentrations in 
rat cardiac myocytes (Aizman et al., 2001; Kennedy et al., 2006), the present 
study examined the effects 500 nM ouabain and 100 µM H2O2 in the presence 
of L-NAME and indomethacin on calcium-induced contraction in calcium-free 
.UHEV¶-Henseleit solutions. The presence of 100 µM H2O2 had no effect on the 
calcium-induced contraction whereas 500 nM ouabain significantly shifted the 
curve 10.7-fold to the right (pEC50 = 3.88 ± 0.08, control; 2.85 ± 0.06, ouabain, 
n=4) (P<0.0001) (Figure 3.11A) (See Figure 3.11B and C for original traces). 
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Figure 3.11 (A) Log concentration-response curves for the contractile effects 
of reintroduction of Ca2+ in KCl-depolarised porcine coronary arteries in the 
presence of 300 µM L-NAME, 10 µM indomethacin, 500 nM ouabain or 100 
µM H2O2. Data are expressed as the absolute KCl-induced contraction and are 
mean ± S.E.M. of 4 experiments. Original traces showing the responses to 
increasing concentration of Ca2+ in Ca2+-IUHH .UHEV¶-Henseleit solution in the 
presence of (B) 300 µM L-NAME, 10 µM indomethacin and (C) addition of 
500 nM ouabain. 
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3.3.11 The effects of ouabain, H2O2 or removal of endothelium on KCl-
induced response in PCAs from either sex 
To examine the effects of ouabain and H2O2 on 3Na+/2K+-pump activity, small 
gradual increases in extracellular K+ were used (Edwards et al., 1998; Harris et 
al., 2000). Addition of KCl to PCAs precontracted with U46619 caused a 
biphasic response with a maximum relaxation at 5.0 mM KCl, followed by 
contraction at 20 mM KCl under control conditions. 100 µM H2O2 (n=5) 
(Figure 3.12A) or removal of the endothelium (n=4) (Figure 3.12B) had no 
effect on the potassium-induced vasorelaxation compared to the control 
conditions.  
The presence of 500 nM ouabain essentially abolished the K+-induced 
vasorelaxation at low concentrations of KCl and contractile responses at high 
concentrations of KCl (n=6) (Figure 3.12C). The presence of 1 mM H2O2 
significantly inhibited the K+-induced vasorelaxation producing a maximum 
relaxation of 63 ±3% (n=6) at 5 mM KCl (P<0.01) compared to 99 ± 3% (n=6) 
under control conditions. At concentrations >15 mM KCl, 1 mM H2O2 
significantly inhibited the KCl-induced vasocontraction (P<0.05) (Figure 
3.12C). Here, relaxation to KCl under control conditions was transient (See 
control curve of Figure 3.12A and C). 
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Figure 3.12 Concentration-response curves to KCl in the presence of (A) 100 
µM H2O2, (B) denuded endothelium and (C) 500 nM ouabain or 1 mM H2O2 in 
U46619 pre-contracted porcine coronary arteries from either sex. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 4-6 experiments. *P<0.05, **P<0.01, ***P<0.001 and 
****P<0.0001; one-way ANOVA followed by BonfHUURQL¶V post hoc test. 
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3.4 Discussion  
This chapter has clearly shown that H2O2 causes complex vasorelaxant effects 
which are ouabain-sensitive in PCAs. The vascular effects are concentration-
dependent such that at concentrations up to 100 µM, H2O2 appears to be 
selective and sensitive to ouabain. However, at higher concentrations, the 
responses appear non-selective where 1 mM H2O2 has been shown to inhibit 
the sodium-pump activity and produce vasorelaxation concurrently. Here, no 
sex differences in the H2O2-induced vasorelaxation were observed, therefore 
subsequent experiments were conducted using PCAs from either sex.  
In contrast to a previous study where removal of the endothelium or 
presence of indomethacin significantly reduced the H2O2-induced 
vasorelaxation in PCAs (Thengchaisri & Kuo, 2003), the present study 
demonstrated that neither the endothelium nor nitric oxide and cyclo-
oxygenase play a role in the H2O2-mediated relaxations. However, results from 
this chapter are in agreement with those of Rogers et al. (2006) and Miura et 
al. (2003) in canine coronary arteries and in human coronary arterioles 
(HCAs). The differences in findings in the present study with those of 
Thengchaisri & Kuo (2003) could be due to the age of the pigs used, as the 
present study used pigs from 4-6 months old while Thengchaisri & Kuo used 
younger pigs (8-12 weeks old). Apart from that, the vessel size used in this 
study was 8- WLPHV ODUJHU WKDQ 7KHQJFKDLVUL 	 .XR¶V SDSHU DQG UHVXOWV IURP
the present study are consistent with a previous study using PCAs from larger 
vessels (2-4 mm diameter) (Barlow & White, 1998).  Indeed, Rogers et. al. 
(2006) mentioned that coronary microvessels could be more sensitive to H2O2 
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than larger vessels, therefore it is possible that mechanism of action of H2O2 
differs between vessel size (Ohashi et al., 2012; Shimokawa, 2010).  
Experiments with elevated extracellular potassium (Edwards et al., 
1998; Ellis et al., 2003; Miura et al., 2003; Ray et al., 2011; Rogers et al., 
2006; Wheal et al., 2012) or non-selective inhibition of K+ channels with TEA 
(Ellis et al., 2003; Gao et al., 2004; Rogers et al., 2006) in the present study 
significantly inhibited the H2O2-induced vasorelaxation  demonstrating that 
potassium channels are involved in the H2O2-induced vasorelaxation in PCAs. 
These findings are consistent with previous studies (as summarized in Table 
3.1), except for one study where it was reported that TEA alone or in 
combination with 4-AP had no effect on H2O2-induced vasorelaxation in 
mouse small mesenteric arteries (Ellis et al., 2003), a finding that could be due 
to species difference.  
As H2O2 has been proposed to be a factor for EDH-type relaxation, the 
effects of H2O2 DFWLQJ WKURXJK WKH µFODVVLFDO¶ ('+ SDWKZD\ LQYROYLQJ WKH
SKCa, IKCa and barium-sensitive Kir channels were examined. 500 nM apamin 
and/or 10 µM TRAM-34 or 30 µM barium chloride had no effect on the H2O2-
induced vasorelaxation. The presence of 1 mM 4-AP also failed to inhibit the 
H2O2-induced vasorelaxation in the present study suggesting that inhibiting 
SKCa, IKCa, Kir and KV channels separately had no effect on the H2O2-mediated 
response (For similar effects with previous studies see Table 3.1). 
Next, the role of guanylyl cyclase and large-conductance calcium 
activated potassium channels in H2O2-mediated relaxations were investigated 
as previous studies have reported that inhibition of these pathways 
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Vascular bed of study References Significantly reduced H2O2 relaxation  No effects on H2O2 relaxation 
Porcine coronary arteries Present study 60 mM KCl, 10 mM TEA,  
500 nM ouabain 
500 nM apamin±10 µM TRAM-34,  
1 µM glibenclamide, 30 µM barium,  
1 mM 4-AP, 300 nM/1 µM paxilline 
Porcine coronary arteries Hayabuchi et al., 1998 100 nM ChTx 20 µM glibenclamide, 1 mM 4-AP 
Porcine coronary arteries Barlow & White, 1998 80 mM KCl   
Porcine coronary arteries Thengchaisri & Kuo, 2003 35 mM KCl 5 µM glibenclamide 
Porcine coronary 
microvessels 
Matoba et al., 2003 40-60 mM KCl, 1 mM TBA   
Mouse mesenteric arteries 
and aortae 
Ohashi et al., 2012 1 mM TBA   
Mouse small mesenteric 
arteries 
Matoba et al., 2000 20-60 mM KCl, 1 mM TBA 100 nM ChTx+1 µM apamin 
Mouse small mesenteric 
arteries 
Ellis et al., 2003 60 mM KCl 10 mM TEA±1 mM 4-AP, 100 µM ouabain+ 
30 µM barium, 100 nM ChTx+1 µM apamin 
Human mesenteric arteries Matoba et al., 2002 40-60 mM KCl   
Human coronary arterioles Miura et al., 2003 40 mM KCl, 100 nM ChTx+ 
1 µM apamin 
1 µM glibenclamide,  
Canine coronary arteries Rogers et al., 2006 60 mM KCl, 10 mM TEA,  
3 mM 4-AP  
 
 
Table 3.1 A comparison of effects of various potassium channels inhibitors on H2O2-induced vasorelaxation in different arteries and species 
examined in the present and previous studies. ChTx charybdotoxin; TEA tetraethylammonium; TBA tetrabutylammonium; 4-AP 4-
aminopyridine. 
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significantly attenuate the H2O2-induced vasorelaxation (Burke & Wolin, 
1987; Hayabuchi et al., 1998). However, in the present study, the lack of effect 
of ODQ, iberiotoxin or paxilline would rule out the involvement of cGMP or 
BKCa in H2O2-mediated relaxations in PCAs (Barlow & White, 1998; Ellis et 
al., 2003; Rogers et al., 2007; Rogers et al., 2006; Thengchaisri & Kuo, 2003). 
The ability of raised KCl to inhibit responses to H2O2 could be 
consistent with EDH-type responses being involved.  Therefore, the effects of 
ouabain on H2O2-induced vasorelaxation were examined as EDH-responses 
have been reported to be inhibited by ouabain, an inhibitor of the Na+/K+-
ATPase pump (Edwards et al., 1998). Here, the presence of 500 nM ouabain 
significantly inhibited the H2O2-induced vasorelaxation and bradykinin-
stimulated EDH-type responses, suggesting a role of the Na+/K+-ATPase 
pump. 
To further characterize the effects of ouabain on PCAs, endothelium-
dependent and -independent vasorelaxants were examined. Here, using 
bradykinin, an endothelium-dependent vasorelaxant, demonstrated that the 
Na+/K+-pump is involved in both the endothelium-dependent and EDH-
mediated (non-nitric oxide, non-cyclooxygenase products) vasorelaxation, 
where the vasorelaxation was essentially abolished in PCAs from male and 
female pigs. Findings from the present study differ slightly from Matoba et al. 
(2003) in porcine coronary microvessels where they have reported that, in the 
presence of L-NAME and indomethacin, barium plus ouabain significantly 
shifted the bradykinin curve to the right but had no effect on the maximum 
relaxation. Again, these differences could be due to the size of the vessel used. 
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The present study demonstrated that the ouabain-sensitive Na+/K+-pump plays 
a role in mediating endothelium-dependent vasorelaxation in distal PCAs.  
Next, the effects of ouabain against other vasorelaxants, verapamil, 
sodium nitroprusside, and forskolin were examined where ouabain 
significantly reduced the responses to SNP- and cAMP-induced 
vasorelaxation, but not relaxation associated with L-type calcium channel 
inhibition. Although ouabain significantly affected responses to both SNP and 
forskolin, the relaxations to SNP and forskolin were not abolished. Here, it is 
possible that ouabain has non-selective effects on the vasorelaxation. The fact 
that verapamil-induced responses were unaffected demonstrates that the effects 
of ouabain on the H2O2 relaxation are not due to non-specific effects on 
smooth muscle relaxation responses.   
As  previous studies have reported a role for the Na+/Ca2+ exchanger in 
increasing calcium influx following inhibition of the Na+/K+-pump (Barry et 
al., 1985) and activation of the Na+/K+-pump subsequently stimulates the 
activation of the forward mode Na+/Ca2+ exchanger in mouse aortae (Kim et 
al., 2005), present study hypothesized that the Na+/Ca2+ exchanger could play 
a role in the H2O2-mediated response. H2O2 has also been reported to activate 
the Na+/Ca2+ exchanger in isolated guinea-pig cardiac ventricular myocytes 
(Hinata et al., 2007). However, the present study using DCB and KB-R7943, 
an inhibitor of the Na+/Ca2+ exchanger and a selective inhibitor of the reverse 
mode of the Na+/Ca2+ exchanger respectively, had no effect on the H2O2-
induced vasorelaxation.  
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To further examine the effects of H2O2 on Na+/K+-pump activity in 
intact tissue, atomic absorption spectrophotometry measuring Rb+-uptake 
(replacing K+) (Longo et al., 1991) was used. Here, using 500 nM ouabain as a 
positive control, present study demonstrated that 100 µM H2O2 did not affect 
the Na+/K+-pump activity. However, at higher concentration of H2O2 (1 mM) 
the pump activity was significantly inhibited. This inhibition could be a 
possible explanation for the biphasic effects observed in some vessels (Gao et 
al., 2004; Lucchesi et al., 2005) where exogenously applied H2O2 causes initial 
contraction (Figure 3.10A and B) possibly through inhibition of the pump 
followed by relaxation through hyperpolarization of the vascular smooth 
muscle cells (Beny & von der Weid, 1991; Matoba et al., 2003; Ohashi et al., 
2012). Alternatively, it could also be possible that exposure to high oxidant 
stress (1 mM) damages the pump (Elmoselhi et al., 1994; Ingbar & Wendt, 
1997; Kim & Akera, 1987). Similar to a previous study (Ellis et al., 2003), the 
present study demonstrated that 1 mM H2O2 may have irreversibly damaged 
vascular smooth muscle cell contraction in that incubation with 1 mM H2O2, 
followed by wash out, caused inhibition of the contraction to 60 mM KCl. Ellis 
et al. (2003) suggested that 1 mM H2O2 causes vasorelaxation (or loss in tone) 
through impairment of smooth muscle contractile response. However the 
present study using 100 µM H2O2 (a concentration which produces about 60% 
of relaxation in PCAs) showed that smooth muscle contraction to KCl was not 
impaired. The data demonstrate that low concentrations of H2O2 (below 100 
µM) produce a relaxation of the porcine coronary artery through an ouabain-
sensitive mechanism, whereas at higher concentrations, H2O2 inhibits the 
Na+/K+-pump itself, which may be due to irreversible damage.  
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A previous study has suggested that H2O2 produces a relaxation 
through alteration of calcium-induced contractions, possibly at the level of 
calcium signalling (Ellis et al., 2003). One possible explanation for the 
inhibition of H2O2 relaxation by ouabain is that it inhibits influx of 
extracellular calcium through calcium channels. If H2O2 does the same, or acts 
to inhibit calcium signalling downstream of calcium influx, this could explain 
why ouabain inhibits the H2O2 relaxation. Although it was found that ouabain 
does inhibit calcium-induced contractile responses, H2O2 did not inhibit this 
calcium-induced contraction. These data, therefore, demonstrate that H2O2 
does not produce a relaxation through inhibition of calcium influx or signalling 
downstream of calcium influx.   
To demonstrate that ouabain was affecting the sodium-pump mediated 
vasorelaxation, exogenous K+ was applied to U46619 precontracted PCAs in 
potDVVLXP IUHH .UHEV¶-Henseleit solution (Ding et al., 2000; Edwards et al., 
1998; Harris et al., 2000). Here, reintroduction of K+ to U46619 precontracted 
PCAs produced a biphasic response (with almost 100% relaxation at 5 mM 
KCl followed by >100% contraction at 20 mM KCl). This response was 
endothelium-independent and was essentially abolished in the presence of 500 
nM ouabain. This indicates that exogenous K+ ions can mimic the EDH-
mediated response on smooth muscle cells acting through Na+/K+ pump. 
Similar findings using K+ ions as a factor for EDH in PCAs and rat hepatic 
arteries (Beny & Schaad, 2000; Edwards et al., 1999) have previously been 
reported. Incubating PCAs with 1 mM H2O2 significantly reduced the K+-
induced vasorelaxation up to 5 mM KCl and significantly inhibited the 
contraction induced by  >15 mM KCl. This indicates that H2O2 could possibly 
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be inhibiting the Na+/K+-pump as a previous study in PCAs reported similar 
finding whereby H2O2 and superoxide reduced the Na+/K+-pump activity in the 
KCl-induced vasorelaxation assay (Elmoselhi et al., 1994) and this observation 
is consistent with the effects on rubidium-uptake. Exposure to 100 µM H2O2 
had no effect on the KCl-induced relaxation which is consistent with the 
spectrophotometry experiment where 100 µM H2O2 had no effect on the 
rubidium-uptake level.  
In summary (Figure 3.13), this chapter established that H2O2 acts in an 
ouabain-sensitive manner (a property also shared by EDH responses) at 
concentrations up to 100 µM and that only at higher concentrations (1 mM) 
does it inhibit the Na+/K+ pump, possibly due to dysfunction of the  Na+/K+-
pump (Elmoselhi et al., 1994; Kim & Akera, 1987). The mechanisms and 
effects of different concentrations of H2O2 presented here may provide a better 
understanding of the vascular functions during oxidative stress where different 
levels of H2O2 have been detected in disease (Burgoyne et al., 2013). 
 
Figure 3.13 Summary of mechanism of action of hydrogen peroxide on 
porcine isolated coronary arteries. 
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4.1 Introduction  
To date, almost all of the isometric tension studies use 95% oxygen with 5% 
CO2 for the oxygenation of buffers. However, hyperoxic gassing conditions 
may affect tissue responses, particularly in studies which involved reactive 
oxygen species (ROS). In the 1980s when endothelium-derived relaxing factor 
(EDRF) was first reported, the effect of oxygen tension on the endothelium-
dependent relaxation was also studied, demonstrating that under anoxic 
conditions, relaxations to acetylcholine were abolished (Furchgott & 
Zawadzki, 1980). EDRF was later confirmed to be NO and Palmer et al., 
(1987) reported that NO reacts readily with superoxide anions (O2-) to form 
peroxynitrite (ONOO-)  thereby reducing NO bioavailability (Palmer et al., 
1987). It has also been reported that the synthesis of NO is inhibited under low 
oxygen tensions (PO2 values about 15-25 mmHg) (Kim et al., 1993).  
In Chapter 2, using porcine isolated coronary arteries (PCAs), the 
involvement of NO and endothelium-dependent hyperpolarization (EDH)-type 
relaxation in bradykinin-induced vasorelaxation has been demonstrated. The 
EDH-type pathway is defined as the remaining proportion of endothelium-
dependent relaxation which is insensitive to NO synthase inhibition and 
cyclooxygenase inhibition (Edwards et al., 2010; Weston et al., 2005).  
In the endothelium, superoxide anions (O2-) can be generated from 
sources such as eNOS, NADPH oxidases or cytochrome P450 epoxygenases 
(Shimokawa, 2010). These superoxide anions will in turn form H2O2 either by 
spontaneous dismutation or by dismutation by SOD (Faraci & Didion, 2004). 
Superoxide dismutase (SOD) has been shown to enhance endothelium-
dependent relaxation by increasing the bioavailability of NO (Gryglewski et 
142 
 
al., 1986; Palmer et al., 1987). Tiron®, a drug marketed as a cell permeable 
superoxide scavenger, has previously been used as a cell-permeable SOD 
mimetic in organ chamber studies involving bradykinin-induced 
vasorelaxation in porcine isolated coronary microvessels and human 
mesenteric arteries (Matoba et al., 2003; Morikawa et al., 2004). In these 
studies, they have concluded that H2O2 is a factor for EDH-type responses and 
that Tiron® acts as a superoxide scavenger which facilitates the formation of 
H2O2 in the endothelium (Matoba et al., 2003; Morikawa et al., 2004). 
Previous studies and Chapter 3 of the present study have shown that 
exogenously applied H2O2 produces concentration-dependent vasorelaxation in 
human, porcine, rat and mice vessels (Barlow & White, 1998; Hayabuchi et 
al., 1998; Matoba et al., 2002; Matoba et al., 2000; Miura et al., 2003; Wheal 
et al., 2012).  
Given the possibility that superoxide anions can be generated in well-
R[\JHQDWHG .UHEV¶-Henseleit buffer, this chapter examined if hyperoxic 
gassing conditions could alter the relaxation responses to bradykinin through 
effects on NO. Here, the effects of different gassing conditions (95% O2/5% 
CO2 and 95% air/5% CO2) on endothelium-dependent relaxation in distal 
PCAs were investigated. As studies in Chapter 2 have shown sex differences in 
endothelial function, whereby intracellular H2O2 plays a role in PCAs from 
female, but not male pigs, the present chapter also examined the effects of cell 
permeable superoxide scavenger, Tiron® on endothelium-dependent relaxation 
in PCAs from male and female pigs. 
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4.2 Materials and methods 
4.2.1 Preparation of rings of distal PCAs 
Tissues were set up as previously described in Chapter 2.  
4.2.2 Wire myography 
As previously described in Chapter 2, after 30 min of equilibration, contractile 
responses to 60 mM KCl were determined twice. The vascular tone was then 
raised to about 50 - 80% of the second KCl contraction tone by the addition of 
the thromboxane A2 mimetic, U46619 (1 nM - 90 nM). Once stable tone was 
achieved, concentration-response curves to an endothelium-dependent 
vasorelaxant, bradykinin (0.01 nM - 1 µM) or H2O2 (1 µM - 1 mM) were 
constructed. Tiron® (1 mM) (Matoba et al., 2003) was used as a cell permeable 
superoxide scavenger and catalase (1000 UmL-1) (Wheal et al., 2012) was used 
to breakdown H2O2. In some preparations, NG-nitro-L-arginine methyl ester 
(L-NAME) (300 µM) (Randall & Griffith, 1991) was used as a NO synthase 
inhibitor and indomethacin (10 µM) was used to inhibit the synthesis of 
prostanoids. There were no differences in the concentration of U46619 used to 
pre-contract the tissue when gassed with either 95% O2/5% CO2 or 95% air/5% 
CO2 (Table 4.1A) or in the presence of Tiron®, with or without catalase 
compared to the control (Table 4.1B) or in the presence of L-NAME and 
indomethacin (Table 4.1C). However, in the presence of 100 µM H2O2, a 
higher concentration of U46619 (on average 2-fold) was required to achieve a 
similar level of tone compared to the controls (P<0.05) (Table 4.2). The 
presence of 1 mM Tiron® KDG QR HIIHFW RQ WKH S+ RI WKH .UHEV¶-Henseleit 
solution when gassed with either 95% O2/5% CO2 or 95% air/5% CO2. 
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A Concentration of U46619 (nM) U46619-induced tone (% KCl response) Control (O2) Tiron (O2) Control (air) Tiron (air) Control (O2) Tiron (O2) Control (air) Tiron (air) 
Male 2.58 ± 0.27 2.00  ± 0.52 3.17 ± 0.49 2.25 ± 0.48 56.0 ± 1.1 61.2 ± 2.9 61.5 ± 6.7 72.8 ± 11.2 
Female 12.3 ± 1.8 11.3 ± 2.3 13.4 ± 5.3 10.8 ± 2.9 67.3 ± 2.9 67.1 ± 5.2 61.8 ± 3.5 62.6 ± 3.1 
 
B Concentration of U46619 (nM) U46619-induced tone (% KCl response) Control Tiron Tiron, catalase Control Tiron Tiron, catalase 
Male 7.42 ± 2.73 4.67 ± 1.21 5.17 ± 3.03 60.2 ± 3.72 65.5 ± 3.66 77.7 ± 7.24 
Female 10.9 ± 1.4 10.3 ± 1.1 34.8 ± 10.8 56.0 ± 1.0 61.1 ± 4.2 65.6 ± 6.6 
 
C 
Concentration of U46619 (nM) U46619-induced tone (% KCl response) 
L-NAME, 
indomethacin 
L-NAME, 
indomethacin, Tiron 
L-NAME, 
indomethacin 
L-NAME, 
indomethacin, Tiron 
Male 15 ± 2.6 15 ± 2.7 62 ± 6.9 58.67 ± 5.4 
Female 18.2 ± 4.4 17.9 ± 2.6 55.8 ± 2.6 55.4 ± 4.2 
 
 
Table 4.1 Summary of U46619 concentration used (nM) and the level of tone induced by U46619 expressed in the percentage to 
second KCl-induced tone when (A) gassed with either 95% O2/5% CO2 or 95% air/5% CO2 or (B) in the presence of 1 mM Tiron® 
with or without 1000 UmL-1 catalase compared to the control or (C) in the presence of 300µM L-NAME, 10 µM indomethacin with 
or without 1 mM Tiron in porcine coronary arteries from male and female pigs. Data are expressed as mean ± S.E.M. of 5-11 
experiments.  
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                                 Female Control 100 µM H2O2 
L-NAME, indomethacin 
Control 100 µM H2O2 
Concentration of U46619 (nM) 10.9 ± 1.1 21.6 ± 4.0 12.6 ± 1.6 20.7 ± 1.9* 
U46619-induced tone (% KCl response) 77.4 ± 7.8 65.0 ± 9.6 60 ± 4.8 63.6 ± 6.3 
 
Table 4.2 Summary of U46619 concentration used (nM) and the level of tone induced by U46619 expressed in the percentage to 
second KCl-induced tone in the absence or presence of 300 µM L-NAME, 10 µM indomethacin with or without 100 µM H2O2 in 
porcine coronary arteries from female pigs. Data are expressed as mean ± S.E.M. of 5-7 experiments. *P<0.05, 2-tailed, paired 
6WXGHQW¶V t-test. 
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4.2.3 Biochemical assay to detect hydrogen peroxide using Amplex Red 
.UHEV¶-Henseleit solution (300 PL) was collected before and after the 
pharmacological studies and placed in a 96-well plate (Garry et al., 2009). 
Amplex Red (10 µM) and horseradish peroxidase (0.6 UmL-1) were added into 
each well and the plate incubated in the dark at room temperature for 15 min. 
Absorbance was read at 590 nm with excitation of 530 nm using FLUOstar 
Galaxy (BMG Labtech Ltd, Aylesbury, Bucks, UK). Experiments were 
performed in the absence or presence of Tiron® and/or catalase with or without 
WLVVXH LQ .UHEV¶-Henseleit solution maintained at 37°C gassed with either 95% 
O2/5% CO2 or 95% air/5% CO2. 
 
4.2.4 Biochemical assay to detect superoxide anion using Nitrotetrazolium 
Blue (NBT) reduction assay 
To determine if superoxide is generated in tKH .UHEV¶-Henseleit solution,  NBT 
(1 mg/mL) reduction assay was performed in the absence of tissue (Dehne et 
al., 2001). In the presence of superoxide, NBT is reduced to monoformazan 
(NBT+) forming a blue precipitate which is insoluble in aqueous solutions 
(Goto et al., 2004; Tarpey & Fridovich, 2001). To detect the amount of 
VXSHUR[LGH IRUPHG LQ WKH .UHEV¶-Henseleit solution, the decrease in intensity 
of the absorbance of NBT was measured at 560 nm (Goto et al., 2004; Tarpey 
& Fridovich, 2001) using a SpectraMAX 340 PC microplate reader (Molecular 
Devices, Wokingham, Berkshire, UK). NBT (1 mg/ml) was dissolved in 
.UHEV¶-+HQVHOHLW VROXWLRQ PDLQWDLQHG DW & LQ WKH P\RJUDSK .UHEV¶-
Henseleit solution was either not gassed or gassed with 95% O2/5% CO2 for    
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4 h (the duration of the pharmacological responses). 200 µL of .UHEV¶-
Henseleit solution was then collected from the myograph chamber and placed 
into a 96-well plate followed by reading of the absorbance of NBT at 560 nm. 
 
4.2.5 Statistical analysis 
Data for the functional studies were presented and analysed as described in 
Chapter 2. Data for the H2O2 determinations are presented as the mean of 
arbitrary fluorescence units with standard error of the mean (S.E.M.) and n 
being the number of separate animals.  
 
4.2.6 Drugs and reagents 
All drugs were purchased from Sigma-Aldrich (Poole, Dorset, UK) and were 
dissolved in distilled water except for catalase and NBT (N6876) which were 
GLVVROYHG GLUHFWO\ LQ WKH .UHEV¶-Henseleit solution. Stock solutions of 
bradykinin and U46619 were made to 10 mM in water and ethanol respectively 
while stock solution of H2O2 was made up to 100 mM in water. All further 
dilutions of the stock solutions were made using distilled water. 
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4.3 Results 
4.3.1 The effects of Tiron® on bradykinin-induced vasorelaxation in PCAs 
from male and female pigs under different gassing conditions (95% 
O2/5% CO2 or 95% air/5% CO2 ) 
In PCAs from males under control conditions, gassing with 95% air/5% CO2 
had no effect on the relaxation to bradykinin compared to gassing with 95% 
O2/5% CO2. The presence of Tiron® had no effect on the Rmax of the 
bradykinin-induced vasorelaxation in either gassing condition, but caused a 
11.7-fold leftward shift in the concentration-response curve when gassed with 
95% O2/5% CO2 (P<0.001) such that there was an increase in potency (pEC50 
= 8.74 ± 0.13 compared to 7.67 ± 0.13 in the controls, n=6) (Figure 4.1A). On 
the other hand, the presence of Tiron® had no effect on the bradykinin 
responses when gassed with air (pEC50 = 7.80 ± 0.11, control; 7.73 ± 0.23, 
Tiron®, n=6) (Figure 4.1A). 
Similarly in PCAs from females, gassing with 95% air/5% CO2 had no 
effect on the relaxation to bradykinin compared to gassing with 95% O2/5% 
CO2. The presence of Tiron® did not affect the maximum relaxation under 
either gassing condition (Figure 4.1B) but again significantly increased the 
potency of bradykinin 5.1-fold (P<0.001) (pEC50 = 8.10 ± 0.06, control; 8.81 ± 
0.07, Tiron®, n=9) when gassed with 95% O2/5% CO2 and not with 95% 
air/5% CO2 (pEC50 = 8.09 ± 0.12, control; 8.42 ± 0.13, Tiron®, n=9). 
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Figure 4.1 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 1 mM Tiron® in U46619 pre-
contracted porcine coronary arteries from (A) male and (B) female pigs gassed 
with either 95% O2/5% CO2 or 95% air/5% CO2. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 6-9 
experiments. 
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4.3.2 The effects of Tiron® in the presence or absence of catalase on 
bradykinin-induced vasorelaxation in PCAs from male and female pigs 
gassed with 95% O2/5% CO2 
As Tiron®, a superoxide dismutase mimetic, significantly increased the 
potency of bradykinin when gassed with 95% O2/5% CO2, the effects of 
catalase on Tiron® were examined to determine if Tiron® is generating H2O2. 
In PCAs from males oxygenated with 95% O2/5% CO2, treatment with Tiron® 
alone or in the additional presence of catalase had no effect on the Rmax (Figure 
4.2A). However, the presence of Tiron® significantly increased the potency of 
bradykinin (P<0.05) (pEC50 = 8.09 ± 0.08, control; 8.56 ± 0.09, Tiron®, n=6), 
which was prevented by the presence of catalase (pEC50 = 8.02 ± 0.13, Tiron®, 
catalase, n=6) (Figure 4.2A).  
In the presence of 95% O2/5% CO2, in PCAs from females, the 
presence of Tiron® significantly shifted the curve 3.7-fold to the left (pEC50 = 
8.37 ± 0.04, control; 8.94 ± 0.04, Tiron®, n=8-9) (P<0.001) and this was 
prevented by catalase (pEC50 = 8.08 ± 0.15, Tiron®, catalase, n=9) (Figure 
4.2B). Furthermore, treatment with catalase reduced the Rmax significantly 
from 103 ± 2% in the presence of Tiron® to 87.4 ± 6.37% (n=8) with the 
addition of catalase (n=9) (P<0.05) (Figure 4.2B).  
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Figure 4.2 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 1 mM Tiron® with or without 1000 
UmL-1 catalase in U46619 pre-contracted porcine coronary arteries from (A) 
male and (B) female pigs gassed with 95% O2/5% CO2. Data are expressed as 
a percentage change from U46619-induced tone and are mean ± S.E.M. of 6-9 
experiments. *P<0.05; one-ZD\ $129$ IROORZHG E\ %RQIHUURQL¶V post hoc 
test. 
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4.3.3 Biochemical assay on the effects of Tiron® under different gassing 
conditions (95% O2/5% CO2 or 95% air/5% CO2) in the absence or 
presence of PCAs from female pigs using Amplex Red 
The presence of 1 mM Tiron® significantly increased the fluorescence signals 
WR $PSOH[ 5HG LQ .UHEV¶-Henseleit solution when gassed with 95% O2/5% 
CO2 in the presence of arterial rings before bradykinin (Figure 4.3A) 
(P<0.0001) and after bradykinin (Figure 4.3B) (P<0.0001) response. This was 
prevented by catalase, indicating that the increase in Amplex Red fluorescence 
was due to production of H2O2 (Figure 4.4). A similar effect was seen in the 
absence of arterial segments (Figure 4.3A & B), indicating that the increase in 
H2O2 was from the buffer and not the tissues. On the other hand, there was no 
detectable change in H2O2 OHYHOV GHWHFWHG E\ $PSOH[ 5HG ZKHQ WKH .UHEV¶-
Henseleit buffer was gassed with 95% air/5% CO2 (Figure 4.3A and B). 
In the presence of tissue under control condition after the bradykinin 
response, the concentration of H2O2 DFFXPXODWHG LQ WKH .UHEV¶-Henseleit 
buffer determined using the Amplex Red assay was ~80 µM (gassed with 95% 
O2/5% CO2). In the presence of Tiron® after the bradykinin response (~2.45 h 
after the addition of Tiron®), the concentration of H2O2 was ~3.6 M when 
gassed with 95% O2/5% CO2. The accumulation of H2O2 was almost abolished 
in the additional presence of 1000 UmL-1 catalase (Figure 4.4).  
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Figure 4.3 Measurement of H2O2 OHYHOV LQ WKH .UHEV¶-Henseleit solution in the 
absence or presence of 1 mM Tiron® with or without tissue in 95% O2/5% CO2 
or 95% air/5% CO2 (A) before or (B) after bradykinin response. Data are 
expressed as arbitrary fluorescence units and are mean ± S.E.M. of 3-4 
experiments. ***P<0.001, ****P<0.0001; one-way ANOVA followed by 
%RQIHUURQL¶V post hoc test. 
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Figure 4.4 Measurement of H2O2 OHYHO LQ WKH .UHEV¶-Henseleit solution in the 
absence or presence of 1 mM Tiron® with or without 1000 UmL-1 catalase 
gassed with 95% O2/5% CO2. Data are expressed as arbitrary fluorescence 
units and are mean ± S.E.M. of 3-4 experiments. ***P<0.001, ****P<0.0001; 
one-ZD\$129$IROORZHG E\%RQIHUURQL¶V post hoc test. 
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'HWHFWLRQRIVXSHUR[LGHDQLRQLQWKH.UHEV¶-Henseleit solutions in the 
absence of PCAs using Nitrotetrazolium Blue (NBT) 
,Q WKH DEVHQFH RI WLVVXH JDVVLQJ RI WKH .UHEV¶-Henseleit solutions with 95% 
O2/5% CO2 significantly reduced the intensity of the NBT solution compared 
to the control (Figure 4.5) (P<0.001). This indicates that superoxide anions are 
JHQHUDWHG LQ WKH .UHEV¶-Henseleit solutions when gassed with 95% O2/5% 
CO2. 
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Figure 4.5 $VVHVVPHQW RI WKH VXSHUR[LGH OHYHOV LQ WKH .UHEV¶-Henseleit 
solution in the absence of tissue gassed with 95% O2/5% CO2 using 1 mg/ml 
NBT; where a decrease in absorbance indicates increased level of superoxide. 
Data are expressed as the optical density measured at absorbance of 560 nm 
and are mean ± S.E.M. of 5 replicates. ***P<0.001; 2-WDLOHG SDLUHG6WXGHQW¶V
t-test. 
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4.3.5 The effects of L-NAME and indomethacin on bradykinin-induced 
vasorelaxation in PCAs from female pigs under different gassing 
conditions (95% O2/5% CO2 or 95% air/5% CO2) or with the additional 
presence of Tiron® in PCAs from male and female pigs gassed with 95% 
O2/5% CO2 
As Tiron® significantly enhanced the bradykinin-induced vasorelaxation when 
gassed with 95% O2/5% CO2, the effects of different gassing conditions on the 
non-nitric oxide, non-cyclooxygenase products, (EDH)-type response using L-
NAME and indomethacin were then investigated. Figure 4.6A demonstrates 
that under control conditions different gassing conditions had no effect on the 
Rmax or the pEC50 values of bradykinin-induced vasorelaxation. Similarly in 
the presence of L-NAME and indomethacin, the bradykinin-induced 
vasorelaxation showed no differences in the Rmax or the pEC50 values of when 
gassed with either 95% air/5% CO2 (pEC50 = 7.32 ± 0.17, n=4) or 95% O2/5% 
CO2 (pEC50 = 7.02 ± 0.28, n=7 ). 
Next, the effects of 1 mM Tiron® in the presence of L-NAME and 
indomethacin on bradykinin-induced vasorelaxation in the presence of 95% 
O2/5% CO2 were examined. Here, the presence of 1 mM Tiron® significantly 
enhanced the potency of the bradykinin-induced vasorelaxation in PCAs from 
male pigs by shifting the curve 4.1-fold to the left (Figure 4.6B) (P<0.01) 
(pEC50 = 7.42 ± 0.11; without Tiron®, 8.03 ± 0.10; with Tiron®, n=11) and in 
female pigs by shifting the curve 6.2-fold to the left (Figure 4.6C) (P<0.05,) 
(pEC50 = 7.59 ± 0.10; without Tiron®, 8.38 ± 0.06; with Tiron®, n=5). 
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Figure 4.6 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the absence or presence of 300 µM L-NAME and 10 µM 
indomethacin (A) under different gassing conditions (95% O2/5% CO2 or 95% 
air/5% CO2) and with the additional presence of 1 mM Tiron® in U46619 pre-
contracted porcine coronary arteries from (B) male and (C) female pigs gassed 
with 95% O2/5% CO2. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 4-13 experiments.  
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4.3.6 The effects of different gassing conditions (95% O2/5% CO2 or 95% 
air/5% CO2) on H2O2-induced vasorelaxation in PCAs from female pigs 
As Tiron® generates H2O2 and enhances the bradykinin-induced vasorelaxation 
only when gassed with 95% O2/5% CO2 and not with 95% air/5% CO2, the 
effects of different gassing conditions on H2O2-induced vasorelaxation were 
then investigated. As some of the individual curves did not achieve a 
maximum relaxation, data were analysed using the relaxation generated at the 
highest concentration of H2O2 used. Here, 1 mM of H2O2 produced a 
comparable relaxation in the presence of 95% O2/5% CO2 and 95% air/5% CO2 
(Figure 4.7). 
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Figure 4.7 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in U46619 pre-contracted porcine coronary arteries from female pigs 
under different gassing conditions (95% O2/5% CO2 or 95% air/5% CO2). Data 
are expressed as a percentage change from U46619-induced tone and are mean 
± S.E.M. of 5-8 experiments.  
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4.3.7 The effects of 100 µM H2O2 in the absence or presence of L-NAME 
and indomethacin on bradykinin-induced vasorelaxation (gassed with 
95% O2/5% CO2) in PCAs from female pigs 
As the presence of Tiron® significantly enhanced the potency of bradykinin-
induced vasorelaxation and increased formation of H2O2, the effects of 
exogenously applied H2O2 (100 µM) on bradykinin-induced vasorelaxation 
were examined. Here, the presence of 100 µM H2O2 had no effect on the Rmax 
or pEC50 (pEC50 = 8.28 ± 0.09, control; 8.18 ± 0.05, H2O2, n=5) of the 
bradykinin-induced vasorelaxation (Figure 4.8A). On the other hand, in the 
presence of L-NAME and indomethacin, 100 µM H2O2 significantly enhanced 
the bradykinin-induced vasorelaxation at 10 nM and 30 nM (P<0.05) of 
bradykinin (Figure 4.8B).  
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Figure 4.8 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 100 µM H2O2 in U46619 pre-contracted porcine 
coronary arteries from female pigs in the (A) absence or (B) presence of 300 
µM L-NAME and 10 µM indomethacin, gassed with 95% O2/5% CO2. Data 
are expressed as a percentage change from U46619-induced tone and are mean 
± S.E.M. of 5-7 experiments. *P<0.05; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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4.4 Discussion  
This chapter clearly shows that the level of oxygenation significantly 
influences the local environment for endothelium-dependent vasorelaxations, 
such that under hyperoxic conditions, the antioxidant Tiron® enhances 
endothelium-dependent and EDH-type relaxations through generation of H2O2 
LQ WKH .UHEV¶-Henseleit solution. A previous study measuring the partial 
SUHVVXUH RI R[\JHQ LQ .UHEV¶-Henseleit solution has shown that when gassed 
with 95% O2/5% CO2 the partial pressure of O2 was 619 ± 17 mmHg (n=3) 
while when gassed with 95% air/5% CO2 the partial pressure of O2 was 140 ± 
4 mmHg (n=3) (White, 2012). 
This chapter has demonstrated that bradykinin produced a comparable 
relaxation in the presence of either 95% air/5% CO2 or 95% O2/5% CO2 in 
PCAs from both male and female pigs. However, under hyperoxic conditions, 
the superoxide dismutase mimetic Tiron® caused a substantial increase in the 
potency of bradykinin as an endothelium-dependent vasorelaxant in PCAs 
from male and female pigs.  This was not seen under lower levels of 
oxygenation and suggests that hyperoxia may be associated with an increase in 
superoxide production which suppresses endothelium-dependent relaxations.  
As superoxide anion (O2-) readily reacts with NO forming peroxynitrite 
(Gryglewski et al., 1986; Kerr et al., 1999), it is possible that Tiron® acting as 
a superoxide scavenger reduces the superoxide levels in the PCAs or in the 
.UHEV¶-Henseleit buffer thereby increasing NO bioavailability improving 
endothelium-dependent vasorelaxation. The effects of Tiron® were more 
pronounced in the male arteries in which, as shown in Chapter 2, NO plays a 
more prominent role in endothelium-dependent relaxations. However, if this 
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was the case, one would expect the relaxations to bradykinin to be greater in 
the presence of 95% air/5% CO2, compared to 95% O2/5% CO2 due to the 
lower superoxide level generated in buffer gassed with 95% air/5% CO2. An 
alternative explanation is that Tiron® VFDYHQJHV VXSHUR[LGH LQ WKH .UHEV¶-
Henseleit buffer converting it into H2O2, which then enhances the endothelium-
dependent relaxations. Indeed, in the absence of NO (in the presence of L-
NAME), Tiron® also enhanced the bradykinin-induced vasorelaxation (further 
discussion below).  
Previous studies and present study in Chapter 3 have demonstrated that 
H2O2 itself causes vasorelaxations in PCAs (Barlow & White, 1998; Matoba et 
al., 2003). A higher concentration of superoxide in the presence of 95% O2/5% 
CO2 would mean that there is a greater concentration of H2O2 in the presence 
of Tiron®. As confirmation of this, the effects of Tiron® in enhancing 
endothelium-dependent vasorelaxation when gassed with 95% O2/5% CO2 
were abolished by catalase which breaks down H2O2. The presence of catalase 
significantly reduced the maximum relaxation in PCAs from female, but not 
male pigs, indicating that H2O2 plays a role in the endothelium-dependent 
vasorelaxation induced by bradykinin, as previously reported in Chapter 2. In 
the presence of Tiron®, there was an increase in Amplex Red fluorescence in 
WKH .UHEV¶-Henseleit solution in the presence of 95% O2/5% CO2, but not 95% 
air/5% CO2. Again, the increase in Amplex Red fluorescence was prevented by 
catalase, confirming that Tiron® is producing H2O2 under hyperoxic 
conditions. Here, the generation of H2O2 by Tiron® (acting as a superoxide 
VFDYHQJHU LQ WKH .UHEV¶-Henseleit solution was independent of the presence of 
tissues and the level of H2O2 produced was two- to three fold greater than when 
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gassed with 95% O2/5% CO2 compared to 95% air/5% CO2. This observation 
is comparable with a previous study using the same biochemical assay to 
determine the H2O2 level in the presence of 1 mM ascorbic acid (Garry et al., 
2009). Further study using the NBT reduction assay to detect the superoxide 
level in WKH .UHEV¶-Henseleit solution confirm that in the absence of tissue, 
gassing with 95% O2/5% CO2 generated superoxide in the buffer.  
In this chapter, no increase in vasorelaxation was observed before the 
addition of bradykinin in the presence of Tiron®, although it was hypothesized 
that Tiron® generated H2O2 in the buffer. One possible explanation for this 
observation is that the level of H2O2 JHQHUDWHG LQ WKH .UHEV¶-Henseleit solution 
appears to be increasing over time (comparing Figure 4.3A and B, before and 
after bradykinin response). Furthermore, there could be a potentiation through 
the bradykinin receptor or signal transduction, as bradykinin produced a 
concentration-dependent vasorelaxation.  
Next, the effects of different gassing conditions on the EDH-type 
responses induced by bradykinin were examined as H2O2 has previously been 
reported to be a factor for the EDH-type response (Garry et al., 2009; Matoba 
et al., 2002; Matoba et al., 2003; Matoba et al., 2000; Miura et al., 2003). 
Here, the EDH-type response is defined as the remaining proportion of 
bradykinin-induced vasorelaxation which is insensitive to L-NAME and 
indomethacin, the non-nitric oxide, non-cyclooxygenase products mediated 
response. Previous studies in porcine coronary microvessels and human 
mesenteric arteries have demonstrated that in the presence of L-NAME and 
indomethacin, bradykinin caused an endothelium-dependent hyperpolarization 
(Matoba et al., 2003; Morikawa et al., 2004). The present study demonstrated 
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that different gassing conditions had no effect on the bradykinin-induced 
vasorelaxation in the absence or presence of L-NAME and indomethacin. This 
suggests that the oxygen levels do not affect the bradykinin-induced EDH-type 
vasorelaxation in PCAs. However, under hyperoxic gassing conditions, the 
presence of Tiron significantly enhanced the bradykinin-induced 
vasorelaxation in the EDH-type response in PCAs from both male and female 
pigs. This observation is similar to previous studies using porcine coronary 
microvessels from male pigs and human mesenteric arteries from male and 
female subjects (Matoba et al., 2003; Morikawa et al., 2004). In Chapter 2, it 
was reported that the EDH-type response is greater in PCAs from female 
compared to male pigs. In this chapter, the presence of Tiron seems to have 
generated a greater enhancement in bradykinin-induced EDH-type 
vasorelaxation in PCAs from female pigs, 6.2-fold in females compared to 4.1-
fold in males. The enhancement of the bradykinin response under hyperoxic 
gassing condition is not specific for Tiron as a previous study from another 
laboratory using iliac arteries from male rabbit has demonstrated that when 
gassed with 95% O2/5% CO2, other antioxidants such as ascorbic acid (AA) 
and tetrahydrobiopterin (BH4) also enhanced the EDH-type relaxation induced 
by cyclopiazonic acid (CPA) and acetylcholine which was sensitive to catalase 
(Garry et al., 2009). In the presence of AA and BH4, measurement of the H2O2 
level using Amplex Red assay demonstrated that there is an increase in the 
H2O2 level LQ WKH .UHEV¶-Henseleit solution (Garry et al., 2009). In their study, 
vessels were pre-contracted with phenylephrine and relaxed with CPA and 
acetylcholine. Here, similar effects were seen using U46619 as the pre-
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contracting agent and bradykinin as the endothelium-dependent vasorelaxant, 
suggesting that the effects seen are independent of agonists used. 
Since the enhanced bradykinin-induced vasorelaxation in the presence 
of Tiron was thought to be due to production of H2O2 when gassed with 95% 
O2/5% CO2, the effects of different gassing conditions on H2O2-induced 
vasorelaxation were investigated. Different gassing conditions (95% O2/5% 
CO2 or 95% air/5% CO2) had no effect on the H2O2-induced vasorelaxation. 
This suggests that the effects of exogenously applied H2O2 on PCAs are not 
affected by the oxygen level in the buffers and possibly that the superoxide 
generated in hyperoxic buffer does not interact with the exogenous H2O2.  
Lastly, the effects of exogenously applied H2O2 (100 µM) on 
bradykinin-induced vasorelaxation were examined since Tiron generating 
H2O2 significantly enhanced the relaxation. This chapter demonstrates that the 
presence of H2O2 increased the potency of bradykinin slightly in the EDH-type 
responses but had no effect on the overall endothelium-dependent relaxation. 
Similar observations have been previously reported in iliac arteries from rabbit 
where presence of 100 µM H2O2 significantly enhanced the EDH-type 
responses induced by CPA and acetylcholine (Garry et al., 2009). This is 
consistent with the results as discussed above where the presence of Tiron 
significantly enhanced the bradykinin-induced vasorelaxation in the presence 
of 95% O2/5% CO2 through the formation of H2O2 from superoxide generated 
LQ WKH .UHEV¶-Henseleit solution. In the study conducted by Garry et al. (2009), 
they suggested that the enhanced vasorelaxation to ACh in the presence of 
H2O2 is due to mobilisation of intracellular Ca2+ from the endoplasmic 
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reticulum store through formation of InsP3 where H2O2 sensitize InsP3 receptor 
leading to increase in intracellular Ca2+ release.  
In summary, this chapter demonstrates that in the presence of 95% O2 
/5% CO2, Tiron, a superoxide scavenger is likely to have converted superoxide 
JHQHUDWHG LQ WKH .UHEV¶-Henseleit solution into H2O2 and enhances the 
bradykinin-induced vasorelaxation in both PCAs from male and female pigs 
(Figure 4.9). This provides strong evidence that hyperoxic gassing conditions 
could alter the environment, generating superoxide within the Krebs-Henseleit 
buffer, which may, in turn, influence the in vitro pharmacological responses.  
 
Figure 4.9 Summary of results where hyperoxic gassing (95% O2/5% CO2) 
with 1 mM Tiron enhances bradykinin-induced endothelium-dependent and 
EDH-type relaxation through generation of hydrogen peroxide. 
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5.1 Introduction 
Reactive oxygen species (ROS), including superoxide and hydrogen peroxide 
(H2O2) have been reported to play a role in causing oxidative stress in 
cardiovascular diseases such as hypertension and atherosclerosis (Lacy et al., 
2000; Streeter et al., 2013; Wind et al., 2010a; Wingler et al., 2011). In 
Chapter 2 and in a previous study, clear sex differences in endothelial function, 
where the EDH-type response plays a greater role in females compared to 
males have been reported (McCulloch & Randall, 1998). Other studies in 
young, healthy human subjects, rat aortae, and rat cerebral arteries 
demonstrated that males exhibit greater oxidative stress compared to females 
(Borras et al., 2003; Brandes & Mugge, 1997; Ide et al., 2002; Miller et al., 
2007). In rat aortae and cerebral arteries, NADPH-stimulated superoxide 
generated in males was significantly higher compared to females (Brandes & 
Mugge, 1997; Miller et al., 2007).  
Sex differences in the role of endogenous H2O2 on endothelium-
dependent vasorelaxation have been demonstrated in Chapter 2. Therefore, this 
chapter tested the hypothesis that the sex differences in endothelial function 
could be related to vascular ROS generated by Nox as other studies have 
reported that H2O2 is a factor for EDH-type response in human, mouse and 
porcine arteries (Matoba et al., 2002; Matoba et al., 2003; Matoba et al., 2000; 
Miura et al., 2003). In previous studies, apocynin and Diphenyliodonium 
chloride (DPI) have been widely used as Nox inhibitors. However, there is 
increasing evidence that these inhibitors are non-selective (Miller et al., 2007; 
Wind et al., 2010b; Wingler et al., 2011). Therefore, newer more selective Nox 
inhibitors, ML-171, a phenothiazine derivative (Gianni et al., 2010) and 
170 
 
VAS2870, a derivative of triazolopyrimidine (Kleinschnitz et al., 2010; Wind 
et al., 2010a) were used in this chapter to examine the role of Nox-generated 
ROS in the coronary artery. 
No previous study has specifically examined whether sex differences 
influence the functional role of Nox using small molecule Nox inhibitors in 
coronary artery. Therefore, the aim of this chapter was to compare the role of 
vascular Nox as a source of ROS in porcine isolated coronary arteries from 
male and female pigs using selective Nox inhibitors, ML-171(Gianni et al., 
2010) and VAS2870 (Kleinschnitz et al., 2010; Wind et al., 2010a; Wind et 
al., 2010b). Activity and protein expression of Nox enzymes were also 
investigated in this chapter. This chapter demonstrated that Nox-generated 
ROS play a role in the EDH-type responses in PCAs from male but not female 
pigs and this could be attributed to the higher expression of Nox1 and Nox2 
proteins in males.   
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5.2 Materials and methods 
5.2.1 Preparation of rings of distal PCAs 
Tissues were set up as previously described in Chapter 2.  
5.2.2 Wire myography 
As previously described in Chapter 2, after 30 min of equilibration, contractile 
responses to 60 mM KCl were determined twice. The vascular tone was then 
raised to about 50 ± 90% of the second KCl contraction tone by the addition of 
the thromboxane A2 mimetic, U46619 (0.3 pM ± 100 nM). Once stable tone 
was achieved, concentration-response curves to bradykinin, an endothelium-
dependent vasorelaxant (0.1 nM ± 1 µM), forskolin, a cell permeable adenylyl 
cyclase activator (0.1 nM ± 1 µM) or pinacidil, a KATP channel activator (1 nM 
± 30 µM) were constructed to investigate the effects of NADPH oxidase 
inhibitor on relaxation mediated through other pathways. In some experiments, 
the effects of NADPH oxidase inhibitors on U46619±induced tone (0.1 fM ± 1 
µM) were examined. To examine the non-nitric oxide and non-cyclooxygenase 
products relaxation pathway, NG-nitro-L-arginine methyl ester (L-NAME) 
(300 µM) was used to inhibit the synthesis of NO and indomethacin (10 µM) 
was used to inhibit the synthesis of prostanoids. Diphenyliodonium chloride 
(DPI) (10 µM) (Fleming et al., 2001) was used as a non-selective NADPH 
oxidase inhibitor while 2-acetylphenothiazine (ML-171) (10 µM or 100 µM) 
(Gianni et al., 2010) and VAS2870 (10 µM) (Kleinschnitz et al., 2010) were 
used as selective NADPH oxidase inhibitors. Allopurinol (30 µM) (Qamirani 
et al., 2005) was used as a xanthine oxidase inhibitor. To examine the role of 
cytochrome P450 (CYP450) enzymes on bradykinin-induced vasorelaxation, 
proadifen hydrochloride (10 µM) (Martinkova et al., 2012) was used to inhibit 
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CYP450, 1-aminobenzotriazole (1-ABT) (Martinkova et al., 2012) (100 µM) 
was used as a suicide inhibitor of CYP450 and sulfaphenazole (10 µM) 
(Fleming et al., 2001; Matoba et al., 2003) was used as a specific CYP450 
inhibitor. All inhibitors were incubated with the vessels for 1 h before pre-
contraction with U46619.  
The level of tone achieved with U46619 was the same under all 
conditions except for in the presence of proadifen (with L-NAME and 
indomethacin) in females where a significantly lower U46619-induced tone 
(P<0.05) was achieved (Table 5.1B). The concentration of U46619 required to 
achieve similar level of tone to the control was significantly higher in the 
presence of 100 µM ML-171 in both male (only in the absence of L-NAME 
and indomethacin) (P<0.01) and females (in the absence and presence of L-
NAME and indomethacin) (P<0.05) (Table 5.1A). The concentration of 
U46619 required was also significantly higher in the presence of L-NAME and 
indomethacin with 1-ABT or proadifen in males (P<0.05) (Table 5.1A). The 
presence of VAS2870, allopurinol and sulfaphenazole had no effect on either 
the level of tone or the concentration of U46619 required.  
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A Concentration of 
U46619 (nM) 
  
L-NAME, indomethacin 
Control Inhibitor Control Inhibitor 
ML-171 Male 8.67 ± 1.31 17.8 ± 2.2** 15.2 ± 1.53 20.2 ± 1.685 
Female 10.1 ± 1.5 16.6 ± 1.9* 15.9 ± 1.9 26.8 ± 1.3** 
VAS2870 Male 0.14 ± 0.09 0.16 ± 0.10 12.8 ± 3.4 15.2 ± 3.7 Female 0.30 ± 0.03 0.39 ± 0.06 7.50 ± 1.11 7.92 ± 1.20 
Allopurinol Male   14.1 ± 2.1 15.2 ± 3.2 Female 
  
10.0 ± 1.7 11.0 ± 1.3 
Proadifen Male   6.69 ± 0.70 33.1 ± 10.3* 
Female 
  
3.14 ± 2.40 23.7 ± 10.3 
1-ABT Male 
  
7.4 ± 1.0 14.2 ± 1.9* 
Sulfaphenazole Male   12.1 ± 1.0 14.2 ± 1.0 
Female 
  
10.6 ± 1.6 10.6 ± 0.4 
 
Table 5.1 Summary of (A) U46619 concentration used (nM) in the absence or presence of 300 µM L-NAME, 10 µM indomethacin with or 
without 100 µM ML-171, 10 µM VAS2870, 30 µM allopurinol, 10µM proadifen, 100 µM 1-ABT or 10 µM sulfaphenazole in porcine coronary 
arteries from male and female pigs. Data are expressed as mean ± S.E.M. of 5-8 experiments. *P<0.05, **P<0.01, 2-WDLOHG SDLUHG6WXGHQW¶V t-
test. 
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B U46619-induced tone 
(% KCl response) 
  
L-NAME, indomethacin 
Control Inhibitor Control Inhibitor 
ML-171 Male 79.0 ± 7.9 66.5 ± 7.3 65.8 ± 6.0 65.0 ± 6.1 
Female 71.3 ± 4.8 74.6 ± 6.7 53.3 ± 0.6 52.3 ± 0.8 
VAS2870 Male 64.0 ± 4.3 60.0 ± 7.0 58.8 ± 3.0 60.8 ± 7.7 Female 69.2 ± 7.5 60.0 ± 4.5 64.8 ± 6.4 62.0 ± 6.3 
Allopurinol Male   53.8 ± 1.4 55.2 ± 1.1 Female 
  
52.8 ± 1.1 55.1 ± 2.0 
Proadifen Male   57.7 ± 3.1 51.7 ± 0.6 
Female 
  
67.2 ± 5.9 51.7 ± 0.6* 
1-ABT Male 
  
57.1 ± 1.6 55.6 ± 3.5 
Sulfaphenazole Male   66.1 ± 5.6 58.0 ± 2.6 
Female 
  
63.4 ± 7.3 59.8 ± 4.7 
 
Table 5.1 Summary of (B) the level of U46619-induced tone expressed in percentage to second KCl-induced tone in the absence or presence of 
300 µM L-NAME, 10 µM indomethacin with or without 100 µM ML-171, 10 µM VAS2870, 30 µM allopurinol, 10µM proadifen, 100 µM 1-
ABT or 10 µM sulfaphenazole in porcine coronary arteries from male and female pigs. Data are expressed as mean ± S.E.M. of 5-8 experiments. 
*P<0.05, 2-WDLOHG SDLUHG6WXGHQW¶V t-test.  
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5.2.3 Measurement of NADPH oxidase activity 
NADPH oxidase activity of PCAs was measured using lucigenin-enhanced 
chemiluminescence method (adapted from Wind et. al., 2010 and Guzik & 
Channon, 2005). Briefly, fresh PCAs were finely dissected and cut into 
segments of ~2 cm then gassed with 95% O2/5% CO2 at 37°C for 1 h in the 
myograph. Segments were then stored at -80°C until biochemical 
determinations were carried out. PCAs were homogenized in Krebs¶-HEPES 
buffer (pH 7.4) consisting 99 mM NaCl, 4.7 mM KCl, 1.9 mM CaCl2, 1.2 mM 
MgSO4, 1 mM KH2PO4, 25 mM NaHCO3, 11.1 mM glucose, 20 mM HEPES 
and protease inhibitor cocktail Set I (Calbiochem, VWR International Ltd, 
Lutterworth, Leicestershire, UK) (Guzik & Channon, 2005) in a glass-glass 
homogenizer. Homogenates were then centrifuged at 1,000x g for 10 min at 
4°C to remove cell debris. Protein concentrations of the supernatants were 
determined by the Bradford method as described in Chapter 2. In duplicate, 50 
µg of protein homogenates were incubated at 37°C for 20 min in the absence 
or presence of 300 µM L-NAME, 10 µM indomethacin, 10 µM DPI, 100 µM 
ML-171 or 10 µM VAS2870 with a final concentration of 5 µM lucigenin. 100 
µM NADPH substrate (total volume of 100 µL) was added into each well to 
start the reaction and samples were allowed to equilibrate in a semi-dark 
environment for 5 min. Photon emission was measured using TopCount NXT 
(PerkinElmer, Cambridge, Cambridgeshire, UK) set to single photon-counting 
mode for 10 s per well. Readings were divided by background single photon 
counts. Mean chemiluminescence readings obtained were divided by the 
background single photon counts (in the absence of tissue homogenates) to 
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normalize the results. Results were expressed in basal fold to the background 
photon count. 
 
5.2.4 Western Blotting 
Western Blot studies were carried out to determine the relative expression 
levels of Nox1, 2 and 4 proteins in PCAs from male and female pigs. Similar 
to Chapter 2, the method described below is the result of substantial method 
development including different batches of antibodies and different lysis 
buffers. Results of these developments are included in Appendix C for future 
reference. Methods were as described in Chapter 2. Samples in this chapter 
were homogenised on ice in lysis buffer (20 mM Tris, 1 mM EGTA, 320 mM 
VXFURVH  7ULWRQ ;  P0 VRGLXP IOXRULGH  P0 VRGLXP ȕ-
glycerophosphate, pH 7.6) containing protease inhibitor cocktail Set I 
(Calbiochem, VWR International Ltd, Lutterworth, Leicestershire, UK) 
followed by centrifugation at 3,000x g for 5 min at 4°C. Supernatants of the 
samples were then solubilised in 6x solubilisation buffer and diluted to 1 
mg/ml of protein with 1x solubilisation buffer  
15 or 20 µg of PCAs samples, 15 µg HepG2 cell lysate (positive 
control for Nox1 protein) or 15 µg pig brain lysate (positive control for Nox2 
and 4 protein) were used in this chapter. The primary antibodies used in this 
chapter are rabbit polyclonal anti-NOX1 antibody (ab137603 Abcam®, 
Cambridge, UK) (1:500), rabbit polyclonal anti-gp91-phox antibody (sc-20782 
Santa Cruz Biotechnology, Insight Biotechnology Ltd, Wembley, Middlesex, 
UK) (1:500), rabbit monoclonal anti-NOX4 [UOTR1B492] antibody 
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(ab109225 Abcam®) (1:1000) and mouse monoclonal anti-ȕ-actin antibody 
(A2228 Sigma-Aldrich) (1:100,000). The secondary antibodies used in this 
chapter are IRDye 800CW Goat anti-rabbit IgG (1:10,000) for anti-rabbit 
antibody and IRDye® 680LT Goat anti-mouse IgG (1:10 000) (LI-COR 
Biosciences, Cambridge, UK) for anti-mouse antibody. The immunoblot was 
then visualised using a LI-COR Odyssey Infrared Imaging Scanner. Densities 
of bands were determined using Image Studio (Version 3.1 LI-COR 
Biosciences, Cambridge, UK).  
 
5.2.5 Statistical analysis 
Data for functional studies were presented and analysed as described in 
Chapter 2. In data where the Rmax was not achieved, data were analysed using 
the response generated at the highest concentration of vasorelaxant. NADPH 
oxidase activity assay was analysed using one-way ANOVA followed by a 
'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW DJDLQVW WKH FRQWURO )RU :HVWHUQ EORW
expression levels of Nox1, 2 and 4 proteins in PCAs from male and female 
SLJV ZHUH QRUPDOLVHG WR ȕ-actin level then analysed using 2-tailed, unpaired 
Mann-Whitney U-test. 
 
5.2.6 Drugs and chemicals 
All drugs were purchased from Sigma-Aldrich (Poole, Dorset, UK) unless 
otherwise indicated. ML-171, DPI and forskolin were purchased from Tocris 
Bioscience (Bristol, UK) and VAS2870 from VWR (Nottingham, UK). All 
drugs were dissolved in distilled water except for indomethacin which was 
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dissolved in absolute ethanol and ML-171, DPI, VAS2870, allopurinol, 
pinacidil and forskolin were dissolved in DMSO. Stock solutions of 
bradykinin, pinacidil, forskolin and U46619 thromboxane A2-agonist were 
made to 10 mM. All further dilutions of the stock solutions were made using 
distilled water. 
 
5.3 Results 
5.3.1 The effects of DPI and ML-171 on bradykinin-induced 
vasorelaxation in PCAs from male and female pigs 
In PCAs from female pigs, the presence of 10 µM DPI, a non-selective 
NADPH oxidase inhibitor, had no effect on bradykinin-induced vasorelaxation 
(pEC50 = 7.86 ± 0.11; control, 7.63 ± 0.12; DPI, n=8-9) (Figure 5.1A). 
Similarly neither 10 µM nor 100 µM ML-171 affected the bradykinin-induced 
vasorelaxation (Figure 5.1A). On the other hand, in PCAs from male pigs, 
treatment with 10 µM DPI significantly shifted the curve 2.8-fold to the right 
(P<0.01), but did not affect the Rmax such that in controls Rmax was 103 ± 4% 
(pEC50 = 8.00 ± 0.07, n=6) and after treatment with DPI was 93.2 ± 4.9% 
(pEC50 = 7.55 ± 0.08, n=6) (Figure 5.1B). Treatment with 100 µM ML-171 
had no effect on the Rmax or EC50 values where the Rmax = 95.7 ± 4.1% (pEC50 
= 8.27 ± 0.09, n=6) compared to the controls (Figure 5.1B). 
179 
 
-1 0 -9 -8 -7 -6
- 9 0
- 6 0
- 3 0
0
C o n tro l (n = 9 )
1 0 µ M  D P I (n = 8 )
1 0 µ M  M L -1 7 1  (n = 9 )
1 0 0 µ M  M L -1 7 1  (n = 9 )
lo g  M  [b ra d y k in in ]
R
e
la
x
a
ti
o
n
(%
 
U
4
6
6
1
9
-
in
d
u
c
e
d
 
to
n
e
)
F e m a le
0
30
60
90
A
-1 0 -9 -8 -7 -6
- 9 0
- 6 0
- 3 0
0 C o n tro l (n = 6 )
1 0 µ M  D P I (n = 6 )
1 0 0 µ M  M L -1 7 1  (n = 6 )
lo g  M  [b ra d y k in in ]
R
e
la
x
a
ti
o
n
(%
 
U
46
61
9-
in
du
c
e
d 
to
n
e
)
M a le
3
6
9
B
 
Figure 5.1 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 10 µM DPI, 10 µM or 100 µM ML-171 in 
U46619 pre-contracted porcine coronary arteries from (A) female or (B) male 
pigs. In PCAs from male pigs, treatment with 10 µM DPI significantly shifted 
the curve 2.8-fold to the right (P<0.01; one-way ANOVA followed by 
%RQIHUURQL¶V post hoc test). Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 6-9 experiments.  
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5.3.2 The effects of DPI and ML-171 in the presence of L-NAME, 
indomethacin on bradykinin-induced vasorelaxation in PCAs from male 
and female pigs 
In the presence of L-NAME and indomethacin, again treatment with 10 µM 
DPI did not affect the bradykinin-induced vasorelaxation in PCAs from female 
pigs such that the Rmax in the presence of L-NAME and indomethacin was 73.3 
± 6.3% (pEC50 = 7.72 ± 0.15, n=6) compared to a response of 78.6 ± 8.0% 
(pEC50 = 7.80 ± 0.19, n=6) in the presence of 10 µM DPI (Figure 5.2A). 
Similarly, treatment with 100 µM ML-171 in the presence of L-NAME and 
indomethacin did not affect the bradykinin-induced vasorelaxation producing 
an Rmax of 68.2 ± 8.9% (pEC50 = 7.90 ± 0.25, n=6) (Figure 5.2A).  
Conversely, in PCAs from male pigs, treatment with 10 µM DPI or 100 
µM ML-171 in the presence of L-NAME and indomethacin significantly 
shifted the curve 2.5-fold and 3.2-fold to the left (P<0.0001) respectively with 
no effect on the Rmax values such that the Rmax in the presence of L-NAME and 
indomethacin was 88.3 ± 5.16% (pEC50 = 7.43 ± 0.09, n=5) and additional 
treatment with 10 µM DPI produced an Rmax of 83.5 ± 5.7% (pEC50 = 7.83 ± 
0.12, n=5) while 100 µM ML-171 was 92.4 ± 4.0% (pEC50 = 7.93 ± 0.08, n=5) 
(Figure 5.2B). 
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Figure 5.2 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME and 10 µM indomethacin with or 
without 10 µM DPI or 100 µM ML-171 in U46619 pre-contracted porcine 
coronary arteries from (A) female and (B) male pigs. In PCAs from male pigs, 
presence of 10µM DPI or 100µM ML-171 in L-NAME and indomethacin 
significantly shifted the bradykinin-induced response curve 2.5-fold and 3.2-
fold to the left respectively (P<0.0001; one-way ANOVA followed by 
%RQIHUURQL¶V post hoc test). Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 5-6 experiments.  
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5.3.3 The effects of L-NAME, indomethacin and ML-171 on responses to 
endothelium-independent vasorelaxants (forskolin) in PCAs from male 
pigs 
To examine if the enhanced bradykinin-induced vasorelaxation effect in the 
presence of ML-171 in males is selective for bradykinin, or if it is due to an 
effect on the pre-contractile response, the effects of forskolin, a cell permeable 
adenylyl cyclase activator were examined. In PCAs from male pigs, treatment 
with 100 µM ML-171 in the presence of L-NAME and indomethacin did not 
affect the forskolin-induced vasorelaxation such that Rmax was 128 ± 18% 
(pEC50 = 7.64 ± 0.22, n=8) compared to a response of 121 ± 15% (pEC50 = 
8.13 ± 0.25, n=8) in the presence of 100 µM ML-171 (Figure 5.3).  
-1 0 -9 -8 -7 -6
- 1 2 0
- 9 0
- 6 0
- 3 0
0
M a le
L o g  M  [fo rsk o lin ]
R
e
la
x
a
ti
o
n
(%
 
U
46
61
9-
in
du
c
e
d 
to
n
e
) L -N A M E , in d o m e th a c in  (n = 8 )
L -N A M E , in d o m e th a c in ,
1 0 0 µ M  M L -1 7 1  (n = 8 )
0
0
0
90
1 20
Figure 5.3 Log concentration-response curves for the vasorelaxant effects of 
forskolin in the presence of 300 µM L-NAME, 10 µM indomethacin with or 
without 100 µM ML-171 in U46619 pre-contracted porcine coronary arteries 
from male pigs. Data are expressed as a percentage change from U46619-
induced tone and are mean ± S.E.M. of 8 experiments.  
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5.3.4 The effects of L-NAME, indomethacin and ML-171 on responses to 
endothelium-independent vasorelaxants (pinacidil) in PCAs from male 
pigs 
Treatment with 100 µM ML-171 in the presence of L-NAME and 
indomethacin did not affect the Rmax or EC50 values of the pinacidil-induced 
vasorelaxation such that the Rmax was 131 ± 8% (pEC50 = 6.12 ± 0.09, n=9) in 
the presence of L-NAME, indomethacin and additional presence of ML-171 
produced an Rmax of 122 ± 8% (pEC50 = 6.46 ± 0.11, n=9) (Figure 5.4). When 
the pinacidil-induced vasorelaxation was analysed at individual concentrations, 
the presence of ML-171 significantly enhanced the relaxation at 3 - 300 nM of 
pinacidil (P<0.05) (Figure 5.4). 
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Figure 5.4 Log concentration-response curves for the vasorelaxant effects of 
pinacidil in the presence of 300 µM L-NAME and 10 µM indomethacin with 
or without 100 µM ML-171 in U46619 pre-contracted porcine coronary 
arteries from male pigs. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 9 experiments. *P<0.05 and 
**P<0.01; 2-tailed, SDLUHG6WXGHQW¶V t-test. 
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5.3.5 The effects of L-NAME, indomethacin and ML-171 on U46619-
induced contraction in PCAs from male and female pigs with or without 
endothelium 
In PCAs from male pigs with intact endothelium, as the contraction to U46619 
curves did not fit to a sigmoidal curve, the maximum contractions were 
constrained to 145% and data were analysed based on each individual U46619 
concentrations (Figure 5.5A). Treatment with ML-171 significantly reduced 
the U46619-induced contractions (P<0.05) (Figure 5.5A). In endothelium-
denuded PCAs from male pigs, the presence of ML-171 significantly reduced 
the maximum contraction induced by U46619 (P<0.01) from 143 ± 4% (pEC50 
= 7.86 ± 0.06, n=6) in the presence of L-NAME and indomethacin to 125 ± 2% 
(pEC50 = 7.54 ± 0.02, n=6) with the additional presence of ML-171 (Figure 
5.5B). The presence of ML-171 significantly shifted the curve 2.1-fold to the 
right (P<0.05) (Figure 5.5B). 
In PCAs from female pigs with intact endothelium, treatment with ML-
171 did not affect the maximum contraction to U46619, but significantly 
shifted the curve 2.6-fold to the right (P<0.01) (pEC50 = 8.1 ± 0.07; without 
ML-171 compared to 7.68 ± 0.04; with ML-171 n=6) (Figure 5.6A). In 
endothelium-denuded vessels in PCAs from female pigs, treatment with ML-
171 in the presence of L-NAME and indomethacin significantly reduced the 
maximum U46619-induced contraction (P<0.05) reducing the contraction from 
139 ± 2% in the presence of L-NAME and indomethacin to 128 ± 3% with the 
additional presence of ML-171 (Figure 5.6B). The curve was significantly 
shifted 3.2-fold to the right in the presence of ML-171 (pEC50 = 8.11 ± 0.03 
compared to 7.61 ± 0.04, n=6) (P<0.001) (Figure 5.6B). 
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Figure 5.5 Log concentration-response curves for the contractile effects of 
U46619 in the presence of 300 µM L-NAME and 10 µM indomethacin with or 
without 100 µM ML-171 in porcine coronary arteries from male pigs with (A) 
intact endothelium or (B) denuded endothelium. (A) In PCAs from male pigs, 
contraction to U46619 curves did not fit in to a sigmoidal curve therefore the 
maximum contraction were constraint to 145% and data were analysed based 
on each individual point of U46619 concentration. Data are expressed as a 
percentage change from the second KCl-induced tone and are mean ± S.E.M. 
of 6 experiments. *P<0.05 and **P<0.01; 2-tailed, SDLUHG6WXGHQW¶V t-test. 
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Figure 5.6 Log concentration-response curves for the contractile effects of 
U46619 in the presence of 300 µM L-NAME and 10 µM indomethacin with or 
without 100 µM ML-171 in porcine coronary arteries from female pigs with 
(A) intact endothelium or (B) denuded endothelium. Data are expressed as a 
percentage change from the second KCl-induced tone and are mean ± S.E.M. 
of 6 experiments. *P<0.05; 2-tailed, SDLUHG6WXGHQW¶V t-test. 
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5.3.6 The effects of VAS2870 on bradykinin-induced vasorelaxation in 
PCAs from male and female pigs 
In PCAs from male pigs, using a different Nox inhibitor 10 µM VAS2870 had 
no effect on the bradykinin-induced vasorelaxation such that under control 
conditions the Rmax was 114 ± 3% (pEC50 = 8.79 ± 0.05, n=5) compared to a 
response of 108 ± 2% (pEC50 = 8.63 ± 0.04, n=5) in the presence of 10 µM 
VAS2870 (Figure 5.7A).  
Similarly in PCAs from female pigs VAS2870 did not affect the 
bradykinin-induced vasorelaxation such that the Rmax was 99.9 ± 3.7% (pEC50 
= 8.26 ± 0.08, n=6) under control conditions and Rmax of 92.9 ± 4.3%, pEC50 = 
8.30 ± 0.10, n=6) in the presence of VAS2870 (Figure 5.7B).  
 
5.3.7 The effects of VAS2870 in the presence L-NAME and indomethacin 
on bradykinin-induced vasorelaxation in PCAs from male and female pigs 
In PCAs from male pigs, treatment with 10 µM VAS2870 in the presence of L-
NAME and indomethacin significantly inhibited the bradykinin-induced 
vasorelaxation such that the Rmax was 76.3 ± 2.7% (pEC50 = 7.85 ± 0.07, n=6) 
under control conditions and in the presence of VAS2870 the Rmax was 54.3 ± 
4.1% (pEC50 = 8.09 ± 0.20, n=6) (P<0.05) (Figure 5.8A).  
On the other hand, in PCAs from female pigs, treatment with VAS2870 
had no effect on the bradykinin-induced vasorelaxation in the presence of L-
NAME and indomethacin (Figure 5.8B).  
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Figure 5.7 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence or absence of 10 µM VAS2870 in U46619 pre-
contracted porcine coronary arteries from (A) male or (B) female pigs. Data 
are expressed as a percentage change from U46619-induced tone and are mean 
± S.E.M. of 5-6 experiments. 
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Figure 5.8 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME and 10 µM indomethacin with or 
without 10 µM VAS2870 in U46619 pre-contracted porcine coronary arteries 
from (A) male or (B) female pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 5-6 experiments. 
*P<0.05; 2-tailed, SDLUHG6WXGHQW¶V t-test.  
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5.3.8 The effects of VAS2870 in the presence L-NAME and indomethacin 
on U46619-induced contraction in PCAs from male pigs 
Further experiments to examine the effects of VAS2870 on U46619-induced 
contraction showed that VAS2870 had no effect on the U46619-induced 
contraction producing an Rmax of 130 ± 8% (pEC50 = 7.63 ± 0.16, n=6) in the 
presence of L-NAME and indomethacin  and an Rmax of 135 ± 8% (pEC50 = 
8.35 ± 0.16, n=6) in the additional presence of  VAS2870 (Figure 5.9).  
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Figure 5.9 Log concentration-response curves for the contractile effects of 
U46619 in the presence of 300 µM L-NAME and 10 µM indomethacin with or 
without 10 µM VAS2870 in porcine coronary arteries from male pigs with 
intact endothelium. Data are expressed as a percentage change from the second 
KCl-induced tone and are mean ± S.E.M. of 6 experiments. 
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5.3.9 The effects of L-NAME, indomethacin and xanthine oxidase 
inhibitor (allopurinol) on bradykinin-induced vasorelaxation in PCAs 
from male and female pigs 
As reactive oxygen species are also generated by xanthine oxidase, the effects 
of 30 µM allopurinol, a xanthine oxidase inhibitor were examined in the 
presence of L-NAME and indomethacin on bradykinin-induced vasorelaxation 
in PCAs from male and female pigs. Here, allopurinol had no effect on the 
Rmax or EC50 (Table 5.2) of the bradykinin-induced EDH-type vasorelaxation 
in either PCAs from male or female pigs (Figure 5.10A & B). 
 
Gender  L-NAME, indomethacin 
Maximal relaxation (%), 
pEC50 n 
Control Inhibitor 
Male 30 µM 
allopurinol 
83.7 ± 6.5, 
7.75 ± 0.13 
91.8 ± 8.5, 
7.34 ± 0.13 8 
Female 88.2 ± 8.9, 7.42 ± 0.17 
83.5 ± 16.7, 
7.06 ± 0.30 6 
Male 100 µM 1-ABT 79.2 ± 5.6, 7.73 ± 0.12 
68.8 ± 6.8, 
7.84 ± 0.17 5 
Male 10 µM 
sulfaphenazole 
72.7 ± 4.4, 
7.73 ± 0.10 
85.3 ± 4.4, 
7.94 ± 0.10 9 
Female 99.6 ± 6.6, 7.53 ± 0.11 
98.5 ± 6.4, 
7.85 ± 0.11 5 
 
Table 5.2 Summary of the effects of different CYP450 inhibitors (100 µM 1-
ABT or 10 µM sulfaphenazole) or xanthine oxidase (30 µM allopurinol) in the 
presence of 300 µM L-NAME and 10 µM indomethacin on the maximal 
relaxations and pEC50 values of the bradykinin-induced vasorelaxation in 
U46619 precontracted PCAs from male and female pigs. 
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Figure 5.10 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME, 10 µM indomethacin with or 
without 30 µM allopurinol in U46619 pre-contracted porcine coronary arteries 
from (A) male or (B) female pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 6-8 experiments. 
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5.3.10 The effects of cytochrome P450 inhibitors, proadifen in the 
presence of L-NAME and indomethacin on bradykinin-induced 
vasorelaxation in PCAs from male and female pigs 
As cytochrome P450 (CYP450) enzymes are a source of superoxide 
production, further studies to examine the role of ROS using CYP450 
inhibitors on bradykinin-induced vasorelaxation were conducted. As some of 
the individual curves did not achieve a maximum relaxation, data were 
analysed using the relaxation achieved at 1 µM bradykinin. In PCAs from male 
pigs, treatment with 10 µM proadifen in the presence of L-NAME and 
indomethacin significantly inhibited the bradykinin-induced vasorelaxation 
such that the relaxation at 1 µM bradykinin was 98.8 ± 2.7% (n=7) in the 
presence of L-NAME and indomethacin compared to 71.2 ± 12.8% (n=7) in 
the presence of proadifen (P<0.05) (Figure 5.11A).  
Similarly in PCAs from female pigs, treatment with proadifen in the 
presence of L-NAME and indomethacin significantly inhibited the 
vasorelaxation where the relaxation at 1 µM bradykinin was inhibited from 
94.4 ± 7.4% (n=6) in the presence of L-NAME and indomethacin to 49.4 ± 
11.4% (n=6) with the additional presence of proadifen (P<0.01) (Figure 
5.11B).  
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Figure 5.11 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME, 10 µM indomethacin with or 
without 10 µM proadifen in U46619 pre-contracted porcine coronary arteries 
from (A) male or (B) female pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 6-7 experiments. 
*P<0.05 and **P<0.01; 2-tailed, SDLUHG6WXGHQW¶V t-test. 
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5.3.11 The effects of suicide inhibitor of cytochrome P450, 1-
aminobenzotriazole in the presence of L-NAME and indomethacin on 
bradykinin-induced vasorelaxation in PCAs from male pigs 
On the other hand, a suicide inhibitor of CYP450, 100 µM 1-
aminobenzotriazole (1-ABT) (Figure 5.12) in the presence of L-NAME and 
indomethacin had no effect on the Rmax and EC50 of the bradykinin-induced 
vasorelaxation in PCAs from male pigs (Table 5.2).  
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Figure 5.12 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME and 10 µM indomethacin with or 
without 100 µM 1-ABT in U46619 pre-contracted porcine coronary arteries 
from male pigs. Data are expressed as a percentage change from U46619-
induced tone and are mean ± S.E.M. of 5 experiments.  
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5.3.12 The effects of specific cytochrome P450 inhibitor, sulfaphenazole in 
the presence of L-NAME and indomethacin on bradykinin-induced 
vasorelaxation in PCAs from male and female pigs 
Similarly, a specific CYP450 inhibitor, 10 µM sulfaphenazole (Figure 5.13A 
and B) in the presence of L-NAME and indomethacin had no effect on the 
Rmax of EC50 of the bradykinin-induced vasorelaxation in PCAs from male and 
female pigs (Table 5.2).  
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Figure 5.13 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence 300 µM L-NAME, 10 µM indomethacin with or 
without 10 µM sulfaphenazole in U46619 pre-contracted porcine coronary 
arteries from (A) male or (B) female pigs. Data are expressed as a percentage 
change from U46619-induced tone and are mean ± S.E.M. of 5-9 experiments.  
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5.3.13 NADPH oxidase activity in PCAs from male and female pigs 
Having demonstrated that DPI and ML-171 enhanced the EDH-type response 
induced by bradykinin in PCAs from male, but not female pigs, the effects of 
these inhibitors were then further examined by measuring NADPH oxidase 
activity in homogenates from PCAs using the lucigenin-enhanced 
chemiluminescence method. Here, in the presence of L-NAME and 
indomethacin, DPI and ML-171 significantly reduced the NADPH oxidase 
activity level in PCAs from male and female pigs compared to their respective 
controls (0.1% DMSO) (Figure 5.14). On the other hand, VAS2870 had no 
effect on the NADPH oxidase activity in either PCAs from male or female 
pigs.  
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Figure 5.14 NADPH oxidase activities using lucigenin-enhanced 
chemiluminescence method in tissue homogenates in the presence of 300 µM 
L-NAME, 10 µM indomethacin, 10 µM DPI, 100 µM ML-171, or 10 µM 
VAS2870 in porcine coronary arteries from male and female pigs. After 20 
min incubation with inhibitors, 100 µM NADPH was added and measurements 
were taken in an interval of 10 s per well. Data are expressed as a basal fold 
from tissue blank and are mean ± S.E.M. of 6 experiments. *P<0.05 and 
**P<0.01; one-way ANOVA followed by a DunQHWW¶V PXOWLSOH FRPSDULVRQ
test. 
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5.3.14 Determination of expression of Nox1, Nox2 and Nox4 proteins in 
PCAs from male and female pigs via Western blotting 
Western blotting confirmed the expression of Nox1 (65 kDa) (Figure 5.15A), 
Nox2 (~60 kDa) (Figure 5.16A) and Nox4 (~63 kDa) (Figure 5.17A) proteins 
in PCAs from male and female pigs. Further quantitative analysis of the 
expression level of the Nox protein based on the ratio of the protein band 
intensities to ȕ-actin (42 kDa) as a loading control showed higher level of 
expression of Nox1 (P<0.05) and Nox2 (P<0.01) proteins in PCAs from males 
compared to females (Figure 5.15B & 5.16B). In contrast, the expression level 
of Nox4 (P<0.05) protein was higher in PCAs from female compared to male 
pigs (Figure 5.17B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
199 
 
 
 
 
M ale  P C A s F em ale  P C A s
0 .0 0
0 .0 1
0 .0 2
0 .0 3
0 .0 4
0 .0 5
R
a
ti
o
 
o
f 
N
o
x
 
1:
E-
a
c
ti
n
e
x
pr
e
s
s
io
n
 
le
v
e
ls
n =  4 -5
*
N o x 1B
 
Figure 5.15 (A) Nox1 (65 N'D DQGȕ-actin (42 kDa) protein expression levels 
in 20 µg of porcine coronary arteries (PCAs) homogenates from male (M1-
M5) and female (F1-F5) pigs with HepG2 cells as positive control. (B) Ratio 
of the expression levels of Nox WR ȕ-actin in male and female PCAs based on 
the intensities of their bands. Data are expressed in the ratio of Nox WRȕ-actin 
intensities bands and are mean ± SEM of 4-5 PCAs. *P<0.05; 2-tailed, 
unpaired Mann-Whitney U-test. 
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Figure 5.16 $ 1R[ a N'D DQG ȕ-actin (42 kDa) protein expression 
levels in 15 µg of porcine coronary arteries (PCAs) homogenates from male 
(M1-M5) and female (F1-F5) pigs with pig brain (PB) as positive control. (B) 
5DWLR RI WKH H[SUHVVLRQ OHYHOV RI 1R[ WR ȕ-actin in male and female PCAs 
based on the intensities of their bands. Data are expressed in the ratio of Nox2 
WR ȕ-actin intensities bands and are mean ± SEM of 9 PCAs. **P<0.01; 2-
tailed, unpaired Mann-Whitney U-test. 
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Figure 5.17(A) 1R[ a N'D DQG ȕ-actin (42 kDa) protein expression 
levels in 20µg of porcine coronary arteries (PCAs) homogenates from male 
(M1-M5) and female (F1-F5) pigs with pig brain (PB) as positive control. (B) 
5DWLR RI WKH H[SUHVVLRQ OHYHOV RI 1R[ WR ȕ-actin in male and female PCAs 
based on the intensities of their bands. Data are expressed in the ratio of Nox4 
WR ȕ-actin intensities bands and are mean ± SEM of 8-10 PCAs. *P<0.05; 2-
tailed, unpaired Mann-Whitney U-test. 
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5.4 Discussion 
This chapter has demonstrated sex differences in the expression and function 
of NADPH oxidases (Nox) in porcine isolated coronary arteries. Here, using 
two Nox inhibitors, ML-171 and VAS2870, the role of Nox-generated ROS in 
the EDH-type responses in PCAs from male, but not female pigs were shown. 
The functional role of Nox-generated ROS in PCAs from male pigs observed 
in this chapter could be related to the higher expression level of Nox1 and 
Nox2 proteins in males.  
In the present study, bradykinin, an endothelium-dependent 
vasorelaxant, produced a concentration-dependent vasorelaxation in PCAs 
from male and female pigs. A previous study in human coronary arterioles 
demonstrated that bradykinin produces endothelial ROS through activation of 
Nox (Larsen et al., 2009). Here, the presence of ML-171, a selective Nox1 
inhibitor (Gianni et al., 2010) had no effect on the bradykinin-induced 
vasorelaxation in both PCAs from male and female pigs. 100 µM ML-171 was 
used in the present study as a previous study in HEK293-Nox1 reconstitute cell 
system demonstrated that ML-171 inhibited Nox1-dependent ROS generation 
with an IC50 of 0.25 µM (Gianni et al., 2010). Here, a higher concentration of 
inhibitor was required for penetration of the inhibitor into the multiple cell 
layers of the blood vessels. On the other hand, DPI, a commonly used yet non-
selective Nox inhibitor (Shi et al., 2001; Wind et al., 2010a; Wind et al., 
2010b) significantly reduced the potency of bradykinin by 2.8-fold in PCAs 
from male, but not female pigs. The inhibition by DPI could possibly be due to 
the inhibition of eNOS (Wind et al., 2010b). As previously reported in Chapter 
2, NO plays a greater role in PCAs from male pigs. In the EDH-type response, 
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inhibiting Nox with DPI and ML-171 significantly enhanced the bradykinin-
induced vasorelaxation in PCAs from male pigs, but not from female pigs. 
These data further support the theory that in the absence of L-NAME, DPI acts 
as a NOS inhibitor in the bradykinin-mediated response because when NOS is 
inhibited by L-NAME, the inhibitory response by DPI is turned into an 
enhancement. The enhancement in the EDH-type vasorelaxation observed in 
coronary arteries from male pigs and not from female pigs suggests that there 
may be greater Nox activity in arteries from male pigs compared to female 
pigs, which may be indicative of greater ROS production in males. This is in 
agreement with previous studies in isolated aortae from rats (Brandes & 
Mugge, 1997; Kerr et al., 1999), cerebral arteries from rats (Miller et al., 2007)  
and in young healthy human subjects (Ide et al., 2002) where there generation 
superoxide is greater in males compared to females.   
In transfected HEK293, ML-171 produced an IC50 of 0.25, 5, 3, 5 and 
5.5 µM whereas DPI produced and IC50 of 1.2, 0.5, 0.75, 1.1 and 0.005 µM for 
Nox1, 2, 3, 4 and xanthine oxidase respectively (Gianni et al., 2010). To 
eliminate the possibility that ML-171 inhibits xanthine oxidase, the present 
study examined the role of xanthine oxidase-generated ROS by using 
allopurinol, a xanthine oxidase inhibitor. Here, allopurinol had no effect on the 
bradykinin-induced EDH-type response, indicating that the enhanced 
vasorelaxation to bradykinin in the presence of ML-171 in PCAs from male 
pigs was not due to inhibition of xanthine oxidase. Previous studies in aortic 
abdominal aneurysmal segments from human (Guzik et al., 2013), aortic 
segments of normotensive and hypertensive rats (Beswick et al., 2001; Wind et 
al., 2010a), and aortae from male and female rats (Brandes & Mugge, 1997) 
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similarly demonstrated no role of xanthine oxidase in ROS production. To 
eliminate the possibility that ML-171 or VAS2870 inhibit other ROS-
generating enzymes such as CYP450 epoxygenases, studies using CYP450 
inhibitors were conducted. The lack of effects on the EDH-type response when 
more selective CYP450 inhibitors (1-ABT and sulfaphenazole) were used in 
the present study showed that the CYP450 enzymes do not play a role in the 
ROS generation in PCAs from male or female pigs.  
Alternatively, the enhanced relaxation to bradykinin could be explained 
by an inhibitory effect on the pre-contraction, rather than enhancement of the 
relaxation per se. In PCAs with intact endothelium from both male and female 
pigs, ML-171 reduced the potency of the U46619-induced contraction at low 
concentrations of U46619, but had no effect on the maximum contraction. In 
endothelium denuded vessels, the presence of ML-171 significantly reduced 
the potency and maximum contraction to U46619 in PCAs from both sexes. 
The fact that ML-171 inhibited the U46619-induced contraction indicates that 
activation of thromboxane receptors increases ROS production and may be the 
source of ROS that influences the bradykinin response. Indeed, a previous 
study in human vascular smooth muscle cells (hVSMCs) demonstrated that 
incubation with 100 nM U46619 significantly increase the thromboxane A2 
synthase mRNA and protein level which was inhibited by apocynin, a Nox 
inhibitor (Muzaffar et al., 2011). Further studies using siRNA demonstrated 
that Nox1 but not Nox4 upregulated the thromboxane A2 synthase expression 
and activity (Muzaffar et al., 2011). These authors concluded that the 
upregulation of thromboxane A2 synthase and Nox1 expression represent a 
self-amplifying cascade (Muzaffar et al., 2011).  
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The effect of ML-171 on the U46619-induced contraction appears to be 
greater in endothelium intact vessels from male pigs, compared to female pigs. 
This may explain why ML-171 and DPI enhanced the EDH-type relaxation in 
coronary arteries from male pigs, but not from female pigs. Furthermore, in the 
absence of ML-171, the U46619-induced contraction appears to be greater in 
PCAs with intact endothelium in males compare to females but upon removal 
of the endothelium in PCAs from males, the potency of U46619 decrease to a 
level similar to females. Indeed, a previous study in rat aortae has 
demonstrated that endothelium-intact aortic rings from males generate a higher 
amount of superoxide compared to females, and removal of the endothelium 
reduced the superoxide production (Brandes & Mugge, 1997). This would 
explain why the effect of ML-171 on the U46619-induced contraction in the 
absence of the endothelium was not as great as that seen in the presence of the 
endothelium.  
To further investigate the effects of ML-171 on relaxation mediated 
through other pathways, forskolin, a cell-permeable adenylyl cyclase activator, 
and pinacidil, an ATP-sensitive potassium channel activator, were used. The 
presence of ML-171 had no effect on the maximum relaxation and pEC50 of 
both the forskolin-induced and pinacidil-induced vasorelaxation, therefore the 
possibility that the enhancement of the bradykinin-mediated relaxation is due 
to inhibition of the U46619-induced contraction can be ruled out. At low 
concentrations of pinacidil, the presence of ML-171 significantly enhanced the 
vasorelaxation. At a low concentration, pinacidil causes vascular smooth 
muscle relaxation through activation of the KATP channel, decreasing [Ca2+]i 
(Anabuki et al., 1990). Superoxide production has been shown to inhibit KATP 
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channel activity (Armstead, 1999), therefore, the reduction in superoxide 
production by ML-171 would enhance the vasorelaxation induced by pinacidil. 
The differential effect of ML-171 and DPI on PCAs from males 
compared to females may be due to different levels of Nox activity. However, 
a biochemical assay using lucigenin-enhanced chemiluminescence to measure 
Nox activity showed that DPI and ML-171 significantly reduced superoxide 
production in PCAs from both male and female pigs and no sex differences in 
total Nox activity were detected. This result differs slightly from that of Miller 
et al. (2007) where they have reported that superoxide generated by Nox in rat 
cerebral arteries were approximately 50% higher in males compared to 
females. However, this assay measured Nox activity in both smooth muscle 
and endothelium. As ML-171 enhanced the endothelium-dependent EDH-type 
relaxation, the difference in Nox activity may only be seen within the 
endothelial cells.  
As no sex differences were detected in the total Nox activity stimulated 
by NADPH, the possibility that the differences in the pharmacological 
responses may be related to the differential expression of Nox isoforms were 
then explored. Indeed, there was a higher level of Nox1 and Nox2 proteins 
expressed in PCAs from male pigs, but in contrast, a higher level of Nox4 
protein was expressed in female pigs. This result is consistent with a previous 
study in porcine coronary microvessels from female pigs where Nox1 and 
Nox2 proteins have been reported to be poorly expressed while the expression 
of Nox4 was abundant (Xie et al., 2012). The higher expression level of Nox1 
and Nox2 in PCAs from males could be a possible explanation for the effects 
of the Nox inhibitors, ML-171 and DPI observed in PCAs from male, but not 
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female pigs. A previous in vivo study in mice reported that transgenic mice 
overexpressing endothelial Nox4 are associated with an increased production 
of H2O2 which enhances endothelium-dependent vasorelaxation compared to 
wild-type mice (Ray et al., 2011). Here, the higher expression level of Nox4 
protein in PCAs from female pigs correlates with the results from Chapter 2 
and 4 where endogenous H2O2 plays a role in the bradykinin-induced 
vasorelaxations in PCAs from female, but not male pigs. In the present study, 
although a higher expression level of Nox4 protein was detected in females, 
the lack of response in the EDH-type relaxation in the presence of Nox 
inhibitor suggest that the Nox pathway does not play a role in PCA from 
females or that other compensatory pathways may be involved. For instance, 
Chapter 2 of the present study has demonstrated that gap junction 
communication and IKCa channels play a role in the bradykinin-induced EDH-
type vasorelaxation in PCAs from female but not male pigs.    
 To further confirm the role of Nox in PCAs, the effects of a different 
Nox inhibitor, VAS2870 (Wind et al., 2010a; Wingler et al., 2012) were then 
investigated. Previous studies have reported that VAS2870 inhibits activity of 
all Nox isoforms including Nox1, Nox2 and Nox4 (Kleinschnitz et al., 2010; 
Wind et al., 2010a; Wingler et al., 2012), improving endothelial functions of 
spontaneously hypertensive rat aortae (Wind et al., 2010a) and protecting mice 
from brain damage after cerebral ischaemia (Kleinschnitz et al., 2010).  
Similar to ML-171, VAS2870 had no effects on the bradykinin-induced 
endothelium-dependent vasorelaxation in PCAs from both male and female 
pigs in the absence of L-NAME and indomethacin. These results differ slightly 
from a previous study using aortic rings from WKY and SHR male rats, where 
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the presence of VAS2870 significantly enhanced the acetylcholine-induced 
vasorelaxation (Wind et al., 2010a). This could be due to species or vascular 
bed differences. In contrast to ML-171 and DPI, VAS2870 inhibited the EDH-
type relaxation induced by bradykinin in PCAs from male, but not female pigs. 
The fact that VAS2870 had no effect on the U46619-induced tone indicates 
that ML-171 and VAS2870 may be acting on different pathways. This is 
supported by the finding that VAS2870 had no effect on Nox activity in PCAs. 
Here, it should be noted that all previous studies that exhibit the protective 
effects of VAS2870 have been conducted in rodent and the present study 
conducted in PCAs demonstrated detrimental effects. Therefore, further studies 
on the effects of VAS2870 in vessels from human subject of specified sex are 
required.  
In summary, inhibition of Nox with DPI and ML-171 enhances, while 
VAS2870 inhibited the EDH-type response in PCAs from male, but not female 
pigs. This indicates that Nox-generated ROS regulates the EDH-type response 
in males, but not in females. The sex differences in EDH-type response could 
be attributed to the differential expression of Nox isoforms. This may underlie 
the greater oxidative stress observed in men, whereby increased ROS 
production through Nox1 and Nox2 leads to a reduction in the EDH-type 
response.  
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6.1 Introduction  
The transient receptor potential (TRP) channel superfamily is a diverse group 
of non-selective cation-permeable channels which are divided into six 
subfamilies based on the protein sequence identity (Earley & Brayden, 2010). 
TRP channels have been detected in endothelial cells and vascular smooth 
muscle cells, playing a role in the regulation of vascular tone (Bubolz et al., 
2012; Earley & Brayden, 2010; Huang et al., 2011). Three subfamilies of the 
TRP proteins, TRPM (TRP melastatin), TRPC (TRP canonical) and TRPV 
(TRP vanilloid) channels, have been reported as mediators of oxidative stress 
(Balzer et al., 1999; Bubolz et al., 2012; Kraft et al., 2004; Poteser et al., 
2006). Specifically, the TRPM2 channel has been demonstrated to be activated 
by H2O2 (Bari et al., 2009; Hecquet et al., 2008), whereas endothelial TRPC3 
and TRPC4 channels have been reported to be redox-sensitive cation channels 
(Balzer et al., 1999; Poteser et al., 2006).  
Previous studies have reported that TRPM2 channels play a role in the 
H2O2-mediated calcium influx in human pulmonary arterial endothelial cells 
(Hecquet et al., 2008) and in cultured microglial cells (Kraft et al., 2004). 
Increased levels of H2O2 have been detected in various pathological diseases 
including essential hypertension in human subjects (Lacy et al., 2000) and 
ischaemia and reperfusion of rat brain (Hyslop et al., 1995). Therefore, further 
understanding of the mechanism of action of H2O2 and the role of TRP 
channels in vascular function may benefit the development of new strategies in 
treatment and prevention of diseases related to H2O2 (Burgoyne et al., 2013).  
Other vasoactive substances which regulate vascular tone include 
endothelium-derived relaxing factor (NO), prostacyclin and endothelium-
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derived hyperpolarization (EDH)-type responses (Edwards et al., 2010; 
Furchgott & Zawadzki, 1980; Taylor & Weston, 1988). A previous study in rat 
mesenteric arterial bed and the present study (Chapter 2 and 5) in PCAs have 
demonstrated clear sex differences in endothelial function and it was 
concluded that this could be a possible explanation for the higher 
cardiovascular risk observed in men and postmenopausal women compared to 
premenopausal women (McCulloch & Randall, 1998). However, most of the 
current studies on endothelial function are conducted on arteries from either 
males only or from either sexes and conclusions from these results may be 
biased and inconsistent as previously discussed in Chapter 2. 
Previous studies on TRP channels have demonstrated sex differences in 
other tissues, where inhibition of TRPM2 channels and knockdown of TRPM2 
expression in mice have significantly protected male neurons from cell death, 
but had no effect in females (Jia et al., 2011). In the mouse bladder, a higher 
gene expression level of TRPV1 has been reported in female compared to male 
mice (Kobayashi et al., 2009). To date, no-one has yet investigated if there are 
sex differences in the role of endothelial TRP channels in vascular control. In 
Chapter 2, sex differences in the endothelium-dependent relaxations to 
bradykinin in the PCAs have been demonstrated. Therefore, using 
pharmacological antagonists, this chapter examined whether TRP channels 
contribute to these sex differences in bradykinin-induced vasorelaxation 
specifically the role of TRPC3 and TRPV4 channels and also the roles of TRP 
channels in H2O2-mediated vasorelaxation in PCAs.  
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6.2 Materials and methods 
6.2.1 Preparation of rings of distal PCAs 
Tissues were set up as previously described in Chapter 2.  
6.2.2 Wire myography 
As described in Chapter 2, after 30 min of equilibration, responses to 60 mM 
KCl were determined twice. The vascular tone was then raised to about 40-
90% of the second KCl contraction tone by the addition of the thromboxane A2 
mimetic, U46619 (1 nM - 400 nM). Once stable tone was achieved, 
concentration-response curves to an endothelium-dependent vasorelaxant, 
bradykinin (0.01 nM - 1 µM), A23187 (1 nM - 3 µM) or H2O2 (1 µM - 1 mM) 
were constructed in the presence of various inhibitors. NG-nitro-L-arginine 
methyl ester (L-NAME) (300 µM) was used as a NO synthase inhibitor and 
indomethacin (10 µM) was used to inhibit the synthesis of prostanoids. To 
examine the role of TRP channels in H2O2-induced vasorelaxation and on 
endothelium-dependent vasorelaxation, the following inhibitors were used; 2-
diphenylboranyloxyethanamine (2-APB) (10 µM or 100 µM) (Hagenston et 
al., 2009; Li et al., 2005; Togashi et al., 2008) and 2-[3-(4-pentylphenyl)prop-
2-enoylamino]benzoic acid (ACA) (20 µM or 100 µM) (Bari et al., 2009; 
Kraft et al., 2006; Togashi et al., 2008) as non-selective TRP channels 
blockers. 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl] 
imidazole (SKF96365) (10 µM) (Huang et al., 2011) was used to inhibits 
TRPC channels whereas ethyl-1-(4-(2,3,3-trichloroprop-2-enoylamino) 
phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate (Pyr3) (3 µM) (Huang et 
al., 2011) and 2,4-dichloro-N-propan-2-yl-N-[2-(propan-2-ylamino)ethyl] 
benzenesulfonamide (RN1734) (30 µM) (Bagher et al., 2012; Bubolz et al., 
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2012) were used as selective TRPC3 and TRPV4 antagonist respectively. All 
inhibitors were added into the bath 1 h before pre-contraction with U46619. In 
the majority of cases, a higher concentration of U46619 was required to induce 
tone in the presence of TRP antagonists and in some cases the level of tone 
achieved with U46619 was slightly less than vehicle controls. Table 6.1A and 
B summarises the concentration of U46619 used and the level of tone induced 
under these conditions.  
 
6.2.3 Western Blotting 
The relative expression levels of TRPC3 and TRPV4 in PCAs from male and 
female pigs were compared using Western blotting. PCAs were finely 
dissected and cut into segments of approximately 1.5 cm in length. PCAs were 
then gassed with 5% CO2 and 95% O2 at 37°C for 1 K LQ .UHEV¶-Henseleit 
solution as previously described in Chapter 2 (Samples in this chapter were 
solubilised in 6x solubilisation buffer). Again, the method described below is 
the result of substantial method development using antibodies from different 
companies, different batches of antibodies and different dilutions of antibody. 
Results of these developments are included in Appendix D. For quantification 
of TRPC3 protein, 35 µg of PCA samples with 25 µg of pig brain lysates used 
as positive control were incubated with rabbit polyclonal anti-TRPC3 antibody 
(ab70603 Abcam®, Cambridge, UK) (1:500). For quantification of TRPV4 
protein, 15 µg of PCA samples with 15 µg of KXPDQ ȕ-cell lysates used as 
positive control were incubated with rabbit polyclonal anti-TRPV4 antibody  
(ab94868 Abcam®) (1:1000).   
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A Concentration of   
U46619 (nM) 
 
L-NAME, indomethacin Indomethacin 
Control Antagonist Control Antagonist Control Antagonist 
2-APB 
Male 12.3 ± 1.2 40.2 ± 6.3** 21.5 ± 3.7 99.0 ± 26.9* 
  
Female 11.8 ± 1.1 31.8 ± 2.4*** 13.2 ± 1.7 40.7 ± 4.7** 
  
SKF96365 Male 6.9 ± 1.1 153 ± 41* 12.2 ± 1.3 80.0 ±20.5*   
Female 10.0 ± 1.7 258 ± 53** 10.2 ± 0.9 181 ± 38** 
  
Pyr3 
Male 
  
13.8 ± 1.3 17.7 ± 1.1* 20.0 ± 1.1 19.9 ± 0.9 
Female 
  
18.7 ± 2.0 17.7 ± 1.6 30.5 ± 1.9 28.8 ± 1.8 
RN1734 Male 
9.17 ± 0.70 28.0 ± 7.8 10.5 ± 0.8 47.7 ± 5.8** 28.3 ± 4.5 185 ± 40* 
Female 8.57 ± 1.33 35.6 ± 6.6** 12.0 ± 1.3 49.4 ± 4.8*** 28.5 ± 4.8 111 ± 12*** 
 
B U46619-induced tone 
(% KCl response) 
 
L-NAME, indomethacin Indomethacin 
Control Antagonist Control Antagonist Control Antagonist 
2-APB Male 
76.7 ± 7.0 53.3 ± 0.4* 60.0 ± 5.2 52.2 ± 0.7 
  
Female 70.0 ± 5.5 58.7 ± 4.3 62.0 ± 5.1 54.3 ± 1.0 
  
SKF96365 Male 
62.0 ± 10.3 51.0 ± 5.6 67.6 ± 8.0 56.4 ± 3.1 
  
Female 67.0 ± 6.5 47.2± 3.2** 63.1 ± 4.3 56.5 ± 3.9* 
  
Pyr3 Male   
53.3 ± 1.2 60.2 ± 3.7 67.6 ± 5.6 67.0 ± 5.7 
Female 
  
62.3 ± 4.8 59.7 ± 4.2 63.5 ± 6.7 70.3 ± 6.6 
RN1734 Male 
72.8 ± 6.1 56.7 ± 2.3* 60.8 ± 4.3 50.7 ± 1.1 63.5 ± 7.3 53.5 ± 1.3 
Female 71.9 ± 5.6 53.6 ± 0.8* 62.7 ± 4.4 51.9 ± 0.5* 80.3 ± 6.3 54.2 ± 1.3** 
Table 6.1 Summary of (A) U46619 concentration used (nM) and (B) the level of U46619-induced tone expressed in percentage to second KCl-
induced tone. Data are expressed as mean ± S.E.M. of 3-11 experiments. *P<0.05, **P<0.01, ***P<0.001; 2-WDLOHG SDLUHG 6WXGHQW¶V t-test. 
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Mouse monoclonal anti-GAPDH antibody (G8795 Sigma-Aldrich, Poole, 
Dorset, UK) (1:40,000) was used as loading control for both quantification. 
Secondary antibodies, IRDye® 680LT Goat anti-mouse IgG (1:10 000) (LI-
COR Biosciences, Cambridge, UK) was used for anti-mouse antibody and 
IRDye® 800CW Goat anti-rabbit IgG (1:10 000) (LI-COR Biosciences, 
Cambridge, UK) for anti-rabbit antibody. LI-COR Odyssey Infrared Imaging 
Scanner was used to visualise the immunoblots and densities of the bands were 
determined using Image Studio Analysis Software Version 3.1 (LI-COR).  
 
6.2.4 Statistical analysis 
Data for functional studies were presented and analysed as described in 
Chapter 2. For Western blot, expression levels of TRPC3 and TRPV4 proteins 
in PCAs from male and female pigs were normalised to GAPDH level then 
analysed using 2-tailed, unpaired Mann-Whitney U-test. 
 
6.2.5 Drugs and reagents 
All drugs were purchased from Sigma-Aldrich (Poole, Dorset, UK) except for 
SKF96365, Pyr3 and RN1734 from Tocris Bioscience (Bristol, UK) and ACA 
from Calbiochem (VWR International Ltd, Lutterworth, Leicestershire, UK). 
Stock solutions of L-NAME and SKF96365 were dissolved in distilled water 
while 2-APB, ACA, Pyr3 and RN1734 were dissolved in DMSO. Stock 
solution of indomethacin was dissolved in absolute ethanol. Stock solution of 
A23187 was made up to 1 mM in absolute ethanol and H2O2 was made up to 
100 mM in distilled water. All further dilutions of the stock solutions were 
made using distilled water. 
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6.3 Results  
6.3.1 The effects of 2-APB on bradykinin-induced vasorelaxation in PCAs 
from male and female pigs 
In PCAs from males, the presence of 100 µM 2-APB significantly inhibited the 
Rmax to bradykinin from 104 ± 4% under control conditions to 66 ± 6% in the 
presence of 2-APB (n= 6) (P<0.01), but had no effect on the pEC50 (8.35 ± 
0.09, control; 8.12 ± 0.18, 2-APB, n= 6) (Figure 6.1A).  
Similarly, in PCAs from females, the presence of 100 µM 2-APB 
significantly inhibited the Rmax of the bradykinin-induced vasorelaxation 
compared to the control and had no effects on the pEC50 (8.22 ± 0.07, control; 
7.94 ± 0.14, 2-APB, n= 6) (Figure 6.1B). The Rmax was significantly reduced 
from 98.8 ± 3.6% under control conditions to 75.4 ± 5.6% in the presence of 2-
APB (n= 6) (P<0.001) (Figure 6.1B). 
 
6.3.2 The effects of 2-APB on bradykinin-induced vasorelaxation in the 
presence of L-NAME and indomethacin in PCAs from male and female 
pigs 
In the presence of L-NAME and indomethacin, the additional presence of 100 
µM 2-APB essentially abolished the bradykinin-induced vasorelaxation in 
PCAs from both male and female pigs (Figure 6.2A and B respectively). The 
Rmax in the presence of L-NAME and indomethacin was 74.3 ± 13.0% for 
PCAs from male pigs and 60.7 ± 18.2% for PCAs from female pigs (n=6).  
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Figure 6.1 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 100 µM 2-APB in U46619 pre-contracted 
porcine coronary arteries from (A) male and (B) female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 6 experiments. **P<0.01, ***P<0.001, 2-tailed; SDLUHG 6WXGHQW¶V t-
test. 
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Figure 6.2 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME and 10 µM indomethacin with 
or without 100 µM 2-APB in U46619 pre-contracted porcine coronary arteries 
from (A) male and (B) female pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 6 experiments.  
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6.3.3 The effects of SKF96365 on bradykinin-induced vasorelaxation in 
PCAs from male and female pigs 
SKF96365, a non-selective TRPC channel inhibitor, significantly reduced the 
Rmax (P<0.05) of the bradykinin-induced vasorelaxation in PCAs from male 
pigs from 104 ± 4% under control conditions to 90 ± 3% in the presence of 
SKF96365, but had no effect on the pEC50 (8.80 ± 0.10, control; 8.92 ± 0.10, 
SKF96365, n= 5) (Figure 6.3A).  
On the other hand, in PCAs from females, SKF96365 had no effect on 
the Rmax or pEC50 of the bradykinin-induced vasorelaxation (7.71 ± 0.08, 
control; 7.65 ± 0.08, SKF96365, n= 6) (Figure 6.3B).  
 
6.3.4 The effects of SKF96365 on bradykinin-induced vasorelaxation in 
the presence of L-NAME and indomethacin in PCAs from male and 
female pigs 
In the presence of L-NAME and indomethacin, the presence of SKF96365 
significantly reduced the Rmax of the bradykinin-induced vasorelaxation in 
PCAs from both male (Figure 6.4A) and female pigs (Figure 6.4B) (P<0.05). 
In male PCAs, the Rmax was reduced (P<0.05) from 95.0 ± 3.4% in the 
presence of L-NAME and indomethacin to 69.7 ± 3.0% (n=5) in the additional 
presence of SKF96365. In female PCAs, the Rmax was reduced (P<0.05) from 
84.0 ± 6.4% in the presence of L-NAME and indomethacin to 62.3 ± 5.8% 
(n= 10) in the additional presence of SKF96365.  
 In contrast, the presence of SKF96365 had no effect on the pEC50 of 
the bradykinin-induced EDH-type response in PCAs from both male and 
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female pigs (in males; 8.07± 0.07, without SKF96365; 8.18 ± 0.09, with 
SKF96365) (in females; 7.56 ± 0.12, without SKF96365; 7.69 ± 0.16, with 
SKF96365). 
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Figure 6.3 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 10 µM SKF96365 in U46619 pre-contracted 
porcine coronary arteries from (A) male and (B) female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 5-6 experiments. *P<0.05; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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Figure 6.4 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME and 10 µM indomethacin with 
or without 10 µM SKF96365 in U46619 pre-contracted porcine coronary 
arteries from (A) male and (B) female pigs. Data are expressed as a percentage 
change from U46619-induced tone and are mean ± S.E.M. of 5-10 
experiments. *P<0.05; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
 
6.3.5 The effects of 2-APB or SKF96365 on A23187-induced 
vasorelaxation in the presence of L-NAME and indomethacin in PCAs 
from male pigs 
As 100 µM 2-APB essentially abolished the bradykinin-induced vasorelaxation 
in the presence of L-NAME and indomethacin, the effects of 2-APB on 
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relaxations to A23187, a calcium ionophore which causes endothelium-
dependent relaxations were examined. In PCAs from male pigs, the presence 
of 2-APB (n=6) (Figure 6.5A), but not SKF96365 (n=8) (Figure 6.5B) 
significantly inhibited (P<0.01) the A23187-induced EDH-type 
vasorelaxations. 
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Figure 6.5 Log concentration-response curves for the vasorelaxant effects of 
A23187 in the presence of 300 µM L-NAME, 10 µM indomethacin and (A) 
100 µM 2-APB or (B) 10 µM SKF96365 in U46619 pre-contracted porcine 
coronary arteries from male pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 6-8 experiments. 
**P<0.01; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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6.3.6 The effects of Pyr3 in the presence of indomethacin on bradykinin-
induced vasorelaxation in PCAs from male and female pigs 
Next, the effects of Pyr3, a selective TRPC3 antagonist, on bradykinin-induced 
vasorelaxation in the NO-mediated response in PCAs from male and female 
pigs were examined as previous studies have reported that TRPC3 channels 
play a role in the NO-mediated vasorelaxation (Chen et al., 2009; Huang et al., 
2011). In the presence of indomethacin, 3 µM Pyr3 in PCAs from male pigs 
had no effect on the Rmax of the bradykinin-induced vasorelaxation, but 
significantly reduced the potency of bradykinin by 4.2-fold from pEC50= 8.29 
± 0.10 to pEC50= 7.67 ± 0.06 (n=10) (P<0.05) (Figure 6.6A).  
In contrast, in PCAs from females, Pyr3 (in the presence of 
indomethacin) had no effect on the Rmax or pEC50 of the bradykinin-induced 
vasorelaxation (pEC50= 7.88 ± 0.06, control, n= 5; 7.77 ± 0.05, Pyr3, n=6) 
(Figure 6.6B).  
 
6.3.7 The effects of Pyr3 on bradykinin-induced vasorelaxation in the 
presence of L-NAME and indomethacin in PCAs from male and female 
pigs 
Similarly in the presence of both L-NAME and indomethacin, Pyr3 
significantly reduced the bradykinin-induced vasorelaxation at 30 nM 
bradykinin in males (n=11) (P<0.05) (Figure 6.7A), whereas in PCAs from 
females, Pyr3 had no effect on the bradykinin-induced vasorelaxation (n=6) 
(Figure 6.7B).  
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Figure 6.6 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 10 µM indomethacin and 3 µM Pyr3 in U46619 
pre-contracted porcine coronary arteries from (A) male or (B) female pigs. 
Data are expressed as a percentage change from U46619-induced tone and are 
mean ± S.E.M. of 5-10 experiments.  
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Figure 6.7 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME and 10 µM indomethacin with 
or without 3 µM Pyr3 in U46619 pre-contracted porcine coronary arteries from 
(A) male or (B) female pigs. Data are expressed as a percentage change from 
U46619-induced tone and are mean ± S.E.M. of 6-11 experiments. *P<0.05; 2-
WDLOHG SDLUHG6WXGHQW¶V t-test. 
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6.3.8 The effects of RN1734 on bradykinin-induced vasorelaxation in 
PCAs from male and female pigs 
A previous study has reported that TRPV4 and IKCa channels cluster within the 
endothelial cells¶ projection towards the smooth muscle cells (Bagher et al., 
2012). In Chapter 2, sex differences in the role of IKCa channels in PCAs have 
been reported where IKCa plays a role in the EDH-type response to bradykinin 
in female, but not male pigs. Therefore, sex differences in the role of TRPV4 
on bradykinin-induced vasorelaxation in PCAs from male and female pigs 
were investigated. In PCAs from males, the presence of RN1734, a selective 
TRPV4 antagonist (pEC50= 8.18 ± 0.04), had no effect on the bradykinin-
induced vasorelaxation compared to the control (pEC50= 8.33 ± 0.05) (n= 6) 
(Figure 6.8A).  
Interestingly, in PCAs from females, the presence of RN1734 
significantly reduced (P<0.05) the potency of bradykinin by 4.4-fold (pEC50= 
8.36 ± 0.05, control; 7.72 ± 0.11, RN1734, n=7), but had no effect on the Rmax 
(Figure 6.8B).  
 
6.3.9 The effects of RN1734 on bradykinin-induced vasorelaxation in the 
presence of indomethacin with or without L-NAME in PCAs from male 
and female pigs 
In the presence of indomethacin, RN1734 had no effect on the bradykinin-
induced vasorelaxation in PCAs from male pigs (Figure 6.9A), but 
significantly reduced the potency of bradykinin in PCAs from female pigs by 
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4.9-fold (P<0.05) (pEC50= 8.63 ± 0.03, indomethacin; 7.94 ± 0.08, 
indomethacin and RN1734, n= 6) (Figure 6.9B).  
In the EDH-type response, in the presence of L-NAME and 
indomethacin, RN1734 inhibited the Rmax (P<0.05) of both PCAs from male 
(Figure 6.10A) and female pigs (Figure 6.10B), but had no effect on the pEC50 
of the bradykinin-induced vasorelaxation.  (Rmax in males = 77.6 ± 17.6%, 
without RN1734; 55.6 ± 6.0%, with RN1734, n= 6, in females = 73.2 ± 7.0%, 
without RN1734; 55.4 ± 5.4%, with RN1734, n=7). 
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Figure 6.8 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 30 µM RN1734 in U46619 pre-contracted 
porcine coronary arteries from (A) male and (B) female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 6-7 experiments.  
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Figure 6.9 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 10 µM indomethacin with or without 30 µM 
RN1734 in U46619 pre-contracted porcine coronary arteries from (A) male 
and (B) female pigs. Data are expressed as a percentage change from U46619-
induced tone and are mean ± S.E.M. of 3-6 experiments.  
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Figure 6.10 Log concentration-response curves for the vasorelaxant effects of 
bradykinin in the presence of 300 µM L-NAME and 10 µM indomethacin with 
or without 30 µM RN1734 in U46619 pre-contracted porcine coronary arteries 
from (A) male and (B) female pigs. Data are expressed as a percentage change 
from U46619-induced tone and are mean ± S.E.M. of 6-7 experiments. 
*P<0.05; 2-WDLOHG SDLUHG6WXGHQW¶V t-test. 
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6.3.10 The effects of TRPMs and TRPCs (2-APB and ACA) antagonists in 
the presence of L-NAME and indomethacin on H2O2-induced 
vasorelaxation in PCAs from female pigs 
Next, the effects of various TRP channel antagonists on H2O2-induced 
vasorelaxation were studied as a previous study demonstrated a role for the 
TRPM2 channels in H2O2-induced calcium influx (Kraft et al., 2004). Previous 
studies have also demonstrated that H2O2 is a factor for EDH-type responses 
(Matoba et al., 2002; Matoba et al., 2003; Matoba et al., 2000; Miura et al., 
2003). Therefore, in the present study, relaxations were conducted in the 
presence of L-NAME and indomethacin. As Chapter 2 has demonstrated a role 
for H2O2 in bradykinin-induced vasorelaxation in PCAs from female but not 
male pigs, the present chapter only investigated the effects of TRP antagonists 
on H2O2-induced vasorelaxation in PCAs from female pigs only. 
At 10 µM, 2-APB an antagonist of TRPMs and TRPCs channels, had 
no effect on the H2O2-induced vasorelaxation (pEC50= 3.77 ± 0.07) compared 
to the control (pEC50= 3.71 ± 0.08, n=8) (Figure 6.11A). However, at 100 µM, 
2-APB significantly (P<0.001) shifted the curve 2.5-fold to the right (pEC50 = 
3.32 ± 0.05, n= 8) (Figure 6.11A). As the data for 100 µM 2-APB did not 
achieve an Rmax, all curves in Figure 6.11A were constrained to an Rmax of 
100%.  
ACA (20 µM), an antagonist of TRPMs and TRPCs channels, had no 
effect on the single concentration of H2O2-induced (100 µM) vasorelaxation 
(n= 5) (Figure 6.11B). Here, a single concentration of H2O2 was used because 
the U46619-induced tone could not be maintained in the presence of 20 µM 
ACA, whereas at 100 µM ACA, U46619 failed to induce tone.  
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Figure 6.11 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the presence of 300 µM L-NAME and 10 µM indomethacin, with or 
without (A) 10 µM or 100 µM 2-APB or (B) 20 µM ACA in U46619 pre-
contracted porcine coronary arteries from female pigs. Data are expressed as a 
percentage change from U46619-induced tone and are mean ± S.E.M. of 5-8 
experiments.  
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6.3.11 The effects of selective TRPCs (SKF96365), TRPC3 (Pyr3) and 
TRPV4 (RN1734) antagonists in the presence of L-NAME and 
indomethacin on H2O2-induced vasorelaxation in PCAs from female pigs 
SKF96365 (10 µM), a non-selective TRPC channels antagonist, significantly 
inhibited the Rmax (P<0.01), but had no effect on the pEC50 of the H2O2-
induced vasorelaxation compared to the control (pEC50= 4.01 ± 0.06, control; 
4.04 ± 0.07, SKF96365, n= 5) (Figure 6.12A). The Rmax of the H2O2-induced 
vasorelaxation under control conditions was significantly reduced (P<0.01) 
from 104 ± 7% to 84 ± 6% in the presence of SKF96365 (n= 5). 
Pyr3, a selective TRPC3 antagonist, had no effect on the Rmax or pEC50 
of the H2O2-induced relaxation in PCAs from female pigs (n= 6) (Figure 
6.12B). Whereas, 30 µM RN1734, a selective TRPV4 antagonist, significantly 
reduced (P<0.05) the H2O2-induced relaxation at 100 µM-1 mM H2O2 (n= 5) 
(Figure 6.12C). Here, TRPV4 channels were examined because a previous 
study in human coronary arterioles reported that activation of TRPV4 channels 
ZLWK Į-PDD increased superoxide and H2O2 formation (Bubolz et al., 2012) 
and in human coronary artery endothelial cells, exogenously applied H2O2 
sensitises TRPV4 to channel agonist (Zheng et al., 2013a).  
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Figure 6.12 Log concentration-response curves for the vasorelaxant effects of 
H2O2 in the presence of 300 µM L-NAME and 10 µM indomethacin with or 
without (A) 10 µM SKF96365, (B) 3 µM Pyr3 or (C) 30 µM RN1734 in 
U46619 pre-contracted porcine coronary arteries from female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 5-6 experiments. *P<0.05, **P<0.01; 2-WDLOHG SDLUHG 6WXGHQW¶V t-
test. 
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6.3.12 Determination of expression of TRPC3 and TRPV4 proteins in 
PCAs from male and female pigs via Western blotting 
Western blot analysis of TRPC3 (Figure 6.13A) and TRPV4 (Figure 6.14A) 
protein expression levels demonstrated no differences between PCAs from 
male and female pigs. Quantification of the TRPC3 (Figure 6.13B) and 
TRPV4 (Figure 6.14B) proteins were analysed based on ratio of the protein 
band intensities to their respective loading control (GAPDH) within each lane.  
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Figure 6.13 (A) TRPC3 (~100 kDa) and GAPDH (~37 kDa) expression levels 
in 35 µg of porcine coronary artery homogenates (PCAs) from female (F1-F5) 
and male (M1-M5) pigs using 25 µg of pig brain (PB) lysates as positive 
control. (B) Ratio of expression levels of TRPC3 to GAPDH in PCAs from 
male and female pigs based on the intensities of the bands. Data are expressed 
in the ratio of protein to GAPDH intensities bands and are mean ± S.E.M. of 5 
PCAs. 
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Figure 6.14 (A) TRPV4 (~100 kDa) and GAPDH (~37 kDa) expression levels 
in 15 µg of porcine coronary artery homogenates (PCAs) from female (F1-F5) 
and male (M1-0 SLJV XVLQJ  J RI KXPDQ ȕ-cell lysates as positive 
control. (B) Ratio of expression levels of TRPV4 to GAPDH in PCAs from 
male and female pigs based on the intensities of the bands. Data are expressed 
in the ratio of protein to GAPDH intensities bands and are mean ± S.E.M. of 5 
PCAs. 
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6.4 Discussion 
This chapter provides evidence for a functional role of TRP channels in 
endothelium-dependent and H2O2-mediated vasorelaxation in distal PCAs. 
Here, clear sex differences in the role of TRPC3 and TRPV4 channels in PCAs 
induced by bradykinin were demonstrated, where TRPC3 plays a role in the 
NO- and EDH-type response only in males, whereas TRPV4 plays a role in the 
endothelium-dependent vasorelaxation only in females.  
Initial experiments in this chapter were performed using the 
commonly-used, but non-selective TRP channel inhibitor 2-APB. 2-APB 
significantly reduced the bradykinin-induced vasorelaxation and abolished the 
EDH-type response in PCAs from both male and female pigs. Using A23187, a 
calcium ionophore to examine the effects of 2-APB on the EDH-type 
responses demonstrated consistent results with the bradykinin-induced 
vasorelaxation, where the EDH-type response was abolished. These data 
suggest a role for TRP channels in the EDH-type response in the porcine 
coronary artery. However, 2-APB has been suggested to inhibit other channels 
including multiple voltage and Ca2+-dependent K+ conductance in pyramidal 
neurons (Hagenston et al., 2009). This could explain the effects seen (where 
the EDH-type response was abolished) as KCa channels on the endothelial cells 
SOD\ D UROH LQ WKH µFODVVLFDO¶ ('+-type responses (Edwards et al., 2010; Gluais 
et al., 2005a).  
2-APB (100 µM) reduced the potency of the H2O2-mediated 
vasorelaxation, suggesting a role for TRP channels in this response as well, 
although, again, an effect on K+ channels cannot be ruled out. Another study 
has also demonstrated that 2-APB inhibits gap junctions (Bai et al., 2006). 
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However, the effects of gap junctions in the H2O2-mediated response can be 
ruled out as the study from Chapter 3 has shown that a gap junction inhibitor 
has no effect on the H2O2-induced vasorelaxation. 2-APB can inhibit TRPM2 
channels (Togashi et al., 2008), therefore the effects of a purported inhibitor of 
TRPM2 channel inhibitor, ACA (Kraft et al., 2006; Togashi et al., 2008), were 
investigated.  In H2O2-mediated vasorelaxation, 20 µM ACA had no effect on 
the H2O2-induced vasorelaxation in PCAs. This lack of effect could be due to 
the concentrations of inhibitor used. In previous studies using HEK293 cells 
transfected with human TRPM2 channels, 10 µM 2-APB and 20 µM ACA 
have been shown to completely inhibit whole cell current (Kraft et al., 2006; 
Togashi et al., 2008). In the present study, a higher concentration of inhibitors 
may be required due to lower penetration of the inhibitors into the multiple cell 
layers in blood vessels. However, with 100 µM ACA, PCAs failed to develop 
any U46619-induced tone and therefore the effect of higher concentrations of 
this compound on the H2O2 relaxation could not be studied.  The shift in the 
potency of H2O2-mediated response in the presence of 2-APB may indicate a 
role for TRPM and TRPC channels in the H2O2-induced vasorelaxation. As a 
selective TRPM2 antagonist is currently unavailable, the functional roles of 
TRPM2 in H2O2-mediated and endothelium-dependent vasorelaxation remain 
to be explored. 
As the data obtained with the non-selective TRP channel inhibitor, 2-
APB indicated a potential role for TRP channels, the effects of a TRPC 
channels antagonist, SKF96365 (Huang et al., 2011) on endothelium-
dependent and H2O2-induced vasorelaxation were examined. In the bradykinin-
induced endothelium-dependent vasorelaxation, the presence of SKF96365 
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reduced the Rmax in PCAs from male, but not female pigs. This could be due to 
differential regulation of the release of NO through TRPC channel activation. 
The role of NO playing a more prominent role in PCAs from male pigs 
compared to female pigs has been previously demonstrated in Chapter 2 and a 
previous study in PCAs demonstrated that inhibition of TRPC3 channels 
reduces the amount of endothelial NO released (Huang et al., 2011). Here, it is 
possible that a significant reduction in the relaxation was not seen in PCAs 
from female pigs owing to the greater role that EDH plays in the endothelium-
dependent vasorelaxation (McCulloch & Randall, 1998; White et al., 2000). In 
the EDH-type responses, the presence of SKF96365 significantly reduced the 
Rmax in PCAs from both sexes indicating that TRPC channels play a role in the 
bradykinin-induced EDH-type response in both male and female pigs. It is 
possible that the reduction in EDH-type response is due to the reduction in 
increased [Ca2+]i level due to the inhibition of SOCE by SKF96365 (Chen et 
al., 2013) as endothelial [Ca2+]i ions are required for activation of SKCa and 
IKCa channels in the EDH-type response (Edwards et al., 2010). This 
possibility is further supported by the A23187 data where SKF96365 had no 
effect on the A23187-induced vasorelaxation in the EDH-type pathway. 
SKF96365 reduced the Rmax of the H2O2-induced vasorelaxation suggests that 
TRPC channels may also play a role in the H2O2-induced vasorelaxation. 
To further study the role of TRPC channels, the effects of a selective 
TRPC3 antagonist, Pyr3 were investigated. The presence of Pyr3 reduced the 
potency of bradykinin in the NO- and EDH-type response in PCAs from male, 
but not female pigs and these differences are not due to the expression level of 
the protein as shown in the Western blot study. However, it is possible that 
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there are differences in the activation of the receptor, or downstream 
signalling. Interestingly, a previous study in porcine aortic endothelial cells 
suggested that TRPC3 channels can be activated by oxidative stress (Balzer et 
al., 1999) and Chapter 5 of the present study demonstrated that NADPH 
oxidase generated reactive oxygen species play a role in PCAs from males but 
not females. Other studies have also reported that there is a greater oxidative 
stress observed in men compared to premenopausal women (Ide et al., 2002) 
and higher superoxide anion generated in aortae from male rats compared to 
female rats (Brandes & Mugge, 1997). It is therefore possible that TRPC3 
channels play a role in the endothelium-dependent and EDH-type 
vasorelaxation activated by reactive oxygen species in males. Furthermore, as 
discussed above, Huang et al., (2011) reported that endothelial TRPC3 channel 
contributes to the bradykinin- induced NO release.  
In contrast, the present study demonstrated that TRPC3 do not play a 
role in the H2O2-induced vasorelaxation suggesting that TRPC3 may not be 
activated by oxidative stress and this finding differ to that of Balzer et al. 
(1999) as mentioned above. The differences in finding could be due to the 
differences in experimental condition as the study by Balzer et al. (1999) was 
conducted on endothelial cells whereas the present study was conducted on 
whole vessels. Chapter 3 of the present study demonstrated that H2O2-induced 
vasorelaxation is endothelium-independent, therefore it is possible that 
endothelial TRPC3 is activated by oxidative stress as demonstrated by Balzer 
et al. (1999) which also support the finding from the present study using 
bradykinin as an endothelium-dependent vasorelaxant. Whereas in the H2O2-
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induced vasorelaxation, it is possible that H2O2 had a direct effect on the 
vascular smooth muscle causing vasorelaxation through a different pathway.  
Lastly, the effects of a selective TRPV4 antagonist, RN1734 on 
bradykinin-induced and H2O2-induced vasorelaxation in PCAs from male and 
female pigs were examined. In the present study, Chapter 2 demonstrated a 
role for the IKCa channel in female but not male pigs in the bradykinin-induced 
EDH-type response. A study from another laboratory reported that TRPV4 and 
IKCa channels cluster within the endothelial cells¶ projection toward the 
smooth muscle cells (Bagher et al., 2012). Therefore, this chapter also 
examined if TRPV4 contribute to sex differences in endothelial function. In the 
bradykinin-induced vasorelaxation, this chapter showed sex differences in the 
effects of RN1734, indicating that TRPV4 channels play a role only in PCAs 
from female pigs. Similarly, sex differences in the functional response to 
RN1734 are not due to the expression level of the TRPV4 proteins. A previous 
study measuring flow induced dilatation of human coronary arterioles (HCAs) 
reported that RN1734 had no effect on the bradykinin-induced vasorelaxation 
(Bubolz et al., 2012). One possible explanation for this observation is that the 
HCA from male and female subjects were not investigated separately. This 
study DOVR UHSRUWHG WKDW LQ +&$V DFWLYDWLRQ RI 7539 FKDQQHOV XVLQJĮ-PDD 
enhanced the production of mitochondrial ROS, examined using MitoSOX 
(Bubolz et al., 2012). In their HCAs perfusion study, catalase significantly 
LQKLELWHG WKH Į-PDD-induced vasorelaxation and further semi-quantitative 
DQDO\VLV XVLQJ '&)+ DQG '+( GHPRQVWUDWHG WKDW Į-PDD significantly 
increased the H2O2 and superoxide production (Bubolz et al., 2012). Chapter 2 
of the present study reported that endogenous H2O2 plays a role in the 
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bradykinin-induced, NO-mediated pathway in PCAs from female but, not male 
pigs. Taking together the results from these studies, it is possible that inhibition 
of TRPV4 channels in the NO-mediated pathway reduced the production of 
endogenous H2O2, therefore reducing the potency of the bradykinin-induced 
vasorelaxation only in female pigs. In the EDH-type response induced by 
bradykinin, the presence of RN1734 had little effect on the Rmax in PCAs from 
both male and female pigs. Again, the slight reduction in vasorelaxation could 
possibly be due to the decrease in [Ca2+]i release following inhibition of 
TRPV4 channels (Bubolz et al., 2012). In the H2O2-mediated response, 
RN1734 caused a modest inhibition at 100 µM-1 mM H2O2. In a previous 
study using overexpressed TRPV4 channels in human coronary artery 
endothelial cells, a high concentration of H2O2 (1 mM) produced a transient 
increase in [Ca2+]i whereas at 10 µM  H2O2 WKH HIIHFWV RI7539DJRQLVW Į-
PDD-induced increased in [Ca2+]i was enhanced (Zheng et al., 2013a). 
Therefore, in this chapter, inhibition of the endothelial TRPV4 may have 
reduced the release of endothelial [Ca2+]i. 
In summary, this chapter demonstrates clear sex differences in the role 
of TRPC3 and TRPV4 channels in the bradykinin-induced vasorelaxation, 
where TRPC3 plays a role in the NO- and EDH-type response in PCA from 
male pigs only, whereas TRPV4 plays a role in the NO-mediated response in 
PCA from female pigs only. This chapter further demonstrates that gender-
specific drug treatment may be a potential strategy in the treatment for 
cardiovascular diseases in the future.  
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7.1 Sex differences in the endothelium-dependent vasorelaxation 
In the present study, sex differences in endothelial function in PCAs have been 
clearly demonstrated where different ion channels and Nox isoforms have been 
found to be involved in the bradykinin-induced vasorelaxation in male and 
female pigs. Preliminary studies in Chapter 2 demonstrated that bradykinin is 
an endothelium-dependent vasorelaxant which stimulates the release of NO- 
and EDH-type responses in PCAs from male and female pigs and this finding 
is in agreement with previous studies in PCAs (Matoba et al., 2003; Nagao & 
Vanhoutte, 1992). This study was then extended to examine if there are any 
sex differences in the EDH-type response, defined as the remaining proportion 
of vasorelaxation which is insensitive to NO synthase and cyclo-oxygenase 
inhibition. Chapter 2 demonstrated that the NO-mediated vasorelaxation is 
more prominent in PCAs from males whereas the EDH-type response plays a 
greater role in females and this is in agreement with previous studies in rat 
mesenteric arteries and eNOS/COX-1 double knockout mice (McCulloch & 
Randall, 1998; Scotland et al., 2005; White et al., 2000).  
As H2O2 has previously been proposed to be a factor for EDH-type 
relaxation in human and mouse mesenteric arteries, human and porcine 
coronary arteries (Matoba et al., 2002; Matoba et al., 2003; Matoba et al., 
2000; Miura et al., 2003), the present study examined the role of H2O2 in 
bradykinin-induced vasorelaxation in PCAs. Chapter 2 demonstrated that 
endogenous H2O2 plays a role in the bradykinin-induced vasorelaxation only in 
PCAs from female pigs and is not a factor for EDH-type response in PCAs 
from both sexes. Possible explanations for differences in the EDH-type 
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response between the present study and previous studies have been discussed 
in detail in Chapter 2.  
Chapter 2 demonstrated that whilst SKCa channels play a role in PCAs 
from both male and female pigs, IKCa channels and gap junctional 
communication appear to be more important in the EDH-mediated pathway in 
PCAs from female pigs. These mechanisms could possibly be acting as 
compensation for the diminished response in the NO-mediated pathway in 
PCAs from female pigs. Indeed, previous studies in saphenous arteries from 
male obese rats and mesenteric arteries from male ZDF rats reported an up-
regulation in expression and activity of IKCa channels and gap junction 
communication to compensate for the loss of NO-mediated response (Chadha 
et al., 2010; Schach et al., 2014). However, Western blot study did not detect 
any differences in protein expression for Cx40, Cx43 and IKCa channels in 
PCAs from male and female pigs. The upregulated EDH-type response in 
females may be a possible explanation for the lower cardiovascular risk 
observed in premenopausal women compared to age-matched men or 
postmenopausal women.  
As H2O2 was shown to play a role in the endothelium-dependent 
vasorelaxation, Chapter 3 and Chapter 6 examined the mechanism of action of 
exogenously applied H2O2-induced vasorelaxation in PCAs from male and 
female pigs, specifically in the role of K+ channels and TRP channels 
respectively. Furthermore, previous studies in human subjects have reported 
that the plasma level of H2O2 is significantly higher in subjects with essential 
hypertension compared to normotensive subjects (Lacy et al., 2000) and during 
inflammation, activated macrophages may produce up to 100 µM of  H2O2 
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locally (Droge, 2002). Therefore, further understanding on the mechanism of 
action of H2O2 may be beneficial for future drug development (Burgoyne et 
al., 2013). Chapter 3 demonstrated that H2O2-induced vasorelaxation was 
unaffected by removal of the endothelium, inhibition of NOS, cyclo-
oxygenase, gap junctions, SKCa, IKCa, BKCa, Kir, KV, KATP, cGMP or Na+/Ca2+ 
exchanger. However, the presence of ouabain significantly inhibited the H2O2-
induced vasorelaxation at concentrations up to 100 µM. At higher 
concentrations of H2O2 (1 mM), a biochemical assay demonstrated that the 
Na+/K+ pump was inhibited, possibly due to dysfunction of the  Na+/K+-pump 
(Elmoselhi et al., 1994; Kim & Akera, 1987). On the other hand, it was 
demonstrated in Chapter 6 that TRP channels may also play a role in the 
H2O2±induced vasorelaxation as 2-APB (non-selective TRPM and TRPC 
antagonist), SKF96365 (TRPC antagonist) and RN1734 (TRPV4 antagonist) 
but not Pyr3 (TRPC3 antagonist), significantly inhibited the H2O2±induced 
vasorelaxation. However, future studies involving more selective antagonists 
or siRNAs may be required. Furthermore, the signalling pathway of the H2O2±
mediated response was not examined in the present study. Therefore, the 
mechanism by which H2O2 alters TRP channel activity needs to be 
investigated. Nonetheless, previous studies using Rp-8-Br-cGMPS to inhibit 
SURWHLQ NLQDVH *Į 3.*Į LQ SRUFLQH FRURQDU\ DUWHULHV KXPDQ FRURQDU\
arterioles and mouse mesenteric arteries demonstrated that dimerization of the 
3.*Į SOD\V D UROH LQ WKH H2O2-induced vasorelaxation and hyperpolarization 
(Dou et al., 2012; Ohashi et al., 2012; Zhang et al., 2012a). In these studies, 
100 µM and 1 mM of H2O2 significantly increased the protein expression of 
PKG1 dimer (Dou et al., 2012; Zhang et al., 2012a). Due to the lack of effects 
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of ODQ on H2O2-induced vasorelaxation, Zhang et al. (2012) suggested that 
H2O2 acts on downstream signalling of sGC in human coronary arterioles. On 
the other hand, Ohashi et al. (2012) reported that the effect of Rp-8-Br-cGMPS 
is vascular bed dependent, where the PKG1Į SDWKZD\ RQO\ SOD\V D UROH LQ WKH
H2O2-induced vasorelaxation in mouse mesenteric arteries, but not aortae.  
In Chapter 4, different gassing conditions (95% O2/5% CO2 or 95% 
air/5% CO2) on bradykinin- and H2O2-induced vasorelaxation in PCAs from 
male and female pigs were examined as previous studies have demonstrated 
that low oxygen tension affects synthesis of NO and superoxide anions react 
readily with NO to form peroxynitrite (Kerr et al., 1999; Kim et al., 1993; 
Palmer et al., 1987). Chapter 4 demonstrated that when gassed with 
95%O2/5% CO2, Tiron®, a superoxide scavenger is likely to have converted 
VXSHUR[LGH JHQHUDWHG LQ WKH .UHEV¶-Henseleit solution into H2O2 and enhances 
the bradykinin-induced vasorelaxation in PCAs from both male and female 
pigs. Further Amplex Red assay confirmed the formation of H2O2 in the 
.UHEV¶-Henseleit buffer when gassed with 95%O2/5% CO2 in the presence of 
Tiron® independent of tissue. Hyperoxic gassing conditions may possibly be 
generating superoxide within the Krebs-Henseleit buffer and may affect in 
vitro pharmacological responses involving endothelium-dependent 
vasorelaxation. Therefore, in vitro organ studies involving reactive oxygen 
species should be interpreted with care. Gassing with 95% air/5% CO2 should 
preferably be used in organ bath studies as it is more physiological relevant. 
Furthermore, Chapter 4 demonstrated that gassing with 95% air/5% CO2 does 
not generate H2O2 in the Krebs-Henseleit buffer in the presence of Tiron®.  
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Chapter 5 explored the possibility of sex differences in the Nox-
generation of ROS pathway using Nox inhibitors, DPI, ML-171 and VAS2870 
as previous studies have reported greater oxidative stress in males compared to 
females (Brandes & Mugge, 1997; Ide et al., 2002; Kerr et al., 1999) and Nox 
is a source of superoxide generation in the endothelial cells (Shimokawa & 
Morikawa, 2005). In this chapter, inhibition of Nox with DPI and ML-171 
enhances while VAS2870 inhibited the EDH-type response only in PCAs from 
male, but not female pigs. This suggests that in vessels where the endothelial 
function of NO and PGI2 is compromised, the role of Nox-generated ROS was 
uncovered only in PCAs from males but not females. Western blot analysis in 
this chapter demonstrated that a higher level of Nox1 and Nox2 proteins are 
expressed in PCAs from males compared to females. This may underlie the 
greater oxidative stress observed in men, whereby increased ROS production 
through Nox1 and Nox2 leads to a reduction in the EDH-type response. 
Putting together the results from Chapter 2 and Chapter 5, the present study 
demonstrated sex differences in the different pathways involved in the EDH-
type mediated response where IKCa and gap junctional communications are 
involved in PCAs from females while the Nox-generated ROS only plays a 
role in the EDH-type response in males. However, given the possibilities that 
ML-171 or VAS2870 may have non-selective effects on different Nox 
isoforms, future studies using siRNAs selective for Nox1 and Nox4 may be 
required for further verifications. Furthermore, as discussed in Chapter 1, 
Nox4-generated ROS may exert both protective (Ray et al., 2011) and 
detrimental (Kleinschnitz et al., 2010) effects depending on the species or 
vascular bed of study. Therefore, future studies involving in vivo work may 
249 
 
provide information about the overall effect on different vascular bed. 
Whereas, as for the opposing effects of VAS2870 observed in the present 
study compared to a previous study in mice where treatment with VAS2870 
after ischaemia improve neurological functions (Kleinschnitz et al., 2010), 
further studies involving vessels from human subjects of specified sex may be 
required.  
Having demonstrated sex differences in oxidative stress in endothelial 
function in Chapter 5 and sex differences in the role of gap junctional 
communication and IKCa channels in the EDH-type response in Chapter 2, 
Chapter 6 examined if there are any sex differences in the role of TRP 
channels in PCAs. TRPC and TRPV4 channels have previously been reported 
as mediators of oxidative stress in porcine aortic endothelial cells and human 
coronary arteries (Balzer et al., 1999; Bubolz et al., 2012; Poteser et al., 2006). 
In PCAs, TRPC3 channels have been reported to be involved in NO release 
(Huang et al., 2011) whereas in rat mesenteric arteries, TRPC3 channels have 
been reported to be highly expressed in the internal elastic lamina holes in 
close proximity with MEGJs and IKCa channels (Senadheera et al., 2012). 
Similarly in rat cremaster arterioles, TRPV4 channels and IKCa channels have 
been reported to cluster within the endothelial cell projection microdomain 
(Bagher et al., 2012). In the present study, Chapter 6 demonstrated sex 
differences in the role of TRPC3 and TRPV4 channels in the bradykinin-
induced vasorelaxation, where TRPC3 plays a role in the NO- and EDH-type 
response in PCAs from male pigs only, whereas TRPV4 plays a role in the 
NO-mediated response in PCAs from female pigs only. However, the 
differences in the bradykinin-induced vasorelaxation were not attributed to the 
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differential expression of TRPC3 or TRPV4 proteins. As discussed in Chapter 
6, it is possible that the bradykinin-induced NO release which is more 
prominent in males (Chapter 2) is affected by endothelial TRPC3 channels. 
Whereas in the EDH-type vasorelaxation, TRPC3 channels could have been 
activated by ROS (Balzer et al., 1999) in PCAs from males only as previous 
studies and Chapter 5 of the present study have demonstrated greater oxidative 
stress in males compared to females (Brandes & Mugge, 1997; Ide et al., 
2002). As for the role of TRPV4 in the bradykinin-induced vasorelaxation 
observed only in PCAs from females, it is possible that activation of the 
TRPV4 channels stimulates the production of ROS (Bubolz et al., 2012). 
Chapter 2 demonstrated that H2O2 plays a role only in PCAs from female pigs, 
therefore inhibition of TRPV4 channels could have reduced the production of 
endogenous H2O2. For further confirmation, again use of siRNA selective for 
TRPC3 and TRPV4 may be required. Furthermore, immunohistochemical 
studies to detect the distributions of these channels may provide further 
understanding of the roles of these channels in the vessels.  
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7.2 Seasonal variations in the EDH-type vasorelaxation 
In general, although Figure 2.7A in Chapter 2 clearly demonstrated a greater 
EDH-type response in PCAs from females compared to males, it was noted 
that the EDH-type response varied from ~45% to 100% throughout the study. 
Here, the EDH-type response induced by bradykinin (Figure 7.1 A and B) or 
A23187 (Figure 7.2) in PCAs from male and female pigs appeared to be 
greater during summer compared to winter. It is therefore possible that there 
are seasonal variations in the EDH-type responses in the PCAs. Interestingly, a 
population based human study reported a significant seasonal variation of 
sudden death related to cardiovascular disease, particularly in patients over 65 
(Arntz et al., 2000). The number of sudden death events occurred highest 
during winter months (December to February, n = 6493) and lowest during 
summer months (June to August, n = 5472) (Arntz et al., 2000). Here, the 
seasonal variations in the cardiovascular events could possibly be related to the 
vitamin D status through exposure to sunlight during summer, however further 
work measuring serum vitamin D levels during different seasons may be 
required. A previous study in haemodialysis patients reported that the risk of 
sudden cardiac death events in patients with severe vitamin D deficiency is 3-
fold higher than those with sufficient vitamin D levels (Drechsler et al., 2010). 
In an animal study, the mean arterial pressure and heart rate were significantly 
higher in vitamin D deficient male and female rats (Tare et al., 2011). Further 
vascular functional studies in these rat mesenteric arteries demonstrated 
endothelial dysfunction in vitamin D deficient male and female rats (Tare et 
al., 2011).  
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Figure 7.1 Seasonal variations in the bradykinin-induced EDH-type response 
in porcine coronary arteries from (A) male and (B) female pigs. Data are 
expressed as a percentage change from U46619-induced tone and are mean ± 
S.E.M. of 9-16 experiments (Figures compiled from Chapters 2 - 6).  
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Figure 7.2 Seasonal variations in the A23187-induced EDH-type response in 
porcine coronary arteries from male pigs. Data are expressed as a percentage 
change from U46619-induced tone and are mean ± S.E.M. of 6-8 experiments 
(Figure taken from Chapter 6).  
 
Despite the fact that each set of data has been compared with their 
internal contemporaneous control and sex differences in the role of MEGJs, 
IKCa channels, Nox-generated ROS and TRP channels have been demonstrated, 
limitations of the present study include the possibility of seasonal variation in 
the roles of these protein channels or Nox-generated ROS. Apart from that, 
oestrus cycle of the female pigs was not documented. However, this could also 
be a good representation of a randomised population group study and future 
work involving human arteries may be required due to the possibility of 
variations in species or vascular bed of study (Feletou & Vanhoutte, 2006). 
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7.3 Conclusions 
 The present study demonstrated clear sex differences in the endothelial 
function in PCAs and examined the effects of different gassing conditions 
(95% oxygen vs 95% air) on bradykinin-induced vasorelaxation in PCAs from 
male and female pigs. This study also investigated the mechanism of action of 
H2O2±induced vasorelaxation in PCAs, specifically the role of different K+ 
channels. Chapter 2 demonstrated greater EDH-type response in PCAs from 
females compared to males and showed that H2O2 plays a role in the 
bradykinin-mediated response only in female pigs. Chapter 2 further 
demonstrated sex differences in the entity which regulates the EDH-type 
responses where MEGJs and IKCa play a role in the bradykinin-induced 
vasorelaxation in PCAs from female but not male pigs.  
Chapter 3 demonstrated a possible role for the sodium-pump in H2O2±
induced vasorelaxation in PCAs, however further study involving the 
signalling pathway of H2O2 remains to be elucidated. Chapter 4 established 
that hyperoxic gassing conditions generated superoxide in the .UHEV¶-Henseleit 
buffer, which was then converted to H2O2 in the presence of Tiron® and 
subsequently enhanced the bradykinin-induced vasorelaxation. Chapter 5 and 6 
further demonstrated sex differences in the endothelial function where 
oxidative stress plays a greater role in the EDH-type response in PCAs from 
male pigs which may possibly influenced the role of TRPC3 channels in 
bradykinin-induced response only in PCAs from male pigs. On the other hand, 
the role of H2O2 in PCAs from female pigs could be associated with 
endothelial TRPV4 channels. Therefore, gender-specific drug treatment may 
represent a potential strategy in the treatment for cardiovascular diseases. 
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A. List of buffers and chemicals used for Western Blot 
1. Lysis buffer 
  Concentration 
Tris 20 mM 
EGTA 1 mM 
Sucrose 320 mM 
Triton X100 0.1% 
Sodium fluoride 1 mM 
ȕ-glycerophosphate 10 mM 
pH to 7.6  
Table 1 List of materials in lysis buffer. 
2. MAPK homogenisation buffer 
  Concentration 
6RGLXP ȕ-glycerophosphate 80 mM 
Imidazole 20 mM 
Dithiothreitol 1 mM 
Sodium fluoride 1 mM 
pH to 7.6  
Table 2 List of materials in MAPK homogenisation buffer. 
3. Tris-buffered saline containing 0.1% Tween 20 (TBS-T) 
  Concentration 
Tris 25 mM 
NaCl 125 mM 
Tween 20 0.1% 
pH to 7.6  
Table 3 List of materials in TBS-T. 
4. 6x solubilisation buffer 
  Concentration   
24% SDS 4% 2.4 g 
30% Glycerol 5% 3 mL 
ɴ-mercaptoethanol 5% 3 mL 
2.5% BPB 0.01% 240 µL 
1.5 M Tris-HCl 0.0625 M 2.5 mL 
Make up to 10 mL (Store at -20C)  
Table 4 List of materials in 6x solubilisation buffer. 
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5. Protease Inhibitor Cocktail Set I (Calbiochem) 
Product Concentration Target protease 
AEBSF hydrochloride 500 µM Serine proteases 
Aprotinin, bovine lung, 
crystalline 
150 nM Serine proteases and 
esterases 
E-64 Protease inhibitor 1 µM Cysteine proteases 
EDTA, disodium 0.5 mM Metalloproteases 
Leupeptin, hemisulfate 1 µM Cysteine  and trypsin-like 
proteases 
Table 5 List of materials in protease inhibitor cocktail Set I  
6. 10X electrophoresis buffer 
Tris 30.3 g 
Glycine 144 g 
Dissolve in dH2O 8 L 
Add methanol  2 L 
Store at 4°C  
Table 6 List of materials in 10X electrophoresis buffer  
7. Transfer buffer 
Tris 30.3 g 
Glycine 144 g 
SDS 10 g 
Make up to 1 L in dH2O 
Table 7 List of materials in transfer buffer  
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B. Method development for Western Blot in Chapter 2 
1. Connexin 43 (C8093 Sigma-Aldrich, Poole, Dorset, UK) 
 
Figure 1 Western blot analysis of connexin 43 protein for three different PCAs 
samples at 20 µg, 10 µg and 5 µg of protein concentration detected using 
rabbit polyclonal anti-Cx43 antibody (1:1000) from Cell Signalling blocked 
with 1.5% fish skin gelatine. Multiple bands were detected with no band 
detected at the molecular weight of Cx43 (~43 kDa). 
 
 
Figure 2 Western blot analysis of connexin 43 protein for three different PCAs 
samples at 5 µg, 10 µg and 15 µg protein concentration using mouse 
monoclonal anti-Cx43 antibody (1:1000) from Sigma-Aldrich (lot no. of 
080M4846) with 1.5% fish skin gelatine as blocking agent. Multiple bands 
were detected with strong band detected at the correct molecular weight (~43 
kDa). Last two lanes were incubated with blocking agent in the absence of 
primary antibody.  
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Figure 3 Western blot analysis of connexin 43 (43 kDa) protein in PCAs from 
female (S2-S4) and male pigs (M1-M3) with the first six lanes loaded with 5 
µg protein and the last five lanes with 2.5 µg protein concentrations. Using 5% 
milk as blocking agent, Cx43 proteins were incubated with anti-Cx43 antibody 
(1:1000) (green band) from Sigma-Aldrich (lot no. of 080M4846) and rabbit 
monoclonal anti-GAPDH antibody (36 kDa) (1:20,000) (red band). 
 
 
 
Figure 4 Western blot analysis of connexin 43 (43 kDa) protein using 5% milk 
as blocking agent, incubating blot with anti-Cx43 antibody (1:1000) from 
Sigma-Aldrich (lot no. 080M4846) in 2.5µg PCAs from female (F1-F4) and 
male pigs (M1.1-M1.4). In an attempt to analyse the protein concentration 
between male and female PCAs, three bands were detected instead of one band 
(as specified by the manufacturer). A replacement antibody from a different 
batch was subsequently tested (lot no. 052M4834). 
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Figure 5 Western blot analysis comparing expression level of Cx43 in 5 µg of 
PCAs from male (M1.5-M1.9) and female (F5-F9) pigs using a different batch 
of Cx43 antibody (lot no. 052M4834) (1:1000) and MLC (1:1000). Samples 
(not previously gassed) were homogenized in freshly prepared lysis buffer 
without triton-X. Results could not be analysed as a strong band was observed 
at 50 kDa instead of 43 kDa and MLC as the loading control band was too 
faint. A higher concentration of MLC antibody was used in further study.  
 
 
Figure 6 Western blot analysis comparing two different batches of Cx43 
antibody (1:1000) from Sigma-Aldrich using the same PCAs samples from 
male (M1.1-M1.4) and female (F1-F4, 2C-4C) pigs (6 µg proteins). Samples 
2C-4C (homogenised in MAPK lysis buffer) were samples previously gassed 
with 95% O2 at 37°C for other studies while the remaining samples were finely 
dissected tissues and stored at -80°C until further use. Here, comparing the 
results of the first batch of antibody (lot no. 080M4846) (A) with the 
replacement antibody (lot no. 052M4834) (B) demonstrated that the first batch 
of antibody detected one extra band at 37 kDa. Results also demonstrated that 
previously gassed samples (2C-4C) do not display the 50 kDa bands. 
Therefore, using the replacement antibody, further studies using PCAs samples 
treated under different conditions were conducted.  
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Figure 7 Western blot analysis comparing samples homogenised in different 
lysis buffer using 5 µg PCAs from female pigs incubated overnight with Cx43 
antibody (lot no. 052M4834) (1:1000) and MLC (1:500) (18 kDa). Samples 
(F10-F12) were homogenized in freshly prepared MAPK lysis buffer while 
samples F8 and F9 were same samples as Figure 8.5. Strong band was still 
detected at 50 kDa and no differences were observed between samples 
homogenised in different lysis buffer.  
 
Figure 8 Western blot analysis comparing samples prepared under different 
conditions using 5 µg PCAs from female pigs incubated overnight with Cx43 
antibody (lot no. 052M4834) (1:1000) and MLC (1:500) (18 kDa). F12 and S4 
were previously used sample as above while F13&F13G and F14&F14G are 
samples from the same PCAs. F13G and F14G were gassed with 95%O2 at 
37°C in the myograph subjected to tension, KCl, U46619 and bradykinin and a 
single band was form at ~43 kDa.  
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A1/B1 - No tension (at 37°C with 95%O2) 
A2/B2 - Tension (at 37°C with 95%O2) 
A3/B3 - RT with 95%O2 
A4/B4 - RT without oxygen 
A5/B5 - fresh tissue finely dissected on the same day of delivery then stored at -80°C 
 
Figure 9 Western blot analysis comparing samples prepared under different 
conditions as described above using 5 µg PCAs from female pigs incubated 
overnight with Cx43 antibody (lot no. 052M4834) (1:1000) and MLC (1:500) 
(18 kDa). Samples A1-A5 and B1-B5 were from the same PCA. Samples A1-
A4 and B1-B4 were samples stored overnight at 4°C in ZY)LFROO .UHEV¶-
Henseleit solution. 
 
C1/D1 ± Gas with 95% nitrogen at 37°C 
C2/D2 - No gas at 37°C 
C3/D3 - Gas with 95% O2 at 37°C 
C4/D4 ± 1000 UmL-1 catalase 
C5/D5 ± 1mM Tiron® 
 
Figure 10 Western blot analysis comparing samples prepared under different 
conditions as described above using 5 µg PCAs from female pigs incubated 
overnight with Cx43 antibody (lot no. 052M4834) (1:1000) and MLC (1:500) 
(18 kDa). No band was observed at 50 kDa.  
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2. Connexin 40 (ab38580 Abcam®, Cambridge, UK) 
 
Figure 11 Western blot analysis of Cx40 protein blocked with 1.5% fish skin 
gelatine, incubated with Cx40 antibody (1:500) (40 kDa) overnight with three 
different PCAs samples (5-20 µg protein). A strong band at about 40 kDa was 
observed with 20 µg protein, therefore further experiments were conducted 
using 20 µg of PCAs samples.  
 
Figure 12 Western blot analysis of Cx40 protein blocked with either 5% milk 
or 1.5% fish skin gelatine, with or without primary antibody (1:100) with 20 
µg protein. The band slightly below 37 kDa is a non-specific band produced by 
the secondary antibody, IRDye® 680LT Goat anti-rabbit IgG.  
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Figure 13 Western blot analysis of Cx40 protein blocked with either 5% milk 
or 1.5% fish skin gelatine, with or without primary antibody (1:100) with 20 
µg PCA proteins detected using IRDye® 800CW Donkey anti-rabbit IgG 
(secondary antibody). 5% milk appears to be a better blocking agent compared 
to fish skin gelatine, therefore further experiments were blocked with 5% milk.  
 
Figure 14 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with Cx40 antibody (1:100) using 5 µg human placenta (HP) lysate 
as positive control and 5 µg PCA samples from females prepared in different 
lysis buffer (F1-F2 lysis buffer, F10-F12 MAPK lysis buffer). Here, a lower 
concentration of protein was used to minimise detection of multiple bands. 
However,  only a very faint band was detected at ~40 kDa, therefore 
subsequent experiments were conducted with higher concentration of protein.   
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Figure 15 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with Cx40 antibody (1:100) using 10 or 20 µg human placenta (HP) 
or pig brain lysates as positive controls and 20 µg PCAs samples from female 
pigs (F1). A faint band was detected at ~40 kDa in PCA sample and a strong 
band was detected in 20 µg pig brain lysate. 
 
Figure 16 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with or without Cx40 antibody (1:100) (top half of the blot) using 20 
µg pig brain lysate as positive control and 25 µg PCA samples from male 
(M1.10-M1.12) and female (F15, F17, F19) pigs. Lower half of the blot was 
incubated with MLC (1:1000) as the loading control. MLC bands detected 
were too strong, therefore lower concentration of MLC antibody was used in  
subsequent experiements. In the absence of Cx40 primary antibody, the band 
at 40 kDa was not detected.  
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Figure 17 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with Cx40 antibody (1:100) (top half of the blot) using 20 µg pig 
brain lysate (PB) as positive control and 15 µg PCAs samples from male 
(M1.10-M1.14) and female (F15 - F19) pigs. Lower half of the blot was 
incubated with MLC (1:3000) as the loading control. No MLC band was 
detected in pig brain lysate, therefore GAPDH was used as loading control for 
subsequent experiments. 
 
 
 
 
 
 
Figure 18 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with Cx40 antibody (1:100) (40 kDa) and GAPDH (1:40,000) (36 
kDa) (A) using 20 µg pig brain (PB), pig heart membrane (PHM) and pig 
kidney (PK) lysates as positive controls and 5-20 µg PCAs samples from 
female pigs. MLC (1:3000) (18 kDa) used as loading control (B) was not 
detected in PB, PHM and PK samples. PCA samples in this blot were 
normalised to 1 mg/mL. 
 
 
 
Figure 19 Western blot analysis of Cx40 protein blocked with 5% milk, 
incubated with Cx40 antibody (1:100) (40 kDa) and GAPDH (1:40,000) (36 
kDa) using 20 µg pig heart membrane (PHM) lysate as positive control and 10 
µg PCAs samples from male (M1.16-M1.19) and female (F20-F24) pigs. PCA 
samples in this blot were normalised to 1 mg/mL. 
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3. Connexin 37 (C15878 Assay Biotech, Stratech Scientific Limited, 
Suffolk, UK) 
 
Figure 20 Western blot analysis of Cx37 protein blocked with 5% milk, 
incubated with Cx37 antibody (1:500) (37 kDa) using rat heart lysate (1-5 µg) 
as positive control (first three lanes) and  PCAs samples from female (5-20 µg) 
(F1) pigs (last three lanes). 
 
 
Figure 21 Western blot analysis of Cx37 protein blocked with 5% milk, 
incubated with Cx37 antibody (1:500) (37 kDa) using 1µg rat heart (RH), 20 
µg pig kidney (PK), pig brain (PB) and pig heart membrane (PHM) lysates as 
positive controls and 20 µg of PCA samples from female (F1) pigs. 
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Figure 22 Western blot analysis of Cx37 protein blocked with 5% milk, 
incubated with Cx37 antibody (1:500) (37 kDa) using 20 µg pig kidney (PK) 
lysate as positive control and 20 µg of PCA samples from male (M1.10-
M1.14) and female (F15-F19) pigs with MLC (18 kDa) (1:5000) as the loading 
control (lower half of the blot). Cx37 protein was not detected in the PCA 
samples from both male and female pigs. 
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4. Intermediate conductance calcium-activate potassium channel (IKCa) 
(H00003783-B01P Abnova, Taipei, Taiwan) 
 
 
Figure 23 Western blot analysis of IKCa protein blocked with 5% milk, 
incubated with IKCa antibody (1:500) (47.7 kDa) using  different concentration 
of pig kidney (PK) lysate (5-25 µg) as positive control in the first three lanes 
and PCA samples from female (F1) (5-25 µg) pigs.  
 
Figure 24 Western blot analysis of IKCa protein blocked with 5% milk, 
incubated with IKCa antibody (1:500) (47.7 kDa) using 10 µg pig kidney (PK) 
lysate as positive control and 25 µg PCAs samples from male (M1.10-M1.14) 
and female (F15-F19) pigs. Concentration of MLC antibody (1:1000) used as 
loading control (lower half of the blot) was too high.   
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Figure 25 Western blot analysis of IKCa protein blocked with 5% milk, 
incubated with IKCa antibody (1:250) (47.7 kDa) using 10 µg pig kidney (PK) 
lysate as positive control and 15 µg PCA samples from male (M1.10-M1.14) 
and female (F15-F19) pigs. MLC antibody (1:3000) was used as a loading 
control (lower half of the blot).   
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C. Method development for Western Blot in Chapter 5  
1. NADPH-oxidase 1 (ab55831 & ab137603 Abcam®, Cambridge, UK) 
 
Figure 26 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with Nox1 antibody (ab55831 Lot GR132883-1) (1:1000) (65 kDa) 
using 10 µg pig heart membrane (PHM) lysate as positive control and 5-20 µg 
PCA samples from male (M1.13) pig. No band was dectected on the blot, 
further experiment with different positive controls and different secondary 
antibody was used.  
 
Figure 27 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with Nox1 antibody (ab55831 Lot GR132883-1) (1:1000) (65 kDa) 
using 10 µg pig heart (PH) and 15 µg pig lung (PL) lysates as positive controls 
and 10-20 µg PCAs samples from male pigs. Nox1 protein band was not 
detected on the blot (absence of green band - IRDye® 800CW Goat anti-rabbit 
IgG) while ȕ-actin used as loading control (42 kDa) (red band- IRDye® 680LT 
Goat anti-mouse IgG) was detected.  
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Figure 28 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with Nox1 antibody (ab55831 Lot GR132883-1) (1:500 or 1:250) 
(65 kDa) using samples homogenised in different lysis buffer. 15 µg pig lung 
(PL) lysate was used as positive control and 15 µg PCA samples from male 
pigs were loaded onto gel. PCAA and PLA samples were homogenised in 20 
mM Tris-HCl, 50 mM NaCl, 0.1% Triton X-100, 3 mM EGTA buffer (Xie et 
al., 2012) while PCA and PL samples were homogenised in lysis buffer (Table 
8.1). Again, Nox1 protein band was not detected on the blot (absence of green 
band).  
 
 
Figure 29 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with Nox1 antibody (ab55831 Lot GR132883-1) (1:250, 1:500 or 
1:1000) (65 kDa) using 10µg pig lung (PL) and 12 µg mouse colon (MC) 
lysates as positive controls and 15-20 µg PCA samples from male pigs. Nox1 
SURWHLQ EDQGZDVQRW GHWHFWHGDEVHQFHRIJUHHQ EDQGZKHUHDV ȕ-actin 
(1:100,000) (42 kDa) used as loading control (red band) was detected on the 
blot.  
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Lane 1 marker 
Lane 2 male PCA (60 µg) 
Lane 3 male PCA (60 µg) 
Lane 4 male PCA (60 µg) same lysis buffer as Xie et al., (2012) (Xie et al., 2012)  
Lane 5 Pig Lung (60 µg) same lysis buffer as Xie et al., (2012) 
Lane 6 Pig Lung (60 µg) 
Lane 7 Pig Brain (20 µg) 
Lane 8 Pig Heart (60 µg) 
Lane 9 HL60 (20 µg) 
Lane 10 Calu3 (15 µg) 
Lane 11HepG2 (15 µg) 
Lane 12 Mouse Colon (37 µg) 
 
Figure 30 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with two different batches (A Lot GR76500-4 & B Lot GR76500-5) 
of Nox1 replacement antibodies (ab55831) (1:500) (65 kDa) using samples 
listed as above. Nox1 protein band was not detected in both blots (absence of 
green band - IRDye® 800CW Goat anti-rabbit IgG) whereas red bands detected 
were non-specific bands from the secondary antibody (IRDye® 680LT Goat 
anti-mouse IgG). 
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Lane 1 male PCA (20 µg) 
Lane 2 male PCA (15 µg) 
Lane 3 mouse colon (30 µg) 
Lane 4 Calu3 (15 µg) 
Lane 5 HepG2 (15 µg) 
Lane 6 pig lung (15 µg) 
Lane 7 marker 
Lane 8 male PCA (20 µg) 
Lane 9 male PCA (15 µg) 
Lane 10 mouse colon (30 µg) 
Lane 11 Calu3 (15 µg) 
Lane 12 HepG2 (15 µg) 
 
Figure 31 Western blot analysis of Nox1 protein blocked with 5% milk, 
incubated with a different Nox1 antibody (~65 kDa) (ab137603) in two 
different dilution (1:500 or 1:1000) using a range of positive controls as listed 
above.  
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2. NADPH-oxidase 2 (sc-20782 Santa Cruz Biotechnology, Insight 
Biotechnology Ltd, Wembley, Middlesex, UK) 
 
Figure 32 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with Nox2 antibody (1:500)(~60 kDa) using 10µg pig brain (PB) 
and pig heart membrane (PHM) lysates as positive controls and PCA from 
male pig (M1.13) (5-20 µg).  
 
 
Figure 33 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with Nox2 antibody (1:500)(~60 kDa) using 10 µg pig brain (PB) 
and pig heart (PH) lysates as positive controls and PCA from male pig (M1.13) 
(10-25 µg). A single Nox2 band (~60 kDa)  was detected in the pig brain lysate 
(green band) and only a very faint band was detected in the PCA samples. ȕ-
actin band used as loading control (42 kDa) (1:40,000) was too strong, 
therefore further dilution to 1:100,000 was used in subsequent experiments.  
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Figure 34 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with  Nox2 antibody (1:500)(~60 kDa) using 10 µg pig brain (PB) 
lysate as positive control and 15 µg PCAs from male pigs homogenised in 
different lysis buffer (same samples as Figure 8.28). 
 
 
Figure 35 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with Nox2 antibody (1:500)(~60 kDa) using 10µg pig brain (PB) 
lysate as positive control and 15 µg PCAs from five male (MA- ME) and five 
female (FA- FE) pigs. ȕ-actin (1:100,000) (42 kDa) was used as a loading 
FRQWURO UHGEDQG$VRQHRI WKHȕ-actin bands (FD) appears thinner than the 
others, Western Blot was repeated with more PCA samples from female pigs. 
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Figure 36 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with Nox2 antibody (1:500)(~60 kDa) using 10 µg pig brain (PB) 
lysate as positive control and 15 µg (first 5 lanes) or 20 µg (last 5 lanes) PCAs 
from five female pigs (FF- FJ). ȕ-actin (1:100,000) (42 kDa) was used as a 
loading control (red band).  
 
 
Figure 37 Western blot analysis of Nox2 protein blocked with 5% milk, 
incubated with Nox2 antibody (1:500)(~60 kDa) using 10 µg pig brain (PB) 
lysate as positive control and 15 µg PCAs from five male (MF- MJ) and five 
female (FF- FJ) pigs. ȕ-actin (1:100,000) (42 kDa) was used as a loading 
control (red band).  
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3. NADPH-oxidase 4 (ab109225 Abcam® Cambridge, UK) 
 
Figure 38 Western blot analysis of Nox4 protein blocked with 5% milk, 
incubated with Nox4 antibody (ab109225) (1:500 or 1:1000)(~63 kDa) using 
15 µg HEK cells, pig kidney (PK), pig brain (PB) and rat kidney (RK) lysates 
as positive controls and 15-20 µg PCA from male pig.  
 
 
Figure 39 Western blot analysis of Nox4 protein blocked with 5% milk, 
incubated with Nox4 antibody (1:1000)(~63 kDa) using 15 µg pig brain (PB) 
lysate as positive control and 20 µg PCAs from five male (MA- ME) and five 
female (FA- FE) pigs. ȕ-actin (1:100,000) (42 kDa) was used as a loading 
control (red band). ȕ-actin band in FH sample was not clearly detected, 
therefore Western blotting for the same samples were repeated.  
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Figure 40 Western blot analysis of Nox4 protein blocked with 5% milk, 
incubated with Nox4 antibody (1:1000)(~63 kDa) using 15µg pig brain (PB) 
lysate as positive control and 20 µg PCAs from five male (MA- ME) and five 
female (FA- FE) pigs. ȕ-actin (1:100,000) (42 kDa) was used as a loading 
control (red band). 
 
 
Figure 41 Western blot analysis of Nox4 protein blocked with 5% milk, 
incubated with Nox4 antibody (1:1000)(~63 kDa) using 15µg pig brain (PB) 
lysate as positive control and 20 µg PCAs from five male (MF- MJ) and five 
female (FF- FJSLJV ȕ-actin (1:100,000) (42 kDa) was used as a loading 
control (red band) 
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D. Method development for Western Blot in Chapter 6  
1. TRPC3 (ACC-016) (Alomone Labs, Jurusalem, Israel)  
 
Figure 42 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (1:200)(~100 kDa) using 2.5-5 µg rat heart 
lysate as positive control and 5-20 µg PCA from female pig (F1).  
 
 
Figure 43 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (1:200)(~100 kDa) using 10-20 µg rat heart 
membrane and pig heart membrane (PHM) lysates as positive controls and 20-
40 µg PCAs from female pigs. Multiple bands were detected in all samples, 
but in an attempt to compare the TRPC3 protein expression level between 
males and females, subsequent experiments focused on the top half of the blot 
as the molecular weight of TRPC3 is ~100 kDa.  
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Figure 44 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (1:200)(~100 kDa) using 20 µg pig brain 
(PB), pig heart membrane (PHM) and pig kidney (PK) lysates as positive 
controls and 5-20 µg PCA from female pig.  
 
 
Figure 45 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (1:200)(~100 kDa) (A) using 10 µg PCAs 
from male and female pigs with GAPDH (36 kDa) as the loading control (red 
band) (B). A double band appear slightly below 100 kDa but density of the 
band cannot be determined as they were too close together. With 84% 
sequence identities between TRPC3 and TRPC6 proteins, it is possible that the 
antibody is picking up TRPC3 (97.2 kDa) and TRPC6 (103 kDa) protein 
bands.  
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Figure 46 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (1:200)(~100 kDa) (A) using 20 µg pig heart 
membrane (PHM) and pig kidney (PK) lysates as positive controls and 10 µg 
PCAs from male and female pigs with GAPDH as the loading control (B). 
Density of TRPC3 expression level cannot be determined due to the close 
proximity of the double band at ~100 kDa. 
 
2. TRPC3 (ab70603) (Abcam®, Cambridge, UK) 
 
 
Figure 47 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (ab70603 Lot 960430) (1:1000)(~100 kDa) 
using 15 µg pig brain (PB), pig heart (PH), pig heart membrane (PHM) and 10 
µg SHSY-5Y cell lysates as positive controls and 10 and 20 µg PCA from 
male pig (MF). Only a single band (~75 kDa) was detected in pig brain 
samples. 
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Figure 48 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (both ab70603 Lot 960430) (1:1000)(~100 
kDa) using 15 µg pig brain (PB), pig heart (PH) and 10 µg SHSY-5Y cell 
lysates as positive controls and 10, 15, 20 µg PCA from male pig (MC). Only a 
single band (~75 kDa) was detected in pig brain samples. Replacement 
antibody was requested as the first batch was delivered over the weekend 
(could have been stored at room temperature). 
 
 
 
 
 
Figure 49 Western blot analysis of TRPC3 protein blocked with 5% milk, 
incubated with TRPC3 antibody (ab70603 Lot 960430) (1:250 and 1:500 
dilutions)(~100 kDa) using 35 µg pig brain (PB), 35 and 60 µg  pig heart (PH) 
and 20 µg SHSY-5Y cell lysates as positive controls and 20 and 35 µg PCA 
from male pig (MG). GAPDH (1:40 000) was used as loading control. Multiple 
bands were detected in pig tissue samples.  
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3. TRPV4 (ab94868) (Abcam®, Cambridge, UK) 
 
 
Figure 50 Western blot analysis of TRPV4 protein blocked with 5% milk, 
incubated with TRPV4antibody (1:1000)(~100 kDa) using 15 µg pig brain 
(PB), pig pancreas artery (PPA) and pig heart (PH) lysates as positive controls 
and 10 and 15 µg PCA from female pig (FD).  
 
 
Figure 51 Western blot analysis of TRPV4 protein blocked with 5% milk, 
incubated with TRPV4antibody (1:1000)(~100 kDa) using J KXPDQ ȕ-cell 
lysates as positive control and 15 µg PCA from female and male pigs. ȕ-actin 
(1:100,000) (42 kDa) was used as a loading control (red band). 
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Figure 52 Western blot analysis of TRPV4 protein blocked with 5% milk, 
incubated with TRPV4 antibody (1:1000)(~100 kDa) using J KXPDQ ȕ-cell 
lysates as positive control and 15 µg PCA from female and male pigs. GAPDH 
(1:40,000) (36 kDa) was used as a loading control (red band). 
 
 
 
Figure 53 Western blot analysis of TRPV4 protein blocked with 5% milk, 
incubated with TRPV4 antibody (1:1000)(~100 kDa) using J KXPDQ ȕ-cell 
lysates as positive control and 15 µg PCA from female and male pigs. GAPDH 
(1:40,000) (36 kDa) was used as a loading control (red band). 
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